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Summary        Alice Elizabeth Mary Rees 
Investigating the role of the IP3 signalling pathway in the regulation of RNA interference in          
C. elegans 
 Both inositol 1,4,5-trisphosphate (IP3) mediated signalling and RNA interference are 
widespread processes with fundamental roles in animal cell function.  In the nematode C. elegans 
these two pathways have been shown to intersect such that IP3 signalling mutants display an altered 
exogenous RNAi response.  IP3 is a key second messenger in the transduction of intracellular signals. 
Produced by the hydrolysis of membrane phospholipid PIP2 by phospholipase C (PLC), IP3 triggers 
Ca2+release from internal stores by binding to the IP3 receptor, a ligand gated calcium channel in the 
ER, thus triggering downstream calcium signalling pathways.  It has been previously shown that loss 
of function in the IP3 receptor (ITR-1) or in PLCβ (EGL-8) results in an enhanced response to 
exogenous dsRNA, with a more robust silencing response than that seen in WT worms.  Conversely 
the potentiation of IP3 signalling by the loss of function IPP-5, a phosphatase which catalyses the 
hydrolysis of IP3, results in resistance to RNAi.   
 In order to better understand the context of the IP3 signalling events which are regulating the 
RNAi response I sought to identify the upstream activator of EGL-8 in this mechanism.  EGL-8 is 
canonically activated by Gαq homologue ELG-30.  However, by screening the RNAi responses of Gα 
signalling mutants using a range of assays, EGL-30 was ruled out as an activator of EGL-8 in the 
pathway regulating RNAi, since EGL-30 loss of function does not result in an enhanced RNAi 
response.  The Gαo/i homologue, GOA-1, was identified as the most likely activator of EGL-8 due to 
the strongly enhanced RNAi response in goa-1 loss of function mutants in a number of assays.  Other 
Gα subunits and known regulators of GOA-1 and EGL-30 signalling were also analysed.  
 The RNAi response is a multistep process in which the exogenous RNAi pathway must 
compete with the closely related and interlinked endogenous small RNA pathways for resources. 
With the aim of better understanding how changes in IP3 signalling might be influencing the RNAi 
response, small RNA sequencing was performed to look for evidence of change in the endogenous 
small RNA pathways of itr-1 mutants, and followed up with qPCR.  However, no substantial changes 
to the endogenous small RNA pathways were found.   
 Downstream of the production of primary siRNAs from exogenous dsRNA, separate 
argonautes mediate cytoplasmic and nuclear RNAi responses.  I utilised an established assay to test 
for effects of IP3 signalling on nuclear RNAi.  The results suggest no specific alterations to the nuclear 
RNAi pathway in these mutants. 
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Introduction 
 
1.1 C. elegans as a model organism 
 
C. elegans is a small free-living nematode which feeds on bacteria found in its natural habitat of 
decaying plant matter throughout the temperate and tropical regions (for a brief review of the 
natural history of C. elegans see (Félix and Braendle, 2010)).  Its small size, short generation time, 
ease of cultivation in the lab, transparency and convenient genetics are just a few of the reasons why 
it has become established as a popular model organism; used in the study of a range of biological 
processes since its popularisation as a genetic model by Sydney Brenner in the 1960s (summarised 
(Brenner, 2002)) .  
The lifecycle of C. elegans consists of 4 larval stages, L1-L4, and the reproductive adult stage, 
with the majority of the population consisting of self-fertilising hermaphrodites.  Under stress 
conditions, such as overcrowding and low food availability, or high temperature the L3 stage is 
replaced by a long lived, stress resistant dauer state characterised by an absence of feeding and 
morphological changes.  In the absence of food L1 worms can also enter diapause (see (Corsi et al., 
2015) for a summary of the lifecycle).  The timing of the lifecycle varies with temperature and 
between strains, but for the classical WT strain Bristol N2, at 20°C the time from hatching to egg 
laying is approximately 3 days in the absence of dauer or L1 diapause (Byerly et al., 1976) (see Figure 
1.1).  
The anatomy of C. elegans is simple, consisting of single layers of cuticle, hypodermis and 
body wall muscle surrounding a body cavity, intestine and gonad, with a simple pharynx in the head 
region leading into the intestine and a limited neuronal network (Figure 1.2)  The majority of body 
structure is identical between the male and hermaphrodite, with very few differences detectable 
before the L4 stage, although cell lineage differences giving rise to the sex specific structures (tail fan, 
lack of vulva, and lack of oocyte producing structures in male) are present (Sulston and Horvitz, 
1977)(Sulston and Horvitz, 1977)(Sulston and Horvitz, 1977) (Sulston and Horvitz, 1977; Sulston et al., 
1980).  Facultative males are produced as a result of random non-disjunction of the X chromosome 
during meiosis and occur at a rate of approximately 1:1000.  A self-fertilising hermaphrodite can 
produce about 300 offspring fertilised using stored sperm produced by the ovitestes in the L4 stage 
before switching to oocyte production, whilst a mated individual can produced up to 1000 (Corsi et 
al., 2015).  As a consequence of the low frequency of males and rarity of outcrossing events, within 
strain genetic variation is near null.  This is especially true in the lab but even in the wild out crossing 
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between locally adjacent populations appears to be minimal and genetic bottlenecks common 
(Barrière and Félix, 2005). 
 
Figure 1.1.  Life cycle of C. elegans at 22°C under standard conditions.  Image reproduced from Introduction to 
C. elegans anatomy (Altun, Z.F. and Hall, D.H. 2009. Introduction. In WormAtlas.).  
C. elegans development was found to be highly invariant, uniquely so among the model 
systems, making it a very powerful system to study cell fate.  This invariance combined with 
transparency and limited cell number made it possible for the entire embryonic and postembryonic 
lineage to be mapped (Sulston and Horvitz, 1977; Sulston et al., 1983).  The adult hermaphrodite 
consists of 949 somatic cells, each of a clearly defined type.  Despite its small size, low cell count and 
simple structure C. elegans contains a range of tissue types and displays a surprisingly complex 
behavioural repertoire.  The invariant development and relatively small number of 302 neurones 
made it possible for the entire neuronal map or connectome to be built using serial electron 
microscopy (White et al., 1986); a powerful tool to better understand nervous system development 
and function when coupled to the well-defined behavioural repertoire.  The mapping of the patterns 
of cell division and cell death in C. elegans together with a powerful genetic toolkit allowed for the 
molecular mechanisms of programmed cell death or apoptosis to be investigated and understood 
(reviewed in(Ellis et al., 1991)).   
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Figure 1.2. Anatomy of C. elegans: A- hermaphrodite, B- male, C- transverse cross section.  Image reproduced 
from (Corsi A.K., Wightman B., and Chalfie M.  A Transparent window into biology: A primer on Caenorhabditis 
elegans (June 18,2015), WormBook, ed. The C. elegans Research Community, WormBook, 
doi/10.1895/wormbook.1.177.1, http://www.wormbook.org.) 
 The power of C. elegans as a model organism also stems from a well-established genetic map 
and set of tools to enable genetic manipulation.  The diploid genome consists of 5 chromosomes plus 
the X chromosome (Brenner, 1974).  It was also the first animal for which an entire genome 
sequence was available.  The draft genome was completed in 1998 by the C. elegans sequencing 
consortium, paving the way for the Human Genome Project.  Despite its apparently simplistic 
anatomy and physiology and low cell count, the initial genome sequence revealed 19000 protein 
coding genes; roughly equivalent to the human genome and more than the fly Drosophila 
melanogaster (The C. elegans Sequencing Consortium, 1998). 
 One of the most significant discoveries made in C. elegans was that of RNA interference 
(RNAi)– gene silencing induced by dsRNA (Fire et al., 1998).  The potency, specificity and systemic 
nature of the response in C. elegans made it ideally suited to studies probing the mechanisms of 
RNAi.  As the mechanisms of RNAi became clearer so did the fact that the small antisense RNAs, 
which were identified as the causal agent (Hamilton and Baulcombe, 1999; Zamore et al., 2000), 
were one of several abundant classes of small silencing RNAs that formed an integral part of the 
endogenous gene regulatory systems; namely the small-interfering RNAs, microRNAs, and piwi-
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related RNAS.  The first genes encoding microRNAs had in fact already been identified from C. 
elegans lineage mutants (Lee et al., 1993; Reinhart et al., 2000; Wightman et al., 1993).  The 
discovery of RNA interference not only unleashed a powerful genetic technique but also precipitated 
a growing understanding of the mechanisms and roles of the small silencing RNAs. This has been 
accompanied by the realisation of their extent and importance in endogenous gene regulation and 
genome defence, not just in C. elegans but throughout the eukaryotic kingdom (reviewed in 
(Ghildiyal and Zamore, 2009; Moazed, 2009; Tabara et al., 1998; Zhuang and Hunter, 2012a)). 
 
1.2  Signal transduction 
 
In order to function efficiently a cell must regulate its behaviour depending on its 
environmental context. This ability is pivotal to the survival of all forms of life, from unicellular 
bacteria to multicellular organisms, where each cell has a highly specialised role and must work in 
concert with surrounding cells and respond appropriately to external environmental cues sensed by 
distant cells.  Effective cell-cell communication and transduction of signals within the cell is therefore 
crucial, as misinterpretation of a signal by the receiver could lead to aberrant and inappropriate cell 
activity (for a general discussion see (Marks et al., 2009, chapter 1)).  For a cell to respond to an 
external stimulus a signal must first be detected by the recipient cell.  Detection usually occurs at the 
cell surface membrane- the interface of the inner cell and the outside world- where a great diversity 
of cell surface receptors have evolved to detect a huge range of highly specific stimuli.   
The paradigm of the receptor consists of sensory, transmembrane and catalytic domains, 
with additional regulatory domains which fine tune the response.  Upon stimulation by the agonist a 
conformational change occurs in the receptor which transmits the signal from the substrate binding 
or sensory domain, across the cell membrane to intracellular catalytic domain of the receptor which 
brings about a change inside the cell, often a phosphorylation event.  This intracellular change in turn 
serves as a signal for the activation of further intracellular proteins; triggering a “signalling cascade” 
which transduces the signal via “second messengers” to effector proteins which bring about the 
response.  The same principles of receptors, transducers, and effectors is also used to transmit 
signals in response to internal stimuli (such as the metabolic state of the cell), using the same 
fundamental language of signal transduction: direct contact, conformational changes, 
phosphorylation events and small molecule second messengers.  At each stage along the signalling 
cascade the receiving party is interpreting and transducing the message.  Although the molecular 
changes seen in members of the signalling cascade are in many ways highly stereotyped the meaning 
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of the signal is highly context dependent, with meaning attributed to signal by the receiver, not 
inherent to the messenger (Marks et al., 2009). 
As would be expected, detection of a range of unique agonists requires a large repertoire of 
highly specific receptors, although the majority of this diversity is generated through slight variations 
of a few very common types of receptor, such as G-proteins coupled receptors or receptor tyrosine 
kinases; with large gene families and splice variants encoding receptors which have been adapted for 
each new need.  The same theme of re-use and adaptation can be seen in the diversity of molecules 
and proteins which are involved in signal transduction, with the same, protein types, small 
molecules, lipids and ions, being utilised again and again in signal transduction across and within the 
diversity of organisms.  In a few cases, such as the nuclear steroid hormone receptors, a single 
protein acts as both receptor, transducer and final effector.  However, the use of second messengers 
allows for amplification of the initial signal, as well as providing opportunities for integration and 
divergence of a single signal into a signalling network.  Multiple inputs can feed into the same second 
messenger, allowing for the integration of signalling information via coincidence detection, but also 
allowing for multiple outputs with parallel, synergistic, or independent signalling roles, as well as 
multiple stages of regulatory feedback.  The same second messenger is even commonly used within 
the same cell to respond to different stimuli - and yet specificity of outcome is not lost.  It follows 
that the context of the signal, rather than identity of the messenger itself must therefore be crucial 
to specificity.  Identity of the activator(s) and receiver(s), subcellular localisation, timing and spatio-
temporal pattering of the signal and cellular context and past exposures all shape the outcome of a 
signalling cascade.  It is also becoming increasingly apparent that cross talk between what were 
previously considered distinct pathways is commonplace (Hancock, 2010; Marks et al., 2009). 
 
1.2.i  Generating diversity and specificity in signalling- calcium signalling 
A perfect example of a second messenger being utilised over and over again to achieve a vast 
variety of different outcomes is Ca2+.  Ca2+ is a truly ubiquitous second messenger with a key role in 
the regulation of a vast number of cellular and physiological processes, ranging from immediate 
effects such as exocytosis and muscle contraction to longer term changes to the transcriptional 
profile and cell proliferation and development. With such a wide range of potential outcomes how is 
specificity and discrimination achieved, even when multiple calcium regulated processes co-occur in 
a single cell?  From an extensive toolkit of calcium signalling regulators, buffers, channels, pumps, 
effectors, transducers and receptors a highly specific combination of proteins and isoforms  are 
expressed and spatially localised in each cell type, influencing the spatio-temporal dynamics of the 
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production and amplification of the signal as well as the state and availability of the receiver 
(Berridge et al., 2003).  
Ca2+ is present in all parts of the cell but at carefully regulated concentrations. The 
cytoplasmic Ca2+   level is kept low, approximately 100nM in most cell types, whilst Ca2+ is stored at 
high concentration in subcellular compartments such as the endoplasmic reticulum and 
mitochondria.  External Ca2+ concentration is also higher than cytoplasmic levels, providing two major 
sources of Ca2+ which can be drawn upon for signalling, with the endoplasmic reticulum/sarcoplasmic 
reticulum being the largest internal reservoir.  The relatively low calcium levels compared to 
potassium, sodium or chloride ions means that most calcium signalling events have little effect on 
overall membrane potential.  The activation of Ca2+ ion channels located in the plasma membrane 
and internal stores allows for cytoplasmic [Ca2+] to be increased (reviewed in (Berridge, 2014)).  
Although Ca2+ is free to diffuse in the cytoplasm most changes are highly localised and 
transient, with free calcium quickly bound by local buffers or effectors and then rapidly returned to 
the resting level by calcium pumps.  The temporal pattern and size of the transient signal, playing a 
key part in signal identity.  Protein complexes associated with the channel play a regulatory role in 
determining the sensitivity of the channel to the agonist or stimulus but also shape the feedback and 
feedforward loops which regulate the pattern of calcium transient produced.  Receptors and 
effectors too can be closely coupled to the calcium channel though anchoring.  Global changes such 
as calcium waves require the coordinated action of large arrays of channels (reviewed in (Berridge et 
al., 2003). 
 
1.2.ii  The Inositol 1,4,5-trisphosphate signalling pathway 
One of the key ligand gated calcium channels is the Inositol 1,4,5-trisphosphate receptor.  
Inositol 1,4,5-trisphosphate, or IP3 hereafter, is a small molecule second messenger frequently used 
in the transduction of a range of cell signalling events throughout the animal kingdom.  IP3 is one of 
the most frequently utilised members of a family of inositol containing phospholipid derivatives 
involved in the regulation and transduction of cellular signals (reviewed in (Berridge, 1993; Berridge 
and Irvine, 1989; Czech, 2000; Hancock, 2010; Payrastre et al., 2001)) (Figure.1.3). 
The metabolism and modification of specific phospholipid components of the cell 
membrane, in particular the phosphoinositides, is crucial to regulating the localisation of key 
signalling proteins and in the production of small molecule second messengers.  The transduction of 
many extra-cellular signals, including the classical neurotransmitter acetylcholine and the growth 
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factor EGF, to name but two examples, utilises hydrolysis of phosphoinositides, producing  second 
messengers which trigger a signalling cascade, leading to a range of downstream effects which 
include calcium mobilisation, protein kinase C activation, arachidonic acid production and guanylate 
cyclase activation (Berridge, 1984).  The inositol containing phospholipid phosphatidylinositol 4,5-
bisphosphate (PIP2) is a minor component of the phospholipid membrane but is highly important in 
the localisation and activation of key signalling proteins via PH domains, and in the regulation of the 
actin cytoskeleton and intracellular trafficking (Gilmore and Burridge, 1996; Martin, 2001; Raucher et 
al., 2000; Toker, 1998).  
PIP2 can be hydrolysed to diacyl glycerol (DAG) and IP3, catalysed by the phosphodiesterase 
phospholipase C (PLC).  DAG and IP3 are both able to act as second messengers; with DAG remaining 
membrane associated and stimulating protein phosphorylation, whilst IP3  is free to diffuse through 
the cytoplasm to trigger the mobilisation of intracellular calcium via binding to the IP3 receptor, a 
ligand gated calcium channel, localised to the endoplasmic reticulum (ER) . IP3 production by PLC 
therefore leads to the release of calcium from the ER to the cytoplasm and the subsequent activation 
of downstream calcium signalling pathways (Berridge, 1984). 
The termination of the IP3 signal is controlled in part by metabolism of IP3.  IP3 can be directly 
converted to inositol 1,3,4,5-tetrakisphosphate (IP4) by the IP3 kinase IP3K (lfe-2 in C. elegans) or to 
inositol 1,4-bisphosphate (IP2) by inositol polyphosphatase 5-phosphatase (ipp-5) (Drayer et al., 1996; 
Majerus, 1992, 1996) (Figure 1.3).  IP3K and IPP-5 can act in different roles to regulate IP3 levels and 
the importance of IP3K vs IPP-5 in the negative regulation of IP3 signalling varies with cellular context 
(Bui and Sternberg, 2002).  
   As a frequently utilised second messenger IP3 has been found to play an essential role in a 
diverse range of cellular processes; including the initiation of calcium waves accompanying oocyte 
activation following fertilisation, regulating synaptic plasticity in neurones, platelet activation, cell 
proliferation, differentiation, metabolism,  exocytosis , neuronal response and smooth muscle 
contraction, in response to a range of neurotransmitters, hormones and growth factors (reviewed in 
(Berridge, 2009, 2016)).   
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Figure 1.3. Inositol phosphate metabolism. a- The structure of phosphoinositide PIP2 which is 
broken down to second messengers DAG and IP3. b- Some of the inositol phosphatides, their 
metabolic relationship, and their downstream effectors. 
 
a 
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 1.2.iii  The IP3 Receptor  
 IP3R was first identified as the protein P400 in mice (Furuichi et al., 1989).  A transmembrane 
glycophosphoprotein, it is most closely related to the ryanodine type Ca2+ receptors (RyR).  The IP3 
gated Ca2+ channel follows a popular prototype for cation channels common to both pro and 
eukaryotes- a functional tetramer, each monomer consisting of 6-span transmembrane channel 
forming domain and a p-loop which together form a selectivity filter, central cavity and gate.  Ligand 
dependent gating of the C- terminal channel forming domain is regulated by the N-terminal ligand 
binding domain and modulatory/coupling domains, making for a selective and regulated 
transmembrane pore (Furuichi et al., 1989, 1994).  Specifically each subunit of the IP3R tetramer can 
be considered to consist of 5 functional domains as depicted in Figure 1.4 (Uchida et al., 2003), with 
the latest evidence suggesting that the IP3 binding sites of all 4 subunits must be filled for effective 
channel opening (Alzayady et al., 2016).  The N-terminal suppressor region is also responsible for the 
differing IP3 affinities displayed by the three mammalian IP3R isoforms (Mikoshiba, 2007).   
Figure 1.4. The 5 domains model of the mouse IP3R1 receptor. IP3 binding triggers a conformational change 
which is transmitted through the N-terminal coupling and internal coupling domains to the C- terminal 
gatekeeper domain to allow calcium channel opening. Image reproduced from (Journal of Neurochemistry, 
Volume: 102, 1426-1446, 2007, DOI: (10.1111/j.1471-4159.2007.04825.x) (Mikoshiba, 2007)). 
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 The IP3R also displays calcium-induced-calcium-release (CICR) behaviour with calcium acting 
as an essential co-agonist with IP3.  The bell-shaped response curve of the IP3R to calcium 
demonstrates a maximal response around 300nM [Ca2+], after which calcium becomes increasingly 
inhibitory (Bezprozvanny et al., 1991).  However studies using purified IP3R1 found that high 
concentrations of Ca2+ are not intrinsically inhibitory but require the calcium binding protein 
Calmodulin to bind bring about this inhibitory effect; with calmodulin binding to IP3R in a calcium 
dependent manner at high concentrations of cellular calcium (Michikawa et al., 1999; reviewed in 
(Taylor and Laude, 2002)).  These sequential positive and negative feedback loops are thought to play 
an essential role in the generation of calcium oscillations, characteristic of  signalling via internal 
store calcium release (Berridge, 1993).  For a review of IP3 receptor structure, function and signalling 
dynamics see (Mikoshiba, 2007; Prole and Taylor, 2019; Taylor and Tovey, 2010). 
As well as being a ligand-gated calcium channel the IP3R has a central role in the organisation 
of signalling events as a scaffold for a macro molecular signalling complex, theorised to be important 
in the tailoring of the outcomes of IP3 signalling, as is the spatial regulation of calcium release by the 
subcellular localisation of  IP3R.  The regulation of IP3R localisation through trafficking of ER vesicles 
and IP3R mRNA granules along the microtubule cytoskeleton also plays an important role in the 
regulation of IP3 signalling (reviewed in (Mikoshiba, 2007; Prole and Taylor, 2016, 2019)). 
 
1.2.iv Phospholipase C (PLC) 
 A number of different PLC isoforms have been characterised.  In mammals these fall into 6 
groups: PLC-β, PLC-γ, PLC-ε, PLC-δ, PLC-η and sperm specific PLC-ζ.  In C. elegans there are 5 PLC 
genes, plus pll-1, a homologue of the catalytically inactive PLC-like protein PLC-L1 (aka PRIP). Of the 5 
putative catalytically active PLCs 4 encode clear homologues of the mammalian PLCs: egl-8 (plc-β), 
plc-1(plc-ε), plc-3( plc-γ), plc-4 (plc-δ), while plc-2 is most similar to plc-β (Gower et al., 2005a; Kariya 
et al., 2004; Lackner et al., 1999; Miller et al., 1999; Shibatohge et al., 1998; Yin et al., 2004) (see 
Figure 1.5).  All PLC isozymes share common structural features, the key characteristic of which are 
the central catalytic X and Y domains, responsible for the inositol phospholipase cleavage.  All but 
PLCζ also have an N terminal PH domain, which facilitates binding to inositol phospholipids such as 
PIP2, followed by an EF hand, calcium binding domain and a more C terminal C2 domain (reviewed in 
(Katan, 1998; Suh et al., 2008)). Other domains are more type specific and provide specificity of 
activation (Illenberger et al., 2003; Singer et al., 2002).  For instance, each class of PLC is canonically 
activated by a different class of upstream proteins; PLCγ has been found to be canonically activated 
by RTKs and contains a number of SH2 and SH3 binding domains.  PLCβ has been found to be 
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activated by heterotrimeric G protein signalling in response to GPCR activation and contains a unique 
C terminal region shown to be needed for interaction Gα-proteins, and which has GAP activity 
(reviewed in (Suh et al., 2008)).  
 
1.2.v  IP3 signalling in C. elegans 
In vertebrates 3 genes encode distinct IP3R isoforms with different calcium affinities and 
expression patterns.  By contrast in C. elegans a single IP3R gene, itr-1, encoding multiple isoforms, 
has been identified in the C. elegans genome (Baylis et al., 1999).  Like its mammalian counterparts 
ITR-1 consists of an N-terminal domain required for IP3 ligand binding, followed by an internal 
coupling domain containing MIR and RIH (RyR and IP3R Homology) domains which are shared 
between IP3 receptors and the closely related calcium channels the ryanodine receptors. The C-
terminal region is predicted to form an integral ion channel consisting of 6 transmembrane domains 
and with a pore loop structure between M5 and M6 (Baylis et al., 1999).  
The overall expression pattern of itr-1 is broad with ITR-1 expressed in motor neurones, 
pharynx, vulva, spermatheca, intestine and rectal epithelial cells and gonad. Numerous alternative 
isoforms have been identified from itr-1 cDNA, with variants generated from the use of three 
alternative start sites and alternative splicing (figure 1.6).  3 alternative promoter regions, upstream 
of each alternative first exons, direct tissue specific isoform expression.  Isoform A is expressed from 
promoter pA in the vulva, rectal epithelial cells, pharynx terminal bulb, spicule protractor muscles of 
the proctodeum and in male-specific neuron CP8 or CP9.  Expression from promoter pB drives 
expression in the spermatheca, PDA motor neuron, excretory cells, amphid socket cells, directs 
expression in the spicule retractor muscles, gubernaculum retractor muscles, posterior oblique 
muscles, diagonal muscles, and the vas deferens.  Expression of isoform D from promoter pC drives 
expression in the intestine, pharynx isthumus, spermatheca, spermathecal valve and uterine sheath, 
vas deferens and seminal vesicle (Gower et al., 2001, 2005).  
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Figure 1.5. PLCs and the IP3 signalling pathway. a- The 5 C. elegans phosoplipase C homologues and their 
mammalian counterparts catalyse the hydrolysis of PIP2 to second messengers IP3 and DAG.  IP3 stimulates 
release of ca2+ from the ER via binding to the IP3 receptor. IP3 can be further metabolised by conversion to IP2 or 
IP4.  Image reproduced from (Baylis and Vázquez-Manrique, 2012). b- The structure of 6 mammalian PLC types, 
showing key domains.  All PLC isoforms contain an EF hand domain and X and Y catalytic domains and C2 
domain. All but PLC-ζ also have a PH domain. PLC-β also contains a C-terminal CT domain which allows 
activation by Gαq and has GAP activity.  Reproduced from (Kadamur and Ross, 2013). 
b 
a 
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IP3 is a key component in the regulation of a number of physiological and cellular processes 
including, ovulation, contraction of the spermathecal sheath cells, egg laying, movement, pharyngeal 
pumping, intestinal defecation rhythm, fertility, lifespan and male mating behaviour (for review see 
(Baylis and Vázquez-Manrique, 2012)).  The known IP3 dependent processes in C. elegans, are 
summarised in table 1.1, together with the upstream PLC and other signalling components.  
As is seen in other systems many of the roles of IP3 and calcium signalling in C. elegans 
display a strong rhythmic component; with the spatio-temporal dynamics of IP3 induced Ca2+ 
signalling being a key regulator of the frequency and/or pattern of the rhythmic contractions of 
pharyngeal muscle in pharyngeal pumping, the intestinal muscles in the defecation cycle and the 
myoepithelial sheath and spermathecal contractions controlling ovulation.  In each case disruption of 
the IP3 signalling pathway affects the rhythm and/or amplitude of the contractions.  
Successful ovulation requires the carefully regulated IP3/Ca2+ signalling driven high frequency 
contractions of the sheath cell and correct timing and magnitude of the contraction and dilation the 
spermatheca (Bui and Sternberg, 2002; Clandinin et al., 1998).  IP3 signalling is downstream of two 
secreted ligands; MSP is produced by sperm in the spermatheca whilst LIN-3 is produced by the 
proximal maturing oocyte.  MSP triggers both IP3 dependent oocyte maturation and IP3 dependent 
basal contractile activity of the sheath cell via PLC-3.  LIN-3/LET-23 acts via LIN-1 to trigger IP3 
signalling regulating both sheath cell and spermathecal contractions.  The importance of precise IP3 
regulation in this system is highlighted by the complex range of subtly different phenotypes of failure 
in ovulation seen in the IP3 signalling mutants (Bui and Sternberg, 2002; Clandinin et al., 1998; Kariya 
et al., 2004; Yin et al., 2004).  Sterility can be rescued by loss of function of IPP-5 but is worsened by 
LFE-2 mutation, both of which negatively regulate the IP3 signalling pathways regulating ovulation 
(Bui and Sternberg, 2002; Clandinin et al., 1998; Kariya et al., 2004a; Yin et al., 2004).   
The rate of pharyngeal pumping in C. elegans is regulated depending on food availability, 
increasing from 100 pumps/min to 225 pumps/min when food is present.  IP3 signalling in the 
Figure 1.6. The alternative isoforms of ITR-1 are generated through alternative promoter usage and   
alternative splicing of the single IP3R gene itr-1. Reproduced from (Baylis et al., 1999). 
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pharynx acts downstream of egl-30 activated egl-8 and upstream of serotonin induced contractions 
of the pharyngeal muscle to regulate this response to food. The IP3 mediated regulation of the 
response to food in this instance is dependent on interaction of the IP3R with myosin II, loss of this 
interaction leads to a loss of increased pharyngeal pumping in response to food (Walker et al., 2002b, 
2002a). 
The signals and rhythms which define the defecation cycle have been studied in some detail 
however some aspects are yet to be fully understood.  In WT worms on food a repeated and 
coordinated pattern of intestinal contractions drive a 50s defecation cycle. The defecation motor 
program consists of 3 steps:  contraction of the posterior body wall muscles (pBoc), contraction of 
the anterior body wall muscles (aBoc), contraction of the enteric muscles and enteric sphincter 
relaxation (Exp).  Though largely invariant in WT fed worms, lack of food leads to a pause in the cycle 
while disruption of IP3 or Ca2+ signalling causes mutants to display an altered and dysregulated 
rhythm.  IP3 dependent calcium release in the intestinal cells is the central timekeeper of this rhythm 
of which the IP3R is a central component (Dal Santo et al., 1999).  It was suggested that the intestinal 
rhythm could be regulated by either the rate of activation or rate of shut off of the calcium wave.  
Further studies have led to a model whereby propagation of the calcium waves from the posterior to 
the anterior intestinal cells coincides with the initiation of pBoc contraction and is necessary to 
initiate the further stages of the defecation cycle.  IP3 mediated calcium wave propagation to the 
anterior of the intestine acts upstream of the DVB and AVL motor neurones to coordinate the pBoc 
and Exp steps (Teramoto and Iwasaki, 2006; Walker et al., 2002).   
 A number of roles for IP3 signalling in development have also been identified.  Disruption of 
IP3 signalling though expression of an IP3 sponge results in a high degree of embryonic lethality and 
PLC-1 dependent IP3 signalling  is also a  key signal in the regulation of epidermal morphogenesis 
(Thomas-Virnig et al., 2004; Vázquez-Manrique et al., 2008; Walker et al., 2002).   
IP3 is also known to act neuronally in the regulation of the avoidance response and male 
mating behaviours.  In the ASH neurones which mediate the avoidance response  EGL-8 and EGL-30 
both act up stream of ITR-1 to regulate locomotion in response to nose touch and benzaldehayde 
(Walker et al., 2009).  ITR-1 and EGl-8 are also involved in the regulation male mating behaviour, 
being required for both correct turning behaviour and spicule insertion(Gower et al., 2005).  
Many more processes in C. elegans are regulated by PLC dependent but not IP3 dependent 
pathways, instead acting via DAG and a Protein kinase C triggered phosphorylation cascade.  For 
example  EGL-8 is also known to act neuronally, again downstream of its canonical effector EGL-30,  
in the control of ACh and neuropeptide release from the neurones regulating locomotion, however 
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DAG is the primary downstream effector in this case (Lackner et al., 1999), although IP3 signalling also 
plays a role (Peterkin & Baylis, unpublished).   A summary of IP3 regulated processes in C. elegans are 
given in table 1.1.  
 
Process Upstream 
PLC 
Other 
upstream 
components 
Experimental 
modulation of IP3 
pathway 
Notes References 
epidermal 
migration 
plc-1, egl-8  plc-1 overexpression 
egl-8 overexpression 
itr-1(jc5) 
itr-1(sa73) 
 
 (Thomas-
Virnig et al., 
2004; 
Vázquez-
Manrique et 
al., 2008) 
gastrulation   IP3 sponge 
itr-1(sa73) 
 (Walker et 
al., 2002) 
Other embryonic 
defects 
  IP3 sponge 
itr-1(sa73) 
 (Thomas-
Virnig et al., 
2004; Walker 
et al., 2002) 
ovulation 
(myoepithelial 
sheath cell 
signalling) 
plc-3 
plc-1 
lin-3, let-23, 
pip5k  
 
itr-1 gf (sy327) 
itr-1 (sa73) 
itr-1 RNAi 
ipp-5 (sy605) 
IP3 sponge 
Requires PM 
Ca2+ entry for 
refill 
(Bui and 
Sternberg, 
2002; Chi and 
Reinke, 2009; 
Clandinin et 
al., 1998; 
Hiatt et al., 
2009; Kariya 
et al., 2004a; 
Norman et 
al., 2005; Yin 
et al., 2004) 
Basal contractile 
activity of sheath 
cell 
plc-3 MSP/vab-1, 
pip5k  
 
ovulation 
(spermathecal cell 
signalling) 
plc-1 Lin-3/ let-23, 
pip5k  
 
Ipp-5(sy605) and 
rescue 
lfe-2 lof 
itr-1 gof 
Emo 
phenotype 
oocyte meiotic 
maturation 
 MSP/let-23? itr-1 (sa73) 
itr-1 gof 
itr-1 RNAi 
 (Corrigan et 
al., 2005) 
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defecation  plc-3 vav-1, ced-10, 
mig-2, rho-1 
itr-1(sa73) 
itr-1 (jc5) 
itr-1 (n2559) 
ipp-5 lof 
lfe-2 lof 
IP3 sponge 
egl-8 also 
involved but 
not via IP3 
(Dal Santo et 
al., 1999; 
Norman et 
al., 2005; 
Teramoto 
and Iwasaki, 
2006; Walker 
et al., 2002a) 
pharyngeal 
pumping 
egl-8 egl-30 IP3 sponge 
itr-1 (sa73) 
itr-1(tm902) 
 (Walker et 
al., 2002a) 
 
male mating egl-8  itr-1 gf 
itr-1 (sa73) 
itr-1 RNAi 
 (Gower et al., 
2005) 
lifespan/healthspan plc-3 let-23, lin-3, 
hpa-1/2 
itr-1(sa73) 
itr-1 gof 
daf-16 
independent 
(Iwasa et al., 
2010) 
neuronal 
modulation 
  itr-1 (sa73)  (Hukema et 
al., 2006; 
Kindt et al., 
2007) 
necrosis   itr-1 (sa73) Srp-6 
induced cell 
death 
(Luke et al., 
2007; Xu et 
al., 2001) 
mechanical 
avoidance-ASH 
egl-8, plc-3  itr-1 RNAi 
egl-8 neurone 
specific rescue 
plc-3 neurone 
specific rescue 
IP3 sponge 
 (Walker et 
al., 2009) 
Table 1.1.  The many roles of IP3 signalling in C. elegans. 
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1.2.vi  GPCRs and Heterotrimeric G-Proteins 
G-protein coupled receptors are a highly diversified family of 7 span transmembrane 
receptors which are associated with a membrane bound G-protein heterotrimer through which the 
signal is transduced.  In their inactive state heterotrimeric G proteins consist of a Gβγ dimer bound to 
a Gα:GDP.  In the standard model of heterotrimeric G protein signalling, agonist binding the GPCR 
causes a conformational change which causes the GPCR to act as a GEF, stimulating GDP to GTP 
exchange at Gα. GDP for GTP exchange acts as a molecular switch resulting in release of Gα from Gβγ 
which can each activated downstream effectors.  Upon GTP to GDP hydrolysis the Gα re-associates 
with the Gβγ, terminating the signal.  Most Gα subunits have intrinsic GTPase activity which can be 
accelerated by interaction with GTPase activating proteins (GAPs), such as RGS proteins.  The 
remarkable diversity of the GPCRs is matched by a prolific range of downstream effectors (see Figure 
1.7) and a complex network of regulators of G- protein signalling (reviewed in (Marks et al., 2009; 
Ross and Wilkie, 2000; Siderovski and Willard, 2005; Syrovatkina et al., 2016)).   
All 4 classes of mammalian Gα subunits have well established cannonical effectors 
(summarised (Berridge, 2014; Marks et al., 2009)).  Gαo activates adenylyl cyclase, an action which is 
opposed by Gαi.  Gαi can also stimulate PI3 kinase γ and PLCβ.  Gα12/13 activates rhoA via rhoGEF. 
Finally Gαq signals via PLCβ to activate a range of  downstream effectors including the IP3R and DAG 
kinase or via Trio to stimulate the MAPK pathway (Frooninckx et al., 2012).  Known Gβγ effectors are 
varied and include PLCβ, G-protein coupled receptor kinase (GRK), adenylyl cyclase 2,  and ion 
channels including muscarinic potassium channel GIRK, and calcium channel α1B (Ford et al., 1998).  
Through these effectors the downstream outcomes of Gβγ activation may be synergistic with those 
of the Gα subunit or divergent.  PLCβ family isozymes can  also be activated by both the α and βγ 
subunits and by Rho family small G proteins (Illenberger et al., 2003).  
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1.2.vii Heterotrimeric G-protein signalling in C. elegans 
The pairing of different Gα subunit isomers with different Gβ and Gγ subunits is one way of 
generating specificity and diversity in G-protein signalling as each functional heterotrimer will display 
slightly different signalling dynamics.  The human genome encodes 23 Gα, 5 Gβ and 12 Gγ genes, 
allowing for a great deal of specificity to be generated through the many possible αβγ combinations.  
By comparison in the C. elegans genome there are only 2 Gβ and 2 Gγ homologues encoded but 21 
Gα genes.  The Gγ homologue GPC-2 is widely expressed while GPC-1 is only expressed in select 
neurones. Both GPB-1 and GPB-2 are widely expressed though GPB-2 is not essential for viability.  It 
follows logically that the majority of diversity and specificity must be dependent on the identity of 
the Gα subunit; with the 21 Gα isomers, representing 1 homologues of each mammalian Gα class- 
GSA-1 (Gs), GOA-1 (Gi), EGL-30 (Gq) and GPA-12 (G12/13)- the remainder show no obvious homology to 
particular mammalian subunits.  This combinational variation, though not insignificant is small 
compared to the 1300 GPCRs encoded in the C. elegans genome, most of which are so far orphan 
receptors (reviewed in (Bastiani et al., 2006; Koelle, 2016; Wilkie, 2000)). 
Figure 1.7. The diversity of heterotrimeric G-protein effectors downstream of the GPCR associated G-protein 
cycle. In the active conformation both GαGTP and Gβγ subunits are known to exert a range of effects. Image 
reproduced from Berridge, M.J. (2014) Cell Signalling Biology[module 2].   
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Of the 21 Gα genes goa-1, egl-30, gsa-1, gpa-7, gpa-16,  gpa-12, gpa-10, gpa-9, gpa-15,  and  
gpa-14 are expressed in a range of neuronal and other tissue types whilst gpa-17 is expressed only in 
the intestine and gpa-1, gpa-3, gpa-4, gpa-5, gpa-6, gpa-8, gpa-11 and odr-3 are expressed in 
subsets of neurones, mostly sensory, and seem to be involved principally in chemosensation.  GPA-2 
and GPA-3 also have roles in the Dauer decision, through their roles in detection of the Dauer 
pheromone. GPA-5 is also involved in the negative regulation of RAS/MAPK signalling during vulval 
development (reviewed in (Bastiani et al., 2006)).  The roles of each of the mammalian Gα 
homologues and β/γ effectors in C. elegans are many and varied, including many essential 
developmental processes (reviewed in (Matúš and Prömel, 2018) and numerous physiological and 
neuronal roles (Koelle, 2016).   
In C. elegans, as in other systems PLCβ /EGL-8 is canonically activated by heterotrimeric G-
protein signalling, specifically by heterotrimers containing the Gαq homologue EGL-30.  EGL-30 
activated PLCβ signalling has been found to regulate many processes in C. elegans including 
ovulation, movement and viability, intestinal rhythm and the release of neurotransmitter 
acetylcholine (ACh) in synaptic transmission (Brundage et al., 1996; JH and M, 2000; Lackner et al., 
1999).  But EGL-30 has also been found to act in a PLCβ independent manner in the regulation of egg 
laying (Bastiani et al., 2003), acting through the RhoGEF UNC-73(trio) in this and a number of other 
instances including locomotion and growth (Williams et al., 2007).  
Heterotrimeric G protein subunits Gα GOA-1(Gαo), EGL-30 (Gαq), and GPA-12 (Gα12) and GSA-
1 (Gαs) all have roles in the C. elegans motor neurones and act pre- and post- synaptically in a variety 
of behaviours. GOA-1, EGL-30 and GPA-12 all contribute to the regulation of DAG levels in the 
neurones regulating body wall muscle contractions in locomotion.  EGL-30 acts downstream of 
mAChR to activate EGL-8 leading to DAG production. GOA-1 acts downstream of a serotonin 
activated GPCR to antagonise EGL-30 signalling.  EGL-30 and GPA-12 both activate DAG kinase 
inhibitor RHO-1, via the RhoGEFs UNC-73/Trio and RHGF-1 respectively, to reduced breakdown of 
DAG.  A similar circuit of G-protein signalling regulates the control of egg laying, with GOA-1 and EGL-
30 acting antagonistically upstream of EGL-8. GSA-12 also stimulates neuropeptide release via 
adenylate cyclase activation leading to a cAMP dependent pathway. GOA-1 and EGL-30 mutants also 
both show defects in neuronal migration, male mating behaviour and slow pharyngeal pumping.  
(Perez-Mansilla and Nurrish, 2009).  
Outside of the neuronal networks heterotrimeric G- protein signalling is a key regulator of in 
a diverse range of processes and pathways. EGL-30, GOA-1 and GSA-1, GPA-12, GPA-7 and GPA-16 all 
act in a variety of muscles.  GSA-1 also promotes growth and is required for viability after hatching.  It 
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also has roles in gametogenesis and morphogenesis and excess GSA-1 activity leads to neurotic 
neuronal cell death. GOA-1 and GPA-16 act redundantly in spindle positioning during embryogenesis, 
and GOA-1 null mutants display a low frequency of embryonic lethality and partial sterility.  EGL-30 is 
also required for viability after hatching and loss of function mutants frequently arrest during larval 
development. GOA-1 and EGL-30 also affect vulval development (reviewed in (Bastiani et al., 2006)). 
 
1.2.viii  Modulation of G-protein signalling 
The activity of heterotrimeric G-protein signalling is initiated by the GEF activity of the 
agonist bound GPCR with the length of the signal determined by the strength of the GTPase activity 
of the Gα subunit. This activity is modified by interactions with a range of regulatory proteins. 
GTPase Activating Proteins (GAPs), including RGS domain containing proteins (Koelle, 1997) act to 
stimulate the intrinsic GTPase activity of Gα proteins, hastening the conversion of GTP to GDP and 
hence the termination of the signal.  This activity is opposed by guanonucleotide exchange factors 
(GEFs), which encourage the exchange of GDP for GTP, dissociation of the heterotrimer and initiation 
of the signalling (reviewed in (Siderovski and Willard, 2005)).  Numerous interactions fine tune signal 
transduction by G-proteins.  It is common for effector proteins such as PLCβ to have GAP activity and 
hence contain an intrinsic negative feedback mechanism for the termination of the signal (Koelle, 
1997).  In C. elegans GEFs such as RIC-8 are in turn regulated by AGS proteins such as AGS-3 (Hofler 
and Koelle, 2011; Tall et al., 2003) to promote signalling whilst RGS proteins such as RGS-1, RGS-2, 
EAT-16 and EGL-10 promote its termination.  In some cases interaction of the RGS proteins with the 
Gα subunit is also dependent on the Gβ5 homologue GPB-2 (Van der Linden et al., 2001; Robatzek et 
al., 2001). 
The roles of many G-protein signalling regulators can be clearly seen in the regulation of the 
locomotive and egg laying networks in C. elegans in which GOA-1 and EGL-30 signal antagonistically 
in a neuronal signalling networks upstream of serotonin.  The antagonism between Gαo and Gαq is 
mediated by a number of The RGS protein EAT-16 was found to supress the lethargic phenotype of 
constitutively active GOA-1 (Hajdu-Cronin et al., 1999).  It was further found that EAT-16 and EGL-10 
selectively inhibit action of Gαq and Gαo respectively, with specificity provided by an N-terminal 
region of each RGS.  Inhibition of the opposing Gα subunit by EAT-16 and EGL-10 is necessary for 
signalling of the opposing subunit. EAT-16 and EGL-10 loss of function mutants display phenotypes 
similar though less severe to that of GOA-1 and EGL-30 respectively (Dong et al., 2000; Hajdu-Cronin 
et al., 1999; Patikoglou and Koelle, 2002).  The Gβ5 ortholog  GPB-2, encoded by eat-11 interacts with 
GOA-1, EGL-30, EGL-10 and EAT-16 and is required by the RGS proteins to regulate the antagonism in 
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this circuit with loss of GPB-2 causing a reduction in EAT-16 and EGL-10 activity (Chase et al., 2001; 
Robatzek et al., 2001).  The membrane targeting  subunit RSPB-1 is also necessary for EAT-16 
function (Porter and Koelle, 2010).  The GEF RIC-8/synembryn activates EGL-30 and is itself regulated 
by AGS-3 (Hofler and Koelle, 2011; Lackner et al., 1999; Miller et al., 2000; Tall et al., 2003).   
The calcium/calmodulin-dependent protein kinase II (CaMKII) and the calcium/ calmodulin-
dependent protein phosphatase calcineurin are also involved in the regulation of the EGL-30/GOA-1 
signalling network in both locomotion and egg laying.  In response to high cellular calcium CaMKII 
and calcineurin act antagonistically to promote GOA-1 and EGL-30 signalling respectively (Lee et al., 
2004; Robatzek and Thomas, 2000).  
 
 
 
 
 
 
Figure 1.8 GOA-1 and EGL-30 act antagonistically in the neuronal signalling 
pathways regulating egg-laying and locomotion. Models suggest that the RGS 
proteins EAT-16 and EGL-10 interact directly with GOA-1 and EGL-30 respectively, 
facilitated by GPB-2.  GOA-1 signalling inhibits the action of the EGL-30 pathway, 
perhaps by direct activation of EAT-16, or via DAG-kinase. A reciprocal negative 
regulation of GOA-1 signalling by EGL-30 has also been suggested.  Image 
reproduced from (Van der Linden et al., 2001). 
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1.3  RNA Interference and small silencing RNAs 
 
One of the key roles of intracellular signalling pathways is the regulation of cell behaviour via 
the regulation of gene expression.  One family of epigenetic regulatory mechanisms, the importance 
of which has become increasingly apparent over the last two decades, are the small silencing RNAs 
which act through an RNA induced silencing complex or RISC.  This family of RNA interference-based 
mechanisms are evolutionarily ancient (reviewed in (Carthew and Sontheimer, 2009; Shabalina and 
Koonin, 2008; Zamore, 2002)), being found throughout the eukaryotic tree, where the processes 
have diversified from origins as an antiviral defence mechanisms, to play important roles in the 
regulation of endogenous gene expression, genome surveillance, and protection from foreign genetic 
elements (reviewed in (Ghildiyal and Zamore, 2009; Moazed, 2009)).   
The effects of so called ‘antisense RNA’ on mediating gene silencing in plants, fungi and 
animals had been previously reported, and manipulated; however it was only in 1998 that dsRNA 
was identified as the key trigger in RNA mediated gene silencing or RNA interference  (Fire et al., 
1998).  The observation that long dsRNA could induce gene silencing in C. elegans coincided with 
observations of various forms of virus and transgene induced post transcriptional gene silencing 
phenomena such as co-suppression, in plants and fungi (Cogoni and Macino, 1997; Ratcliff et al., 
1997; Ruiz et al., 1998; Sijen et al., 1996).  As understanding of the mechanisms of RNAi grew it was 
quickly realised that these processes were related and that the same core machinery and 
mechanisms were also required for maintaining transposon silencing (Ketting and Plasterk, 2000; 
Ketting et al., 1999; Montgomery and Fire, 1998; Tabara et al., 1999).  All were using a conserved 
mechanism- triggered by dsRNA (Cogoni and Macino, 1999; Matzke et al., 2001; Montgomery and 
Fire, 1998; Ratcliff et al., 1999; Sharp, 1999; Waterhouse et al., 1998), dependent on the generation 
of small-interfering RNAs (Hamilton and Baulcombe, 1999; Hammond et al., 2000; Zamore et al., 
2000) and utilising shared machinery to silence complementary mRNAs (Catalanotto et al., 2000; 
Fagard et al., 2000; Ketting and Plasterk, 2000; Ketting et al., 1999; Tabara et al., 1999)   
Further still it was found that the same machinery and mechanisms responsible for RNA 
interference were also involved in the generation and actions of genomically encoded small RNA 
regulators -the microRNAs (Grishok et al., 2001). lin-4 and let-7 had been previously characterised as 
small temporal RNAs responsible for the regulation of developmental timing in C. elegans (Lee et al., 
1993; Reinhart et al., 2000). They were subsequently found to be the first of a number of microRNAs 
to be characterised across the multicellular eukaryotes, further expanding the family of RNAi related 
mechanisms to include developmental regulators, conserved between species (Pasquinelli et al., 
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2000).  Concurrently the effects of dsRNA induced gene silencing were being verified in a diverse 
range of eukaryotic systems including drosophila, trypanosomes, zebra fish and mice and the 
potential power of RNAi as an experimental technique was realised (reviewed in (Bosher and 
Labouesse, 2000; Zhuang and Hunter, 2012a)).   
The characterisation of the machinery and mechanisms of RNAi not only allowed the full 
exploitation of a powerful experimental technique, but together with the identification of increasing 
numbers of endogenous small RNAs, opened the door on the world of small silencing RNAs 
(reviewed in (Zamore, 2002)).  In C. elegans the potency of the effect was noted, as was the systemic 
and environmental nature (Fire et al., 1998; Tabara et al., 1998; Timmons and Fire, 1998).  RNAi 
libraries have been created to allow the targeting of almost every gene in the genome, allowing the 
phenotypes of many genes to be characterised for the first time (Kamath et al., 2003).  Observations 
of transgenerational effects of RNAi treatment have been reported in several organisms, particularly 
C. elegans, with important implications for transgenerational epigenetic inheritance (reviewed in 
(Feng and Guang, 2013; Rankin, 2015)). 
 
1.3.i  The evolutionarily conserved machinery and mechanisms of RNA interference  
The exogenous-siRNA, or RNAi, pathway and the endogenous small silencing RNA pathways 
have all evolved from common origins, with the overall mechanism and key proteins being well 
conserved.  At the core in all cases short dsRNAs 21-32 nucleotides in length are bound by a protein 
of the argonaute family.  The argonaute cleaves one stand of the short dsRNA to leave an argonaute 
bound short single stranded guide RNA which forms the central component of the active compound - 
the RNA induced silencing complex, or RISC.  The active RISC is a complex containing a short single 
stranded (ss)RNA, 21-32nt in length, bound to an argonaute protein together with variable auxiliary 
factors (reviewed in (Ghildiyal and Zamore, 2009)).  Sequence specificity is provided by the guide 
RNA which targets the RISC to complementary mRNAs via Watson-Crick base paring.  A range of 
classes of small RNAs with diverse targets have been identified (reviewed in (Aalto and Pasquinelli, 
2012)).  In most (but not all cases) the overall outcome is reduced expression of the target. The 
precise outcome of RNA targeting by ssRNA/argonaute complex is dependent on Argonaute and 
auxiliary factor identity and can include mRNA degradation, destabilisation and inhibition of 
translation in the cytoplasm, or co-transcriptional nuclear effects leading to transcriptional silencing 
and even the deposition of chromatin marks (reviewed in (Holoch and Moazed, 2015; Meister, 2013; 
Peters and Meister, 2007)).  
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The prevailing theory for the original purpose of RNA interference is as a viral defence 
mechanism.  The exogenous siRNA pathway, in which small-interfering RNAs are generated from 
foreign dsRNAs in the cytoplasm and used to target homologous RNA sequences for silencing, 
represents an ancient mechanism of genome defence from virus and transposable elements 
(reviewed in (Obbard et al., 2009; Sarkies and Miska, 2013)).  RNAi based mechanisms still play a 
critical role in viral defence in many invertebrates and plants, which lack a more complex immune 
response, and are still essential for transgene silencing in vertebrates and invertebrates.  
From this ancient origin the endogenous small silencing RNAs have evolved to fulfil diverse 
roles, centred around genome defence and genetic regulation (reviewed in (Carthew and 
Sontheimer, 2009; Moazed, 2009; Shabalina and Koonin, 2008).  With isolated exceptions, where the 
RNAi machinery seems to have been lost, organisms from all branches of the eukaryotic tree have 
been found to be competent of some form of exogenous RNAi and to utilise endogenous RNAi based 
mechanism of gene regulation and genome defence.   
The critical players in all RNAi based pathways are the argonautes.  Argonaute proteins are 
found in all branches of the eukaryotic kingdom and even have prokaryotic homologues (reviewed 
in(Swarts et al., 2014)).  In all RNAi related silencing pathways argonautes are bound to short single 
stranded RNAs which act as a specificity factor to guide the argonaute to a complementary target 
transcript.  The archetypal design of the eukaryotic argonaute centres around 4 conserved functional 
domains, the N-terminal, PAZ , MID and PIWI domains.  The PAZ and MID domains are involved in 
guide RNA binding, with the MID domain forming a nucleotide binding pocket.  The N-terminal and 
PIWI domains are critical for target cleavage with PIWI domain containing an RNase H-like active site 
and DEDX motif needed for the “slicer” activity displayed by many argonautes (reviewed in (Olina et 
al., 2018; Swarts et al., 2014)).  The small RNA/argonaute based regulatory systems are extremely 
adaptable, as can be seen in their largely independent blooming in both plant and animal lineages 
and the cross-over in the roles played by different small-RNA classes between species.  
Three major types of endogenous small RNA have been characterised in animals, primarily 
via deep sequencing; microRNAs (miRNAs), piwi-interacting RNAs (piRNAs) and small-interfering 
RNAs (siRNAs).  Of these the endogenous siRNAs bear the closest resemblance to the products and 
mechanisms of the exogenous RNAi pathway.  Endogenous siRNAs are found in plants, animals, fungi 
and ciliates, and have a diverse set of targets and functions.  microRNAs are abundant in both plants 
and animals where they are key regulators of developmental events (reviewed in (Bartel, 2018; 
Voinnet, 2009)), while piRNAs are found only in animals and are critical for maintaining germline 
stability (reviewed in (Weick and Miska, 2014)).  More recently extensive deep sequencing has led to 
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further classes of argonaute associated small silencing RNAs being identified including tRNA derived 
small RNAs (tsRNAs) which have been found in several organisms, and seem to be involved in 
transgenerational epigenetic inheritance (Chen et al., 2016; Haussecker et al., 2010; Luo et al., 2018; 
Sarker et al., 2019) reviewed in (Li et al., 2018)).  miRNAs, siRNAs and piRNAs each play varied and 
sometimes overlapping roles in gene and genome regulation and are distinguished by differences in 
their biochemical characteristics (length and 3 prime/ 5 prime chemistry) and mechanism of 
biogenesis.  Different classes also typically display difference in argonaute binding partners and 
degree of target complementarity, which influence their downstream effects (reviewed in (Ghildiyal 
and Zamore, 2009; Grishok, 2005)).   
In both plants and animals small RNA mediated gene silencing can act at either the post 
transcriptional level (PTGS) or co-transcriptional level to bring about a variety of different outcomes.  
The effects of RISC targeting include down regulation of gene expression via translational repression 
and mRNA  cleavage or degradation, whilst in the nucleus the RNA- induced initiation of 
transcriptional silencing (RITS) complex effects can include polymerase destabilisation during 
transcription and recruitment of further proteins leading to chromatin modification.  In some cases 
small RNA/argonaute complexes can even promote target gene expression via mRNA stabilisation or 
directing the deposition of activatory chromatin marks.  These pleiotropic outcomes are dependent 
on a diverse set of argonautes together with accessory factors, with argonaute identity and cellular 
context being the key determinant of the outcome of RISC/RITS mediated regulation of a target gene.  
The evolution of the argonaute proteins mirrors the diversifying functions of the small RNA 
pathways with blooms of argonaute clades arising from duplications and subsequent divergence.  
The eukaryotic argonautes can be grouped into clades based on homology to give two main families; 
the members of the AGO clade are found throughout the eukaryotic kingdom, in animals plants and 
fungi whilst members of the PIWI clade have been found only in the metazoa.  Largely independent 
expansions have taken place in plants and animals.  miRNAs bind primarily to AGO clade members in 
both plants and animals whilst siRNAs in animals bind to members of both clades and the animals 
specific piRNAs (piwi-interacting RNAs) associate with only the animal specific PIWI clade argonautes 
for which they are named.  In plants the AGO clade has been diversified to fill many functional niches 
filled by piwi clade argonautes in animals such that there is little meaningful functional difference 
between the two clades.  
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1.3.ii  Small RNA pathways in C. elegans  
Within the Nematoda a further argonaute bloom has taken place giving rise to the WAGO 
clade of argonautes.  In C. elegans the WAGO (Worm argonaute) clade argonautes are responsible 
for many of the more derived argonaute functions and are tightly linked to the amplification of the 
silencing signal via secondary siRNAs to bring about a robust response.  The C. elegans genome 
encodes 21 functional Argonaute proteins, some, such as CSR-1, PRG-1, HRDE-1 and RDE-1, NRDE-3 
and ERGO-1  have unique functions whilst others such as ALG-1 and ALG-2,  ALG-3 and ALG-4, and 
several members of the WAGO clade have overlapping roles.  
 Figure 1.9 shows the phylogeny of the C. elegans argonaute lineage and the class of small 
RNA with which they are most commonly associated.  The specifics of each of the small RNA 
pathways, their associated argonautes and functions shall be discussed in their context in C. elegans, 
much of which is also applicable to other organisms.   
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Figure 1.9. An unrooted phylogeny of the argonaute proteins of C. elegans. Branch length represents 
divergence. The 3 major clades of argonaute are represented by different coloured lines: green- the AGO clade 
common to both plants and animals, pink- the metazoan specific PIWI clade, blue- the nematode specific WAGO 
clade. The class of small RNA most frequently associated with each argonaute is represented by the navy 
groupings. In a few cases such as C04F12.1 where there is a lack of experimental evidence this is assumed based 
on homology to argonaute of better-known function.  Phylogeny generated using protein sequences of each 
argonaute taken from retrieved from WormBase, aligned using Clustal Omega MSA (EMBL-EBI) software and 
most likely phylogenetic relationship generated using Simple Phylogeny (EMBL-EBI)). Where multiple isoform 
sequences were available the longest isoform was used.  
 
1.3.iii  microRNAs 
 The first class of the small silencing RNAs to be identified, miRNAs are a highly abundant class 
of small silencing RNAs in both plants and animals.  microRNAs were first identified during the 
characterisation of heterochronic mutants in C. elegans, with the identification of the non-protein 
coding causal loci lin-4 and let-7 (Reinhart et al., 2000; Wightman et al., 1993).  let-7  was found to 
have highly conserved homologues in many other animal species, in all cases acting late in 
development (Pasquinelli et al., 2000).  Initially known as small temporal RNAs, such small RNA 
35 | C h a p t e r  1 -  I n t r o d u c t i o n  
 
35 
 
regulators were renamed microRNAs as further similar RNAs were identified and found to regulate 
non-temporal genes (Ambros et al., 2003; Lau et al., 2001; Lee and Ambros, 2001).  Mature miRNAs 
are 21-24nt long, derive from highly structured, genomically encoded loci and principally act as 
developmental regulators through post-transcriptional gene silencing of protein coding genes 
(reviewed in (Bartel, 2018; Carthew and Sontheimer, 2009; Voinnet, 2009).   
miRNAs originate from genomically encoded loci, either from non-protein coding genes or 
within the introns of coding pre-mRNA.  Canonical miRNAs are transcribed by RNA polymerase II, as 
long primary transcripts complete with 5’ cap.  These long primary miRNA (pri-miRNA) transcripts 
contain many repeating and palindromic sequences which fold into secondary structures which 
always include at least one hairpin stem-loop.  The double stranded hairpin structures in long pri-
miRNAs are processed into short ds pre-miRNA stem-loops, 60-70nt long, by a ‘microprocessor’ 
heterotrimer consisting of RNAase III drosha together with 2 copies of a dsRNA binding domain 
(dsRDB) protein (known as pasha in flies).  Pre-miRNAs are then exported from the nucleus to the 
cytoplasm where they are processed into mature miRNA 20-24nt in length, with 2 nt 3’ overhang on 
each end by RNAase III Dicer, again assisted by a dsRBD protein.  The miRNA duplex is then loaded 
into an argonaute protein and auxiliaries to form the pre-miRISC, which then becomes the mature 
miRISC as one strand of the duplex is cleaved to leave only the guide strand.   
microRNAs in C. elegans are predominantly bound by the AGO class argonautes ALG-1 and 
ALG-2, with a small number of miRNAs being found to associate with ALG-5 in some studies (Brown 
et al., 2017).  In C. elegans, as in other animals, pairing to the target RNA is typically incomplete but 
with near perfect complementarity within the seed region – a region of 6-8nt at near the 5’end of the 
miRNA (reviewed in (Bartel, 2018)).  In animals pairing most commonly occurs within the 3’UTR of 
target transcripts.  In most cases limited pairing to the target transcript prevents direct cleavage by 
the miRISC and silencing is instead brought about by translational repression, mRNA deadenylation 
and mRNA decay.  In plants, where high complementarity between miRNA and the target is more 
common, mRNA cleavage is a common outcome ( reviewed in (Ghildiyal and Zamore, 2009; 
Huntzinger and Izaurralde, 2011)). 
Tissue specific differences are also seen in the outcome and mechanism of miRISC targeting.  
In the C. elegans soma ALG-1/2 miRISC targeting typically results in translational repression and 
mRNA decay whilst in the germline ALG-1/2 miRISC targeting leads to temporary translational 
repression but mRNA stabilisation.  This dramatic difference in behaviour is seen due to differences 
in auxiliary and associated proteins.  In the germline miRNA targeted mRNAs are localised to the p-
granules along with protein which inhibit translation whilst also protecting transcripts from 
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degradation.  This allows target mRNAs to accumulate to high levels, and is hypothesised to play a 
key role in allowing maternal mRNA accumulation in oocytes (Dallaire et al., 2018).  
 A single pri-miRNA locus can give rise to several mature miRNAs.  Such polycistronic miRNAs 
typically belong to the same ‘family’, meaning they share closely related mature miRNA sequences, 
particularly with respect to the seed region, and as such will often target the same set of target 
genes.  As complementarity is only strictly necessary in the short seed region a single miRISC can 
target a number of genes, often functionally related.  So far 253 miRNA precursors producing 437 
mature miRNAs have been recorded in C. elegans, with 113 precursors meeting stringent confidence 
criteria (miRbase 22).  This is considerably fewer than 1000 (500 high confidence) or more miRNA 
precursors identified in the human genome.  It is predicted that over half of all mRNAs are regulated 
by miRNA (Bartel, 2018).  
 There is some uncertainty over whether plant and animal microRNAs have evolved from a 
common microRNA type ancestral mechanism or if they have been independently derived from 
adaptation of a more basal mechanism (Millar and Waterhouse, 2005).  Despite obvious broad 
similarities in mechanism, biogenesis and function there are sufficient differences between plant and 
animal microRNAs that independent evolutions seem more likely.  It has even been suggested that 
the evolution of a miRNA like mechanism could be a prerequisite to the evolution of complex body 
plans (reviewed in(Carthew and Sontheimer, 2009; Shabalina and Koonin, 2008)).  
  
1.3.iv  21U piRNAs 
piRNA were first identified in the mouse where they were found to be critical for maintaining 
genome stability in the germline, a function which has since been found to apply to flies and worms 
as well as mammals.  piRNAs are so named due to their association with argonautes of the piwi 
clade, which like piRNAs are found only in metazoans.  The critical role of piRNA is to function in the 
germline to maintain genome stability through transposable element silencing, in particular during 
spermatogenesis.  The rewriting of many silencing chromatin marks during spermatogenesis leaves 
the genome vulnerable to mobile genetic elements normally silenced.  piRNAs appear to play a key 
role in maintaining and re-establishing this silencing, with loss of the piRNA pathway leading to 
infertility (reviewed in (Malone and Hannon, 2009; Weick and Miska, 2014). 
Mammalian piRNAs are typically 25-30nt long however the C. elegans equivalents are 21nt 
long with a 5’ monophophorylated Uracil and undergo 3’ 2’-O methylation by HENN-1.  The 21U 
RNAs function exclusively in the germline and bind to the PIWI class argonaute bind PRG-1 to bring 
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about post transcriptional gene silencing in the cytoplasm.  piRNA biogenesis is distinctive and 
requires neither RdRP nor DCR-1 - primary transcripts are transcribed by RNA polymerase II as 
individual 26nt capped-small RNAs from specific clusters of non-coding loci on chromosome IV and 
then processed into 21nt RNAs by cleavage of the 5’ nucleotides including the cap.  piRNA loci 
clusters act as a memory of transposable elements in the genome with the piRNAs acting in trans to 
silence the transposable elements.  Accordingly, piRNA loci are depleted for exons but are enriched 
in the sense orientation at the start and antisense orientation at the end of full length transposon 
loci of the TC3 class in particular.  The sequence of 21nt piRNAs are highly variable, with no evidence 
of sequence conservation.  However loci are identifiable by conserved up-stream motifs - a large AT 
rich motif, with a short core consensus sequence which is bound by forkhead family transcription 
factors, followed by the small motif YRNT which acts as the initiator element for pol II transcription 
and triggers 21U processing (Ruby et al., 2006).  A second group of 21U RNA originate from capped-
small RNAs which map bi-directionally to transcription start sites of coding genes. These TSS 
associated 21U RNAs have the small but not the large upstream motif and are a subset of capped-
small RNAs from TSS, most of which are not processed into 21U RNAs since they lack the YRNT motif.  
The significance of these TSS- associated 21U RNAs is unknown (reviewed in (Billi et al., 2014).  
The effects of piRNAs are not limited to direct PTGS by 21U RNAs but are amplified by the 
RdRP dependent production of secondary siRNA from target transcripts.  In mammalian systems 
which lack RdRPs an alternative and distinctive ‘ping-pong’ mechanism of biogenesis is seen.   
1.3.v  26G endogenous siRNAs  
In C. elegans all primary endo-siRNAs are 26nt in length with a bias for 5’ guanine, are 5’ 
monophosphorylated (26G siRNAs) and are produced by RNA dependent RNA transcription from pol 
II transcribed transcripts.  26G RNAs map predominantly antisense to spliced mRNAs of annotated 
genes, or to long-intergenic-non-coding RNAs (lincRNAs) and other lncRNAs (reviewed in (Billi et al., 
2014))  .  Two major classes of 26G RNA have been identified based on differences in the argonaute 
with which they associate.  ERGO-1 class 26G RNAs are abundant in embryos, larva and in the 
oogenic gonad, whilst ALG-3/4 class 26G RNAs are found in the spermatogenic gonad.  The two 
classes share a core set of biogenesis factors known as the ERI complex.   
The production of both classes of 26G RNAs is dependent on the ERI complex consisting of 
RdRP RRF-3, dicer (DCR-1), dicer-related helicase DRH-3, exonuclease ERI-1, dsRBD protein RDE-4, 
Tudor domain protein ERI-5, and ERI-3.  dsRNAs are produced by RDRP dependent transcription from 
long transcripts in the cytoplasm, such as mRNAs and lincRNAs, then processed by Dicer to give short 
dsRNAs with 2nt overhangs at each end.  This produces a 26nt siRNA with a monophosphorylated 5’G 
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terminus.  For ERGO-1 class siRNAs the methyltransferase HENN-1 is required to produce a 2’O-
trimethylated 3’ end whilst ALG-3/4 class siRNAs remain 3’ hydroxylated.   
The ERI complex dependent mechanism of primary endo-siRNA production seems to be the 
predominant mechanism In C. elegans however other sources of endogenous long dsRNA are also 
possible including dsRNA produced due to overlapping convergent transcription at transposons, 
cryptic loci and aberrant transcripts.  In drosophila some siRNAs are produced from structured loci, 
an origin more typical of miRNA.   
ALG-3/4 siRNAs are produced in the spermatogenic gonad where they are needed for 
successful spermatogenesis.  The paralogues ALG-3 and ALG-4 act largely redundantly but loss of 
function of both results in severe defects in spermatogenesis, in particular at 25 °C  (Conine et al., 
2010).   ERGO-1 class siRNAs are produced in the oogenic gonad and early embryo but perdure 
throughout development (reviewed in (Billi et al., 2014)).  They map antisense to both coding genes 
and non-coding regions and likely play a number of roles including the silencing of recently 
duplicated genes, pseudogenes and transgenes and the maintenance of centromeric regions 
(reviewed in (Billi et al., 2014; Fischer et al., 2013)).  
26G siRNAs display complete or near complete target complementarity and targeting by the 
26G/ERGO-1 or 26G ALG-3/4 complexes acts at a post-transcriptional level in the cytoplasm to bring 
about gene silencing likely via target cleavage.  Target mRNAs are then used as substrates for the 
production of secondary siRNAs which can act at the post-transcriptional or co-transcriptional level 
due to the actions of a diverse set of argonautes belonging to the WAGO clade (reviewed in (Billi et 
al., 2014; Fischer et al., 2013)).  
 
1.3.vi  The exogenous siRNA pathway 
The exogenous siRNA pathway, the primary purpose of which is thought to be as a viral 
defence mechanism, can be easily manipulated as a way of silencing endogenous genes by the 
introduction of exogenous dsRNA complementary to the endogenous target.   
In C. elegans long dsRNAs can be introduced artificially via feeding, soaking, transgene 
expression or microinjection (reviewed in (Zhuang and Hunter, 2012a)).  Once in the cytoplasm the 
long dsRNA is first bound by the DICER family endonuclease DCR-1 and the dsRNA binding protein 
RDE-4.  Following cleavage by DCR-1 the short dsRNA, which is 21-24nt long with 2nt single stranded 
overhang at each 3’ end, is bound by the argonaute family protein RDE-1 together with auxiliary 
proteins to form the pre-RISC.  Following passenger strand cleavage by argonaute RDE-1 and 
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methylation of 3’ end by HENN-1, the mature RISC made up of a guide RNA, an argonaute and 
auxiliary factors are formed.  The short single stranded RNA targets the RISC to complementary RNA 
transcripts in the cytoplasm which are bound and cleaved to induce gene silencing.  
Complementarity between guide and target RNAs in the exogenous pathway is always high, and 
usually perfect (reviewed in (Ghildiyal and Zamore, 2009)). 
RDE-1 is the only Argonaute family member essential for the exo-RNAi pathway (Tabara et 
al., 1999).  It is required for binding primary exo-siRNAs, cleavage of the passenger strand and 
initiation of the RNAi response but studies have found that it does not directly bring about target 
cleavage, slicer activity being very low (Steiner et al., 2009).  Instead RDE-1 recruits ribonucleause 
RDE-8 for target cleavage (Tsai et al., 2015).   
A number of aspects of the exogenous RNAi response in C. elegans contribute to the robust 
organism wide response, which is less apparent in other, particularly mammalian systems. Firstly, 
RNAi can be initiated by environmental uptake of dsRNA, either via feeding or soaking.  Secondly, the 
response is systemic - the RNA induced silencing can spread between cells and tissues. This together 
with the fact that most cell types will readily take up long dsRNA likely contributes to the flexibility 
and seeming indifference the system displays to the mechanism of exposure to the original trigger.  
Thirdly, the amplification of the silencing signal through the production of secondary siRNAs coupled 
to secondary argonautes multiplies the PTGS effects and mediates co-TGS via the nuclear RNAi 
response (Gu et al., 2012; Pak et al., 2012).  This second wave of response is key to the 
transgenerational heritability of RNAi effects seen in the C. elegans germline, with RNAi induced 
phenotypes being frequently reported up to 4 generations after exposure to exo-RNAi triggers and 
over 10 generations for piRNA related silencing (Sapetschnig et al., 2015).  
 
1.3.vii  Amplification and diversification-  22G secondary siRNAs 
The targeting of mRNAs in the cytosol by RDE-1 RISC in the exo-RNAi pathway, PRG-1 RISC in 
piRNA pathway and ALG-3/4 and EGRO-1 RNA induced silencing complexes in the 26G siRNA 
pathways in fact represents only the first stage of the effects of each of these pathways.  The cleaved 
target transcript is then used as a template for the production of secondary siRNAs via an RDRP 
dependent, dicer independent mechanism (Alder et al., 2003; Pak and Fire, 2007; Shi et al., 2013; 
Sijen et al., 2001, 2007; Tsai et al., 2015b).   
These secondary siRNAs are 22nt long, 5’ tri-phosphorylated and 3’ hydroxylated with 5’ 
guanine bias.  22G siRNAs are produced as short single stranded siRNAs by RdRP dependent 
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unprimed synthesis from target transcripts.  The endoribonuclease RDE-8 is recruited by the RDE-1 
RISC to cleave target mRNAs and generate 3’ uridylated fragments which are used as templates for 
22G production (Tsai et al., 2015) via a mechanisms which requires the RDRPs RRF-1 and/or EGO-1, 
the dicer-related-helicase DRH-3 and the tudor-domain protein EKL-1 to form an RDRP module (Gu et 
al., 2009; Pak and Fire, 2007; Sijen et al., 2007).  The exact role of EKL-1 in the RDRP module is 
unknown however it is known to interact with DRH-3.  DRH-3 is a key element of both the EGO-
1/RRF-1 and RRF-3/ERI complexes and is proposed to act in template secondary structure relaxation, 
promoting sequential initiation of polymerisation, and 22G dissociation.  RRF-1 and EGO-1 are 
encoded in an operon but show quite distinct expression patterns.  Both contribute to the 22G 
population with the germline expressed EGO-1 alone responsible for CSR-1 class 22G RNA production 
and RRF-1 responsible for 22G production in the soma (reviewed in (Billi et al., 2014)).  
Secondary siRNA production amplifies the silencing signal and are key to generating a robust 
RNAi response. 22G siRNAs are also the major effectors of the 26G and 21U pathways.  Secondary 
siRNA synthesis also biases the siRNA pool to target expressed genes as only those primary si/piRNAs 
with an expressed target will be amplified.  In addition to amplification of the silencing signal,  the 
secondary siRNA response also allows for a diversification in the downstream effects of RISC 
targeting via the diverse actions of the WAGO (Worm specific Argonaute) clade argonautes with 
which they associate (Yigit et al., 2006) and increases the longevity of the silencing signal.   
The WAGO clade is a greatly expanded nematode specific argonante clade members of which 
seem to bind exclusively to 22G siRNAs.  Unlike the argonautes which bind to primary siRNA, miRNA 
or piRNAs which have the conserved residues of the catalytic triad of the endonuclease like PIWI 
domain necessary for direct target strand cleavage, all but one members of the WAGO clade have 
lost this ‘slicer’ ability, hinting at different mechanisms of actions and functional diversity (Aoki et al., 
2007; Yigit et al., 2006; reviewed in (Buck and Blaxter, 2013)). 
A large number of the WAGO argonautes act semi-redundantly in the cytoplasm to bring 
about robust PTGS via mechanisms such as translational repression, mRNA destabilisation and 
indirect target cleavage and degradation via the recruitment of auxiliary proteins to the target bound 
RISC; enhancing and potentiating the effects of PTGS originated by the primary siRNA/piRNA RISC.  
Such is the redundancy of these cytoplasmic WAGOs that loss of function of multiple argonautes is 
needed for the secondary siRNA response to be completely lost, as evidenced by the MAGO mutants 
(Yigit et al., 2006).  
 However, a number of other members of the WAGO class act non-redundantly in unique 
roles.  Nuclear targeted argonautes such as NRDE-3, HRDE-1 and CSR-1 are able to target nascent 
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transcripts and thus orchestrate co-transcriptional effects, including co-TGS and chromatin 
modifications.  The mechanisms by which these nuclear argonautes exert their effects remain poorly 
understood but they play important roles in a variety of processes including transgenerational gene 
silencing, nuclear RNAi, germline maintenance and even chromosome segregation (for review see 
(Cecere and Grishok, 2014; Holoch and Moazed, 2015)).   
 
1.3.viii  Nuclear targeted argonautes - Nuclear RNAi, heritability and the csr-1 pathway 
 The argonautes NRDE-3 and HRDE-1 both contain bipartite Nuclear localisation signals and 
are imported to the nucleus upon 22G binding (Guang et al., 2008).  NRDE-3 acts in the soma while 
HRDE-1 acts in the germline to mediate transcriptional gene silencing in both exogenous and 
endogenous RNAi pathways(Buckley et al., 2012).  Both engage the same core nuclear silencing 
machinery- the components of the NRDE (nuclear RNAi defective) to form the RNA induced 
transcriptional silencing (RITS) complex.  Upon nuclear localisation 22G/NRDE-3 and 22G/HRDE-1 
bind to nascent complementary transcripts and recruit NRDE-2 which together recruit NRDE-1 to 
mediate inhibition of transcription elongation.  NRDE-1 is also recruited to adjacent chromatin by 
NRDE-4 to direct further silencing through H3K9 trimethylation at target loci (Burkhart et al., 2011; 
Burton et al., 2011; Guang et al., 2010; Mao et al., 2015; Zhuang et al., 2013). The nuclear RNAi 
pathway acts in parallel to the cytoplasmic 22G/WAGO RISCs to ensure robust silencing.  
 22G siRNAs allow for silencing to perdure after the primary trigger is no longer expressed.   
NRDE-3 bound 22G siRNAs in the soma ensure that endogenous ERGO-1 targets continue to be 
effectively silenced throughout larval development, despite the fall in 26G levels after embryogenesis 
just as somatic exo-RNAi silencing perdures after dsRNA trigger removal.  Such perdurance even 
extends across generations, with silencing chromatin marks induced by RNAi being erased and re-
established in the F1 generation via a small RNA dependent mechanism (Burton et al., 2011).  The 
epigenetic inheritance of silencing against somatic targets is NRDE-3 dependent and perdures for a 
single generation whereas the HRDE-1 dependent inheritance of germline silencing can persists for 
far longer (Ashe et al., 2012).  The mechanisms of the establishment and re-establishment of RNA 
induced silencing in the F1 generation and beyond remain unclear but interestingly silencing 
chromatin marks are more robust in the F1 generation than in the parental generation, possibly due 
to the need for very early exposure to the primary trigger to initiate efficient nuclear silencing 
(Burton et al., 2011; Shiu and Hunter, 2017).  After this in the absence of a primary trigger in the 
soma silencing chromatin marks along with 22G siRNA are quickly lost in successive generations.  It 
seems that 22G siRNAs in the soma are unable to undergo further rounds of amplification and it is 
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possible that inherited primary small RNAs are needed to re-establish the secondary siRNA 
population required for nuclear silencing (Burton et al., 2011).  
 In the germline nuclear RNAi is essential for effective genome surveillance of foreign 
elements targeted by the piRNA pathway, acting as an epigenetic memory of non-self which can 
perdure for many generations even in the absence of primary trigger (Ashe et al., 2012).  Loss of 
function of hrde-1, nrde-1, nrde-2 or nrde-4 results in a mrt phenotype equivalent to that seen in 
mutants of upstream piRNA components such as prg-1, resulting in fertility defects (Buckley et al., 
2012).  Unlike in the soma, HRDE-1 bound 22G siRNAs in the germline are capable of undergoing 
further rounds of amplification to form new 22G siRNAs or tertiary siRNAs (Sapetschnig et al., 2015).  
This seems to be the key to the multigenerational perdurance of silencing since like in the soma new 
chromatin marks are laid down each generation.  The germline expressed cytoplasmic argonaute 
WAGO-4 also plays a role in the inheritance of silencing, with WAGO-4 bound siRNAs hypothesised to 
be directly transmitted from parent to progeny (Xu et al., 2018).  
 Interestingly tertiary siRNAs were shown to map to further from the initial target site than do 
the secondary siRNAs, demonstrating the cis spread of silencing along the target gene.  Where 
silencing has been triggered by piRNAs, such as the silencing of a piRNA sensor transgene, tertiary 
siRNAs also mediate the trans spread of silencing, where by a silenced transgene can trigger the 
conversion of an expressed transgene to the silenced state even in the absence of the initial piRNA 
sensor to act as a trigger (Sapetschnig et al., 2015).  This pattern of silencing bears a striking 
resemblance to the phenomenon of paramutation such as that seen in the classic example of 
epigenetic inheritance the maize b1 locus -  a phenomenon now also known to be siRNA dependent. 
 C. elegans argonaute, chromosome segregation and RNAi deficient (CSR-1) is a unique 
member of the WAGO clade.  CSR-1 is the only C. elegans argonaute essential for viability.  As the 
name suggests, loss of CSR-1 leads to defects in chromosome organisation and segregation due to 
failures in chromosome condensation and kinetochore attachment in both germline and somatic 
cells.  Mutants are sterile, show distinctive defects in p-granule aggregation and loss of exogenous 
RNAi efficiency, in particular against germline and embryonic targets.  CSR-1 seems to act in a 
number of unconventional roles; it is the only secondary argonaute to retain ‘slicer’ activity (Aoki et 
al., 2007) yet it seems that the vast majority of CSR-1 target genes are not silenced.  Instead CSR-1 
acts co-transcriptionally to promote the transcription target genes (Cecere et al., 2014).  CSR-1 also 
directs histone modification, is required in holocentromere organisation and chromosome 
segregation (Claycomb et al., 2009; She et al., 2009), plays an important role in the 3’ end processing 
of histone mRNAs (Avgousti et al., 2012), and may also act with pumilio proteins in the cytoplasm to 
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inhibit translation, as well as having a possible role in the exo-RNAi response (reviewed in (Wedeles 
et al., 2013a)).   
CSR-1 22G siRNAs are preferentially transcribed by EGO-1 and are uridylated by CDE-1, 
directing them to the CSR-1 pathway (van Wolfswinkel et al., 2009).  The gene regulatory effects of 
CSR-1 are prolific, targeting and promoting the expression of over 4000 genes which are 
preferentially germline expressed (Cecere et al., 2014; Wedeles et al., 2013a).  These include targets 
of the ALG-3/4 primary siRNA subset and CSR-1 is central to the action of the ALG-3/4 siRNA 
pathway, with CSR-1 acting in the spermatogenic gonad to upregulate expression of target genes 
essential for male fertility (Conine et al., 2013) and to provides a memory of male germline gene 
expression (Conine et al., 2013).  CSR-1 is equally important for protecting gene expression in the 
oogenic germline where it protects germline gene expression (Wedeles et al., 2013b).  CSR-1 target 
transcripts are protected from accidental silencing which could be caused by the spread of tertiary 
siRNA mediated paramutation downstream of the piRNA pathway, therefore acting in antagonistic 
concordance with piRNA mediated genome surveillance (Sapetschnig et al., 2015; Seth et al., 2013).  
Similarly, CSR-1 localisation to chromatin also limits the distribution of centromeric histone identity 
to bounds suitable for proper kinetochore assembly and chromosome segregation.  Antagonism with 
CDE-1 dependent siRNA degradation helps to maintain this balance (van Wolfswinkel et al., 2009).  
CSR-1 also regulates oocyte-embryo transcriptional transition during embryonic genome activation 
(Fassnacht et al., 2018).  The diverse actions of CSR-1, protecting gene expression in the male 
germline via co-transcriptional regulation whilst fine tuning maternal mRNA expression in the 
embryo via PTGS, with even less conventional roles in histone maturation serves to highlight the 
complexity of the small RNA mediated control mechanisms.  
  The full extent of the function of nuclear RNAi in mediating chromatin dynamics is as yet 
unknown.  
1.3.ix  The systemic nature of RNA mediated gene silencing and environmental RNAi 
In C. elegans RNA based silencing signals can be spread between cells, both within the soma 
and from the soma to the germline, mediating parental RNAi.  The molecular basis for the systemic 
nature of RNAi in C. elegans began to be understood with the identification of SID (Systemic RNAi 
Defective) and RSD (RNA spreading defective) mutants (Tijsterman et al., 2004; Winston et al., 2002).  
The SID-1, SID-2, SID-3 and SID-5 mutants are defective in different parts of systemic and 
environmental RNAi (Hunter et al., 2006; Wang and Hunter, 2017).  A number of studies suggest that 
the silencing signal is spread by dsRNA, possibly by a range of different RNA species (Jose et al., 
2011), reviewed in (Chitwood and Timmermans, 2010; Sarkies and Miska, 2014).  
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sid-1 and sid-2 both encode transmembrane channels.  SID-1 is a transmembrane dsRNA 
import channel needed for import of dsRNA into cells (Shih et al., 2009) .  SID-1 is necessary for 
spread of the silencing signal and systemic RNAi is lost with sid-1 (Hunter et al., 2006; Winston et al., 
2002).  Tissues lacking SID-1 transporter expression such as most neurones are refractory to RNAi, 
but susceptibility can be increased by expression of SID-1 (Calixto et al., 2010).  sid-2 loss of function 
mutants are defective in RNAi by feeding.  SID-2 was found to be a transmembrane transporter for 
long dsRNA localised to the apical membrane of the intestinal cells, lining the intestinal lumen.  SID-2 
is required for uptake of dsRNA from the lumen, possibly via endocytosis.  Loss of SID-2 function 
results in an inability for RNAi to be induced via feeding (environmental RNAi) but does not affect the 
ability of the dsRNA induced silencing to spread from cell to cell (Hunter et al., 2006; Winston et al., 
2007).  
SID-5 is required for export of the dsRNA silencing signal from intestine, and from other cells 
and is endosomally localised (Hinas et al., 2012).  RSD-3 is a homologue of human Clathrin interactor 
1, an ENTH (epsin N-terminal homology) domain containing protein involved in vesicle trafficking.  
RSD-3 localises to endosomes and the trans-golgi network and is required for the import of silencing 
RNAs into cells of both the soma and germline, most likely from the pseudocoelom (Imae et al., 2016; 
Tijsterman et al., 2004).  The identification of many endomembrane localised proteins involved in 
RNAi, including the snare sec-22 (Zhao et al., 2017) and RISC components has led to the suggestion 
that rather than taking place freely in the cytoplasm RNAi is a membrane associated process 
(Rocheleau, 2012).    
 
1.3.x  Subcellular localisation/organisation  
There is substantial evidence that RNA silencing processes are membrane associated in C. 
elegans, fly, plant and mammalian systems.  In C. elegans there is a clear role for the endomembrane 
system in systemic and environmental RNAi as both SID-5, RSD-3 are localised to different 
compartments of the endomembrane. The Mammalian homologues of SID-1, SIDT2  has also been 
shown to be localised to the endosome and lysosome (Jialin et al., 2010; Nguyen et al., 2017). 
 Beyond this many core components of the small silencing RNA machinery are 
endomembrane associated, including the RISC and dicer.  The rough ER is emerging is as the most 
likely site of translational repression by the miRISC and the siRISC.  Mammalian AGO2 was first 
isolated as a golgi/ER associated protein (Cikaluk et al., 1999) and  miRNA/siRNA loaded AGO2, along 
with dicer  and other RISC loading complex  (RLC) factors have since been shown to co-sediment with 
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the rough ER (Stalder et al., 2013).  Stalder et al. further show that the siRISC is anchored to the 
cytosolic side of the rough ER by RLC factors TRBP and PACT. In plants, AGO1 also localises to the ER 
and the rough ER localised integral membrane protein AMP1 is required for the translational 
repression of target mRNAs by miRNAs.   
Furthermore, the efficiency of silencing by small RNAs is dependent on endosomal 
trafficking.  miRISC components AGO2 and GW182 congregate in GW-bodies which have been shown 
to correspond the endosome/MVB (Gibbings et al., 2009; Lee et al., 2009).  The maturation to 
multivesicular bodies is necessary for an efficient silencing response; depletion of ESCRT 
components, required for the sorting of proteins into the MVB, compromises miRNA activity 
(Gibbings et al., 2009).  Whilst MVB to lysosome fusion has a negative effect on the RNAi response. 
The snare sec-22 has been found to reduce RNAi efficiency by regulating late endosome/MVB fusion 
to lysosomes, acting in a SID-5 dependent manner (Zhao et al., 2017).  Kim et al. propose that a 
picture is emerging where in the RNAi mediated processes are closely linked to the endomembrane 
system; not only in the transfer of the silencing signal in systemic RNAi, but with the rough ER as the 
site of RISC loading and silencing initiation and the MVBs as sites of RISC recycling (Kim et al., 2014).  
The mutator class of genes are required for transposon silencing as well as exogenous RNAi.  
The six mutator proteins, together with the RDRP RRF-1, and the DEAD box helicases SMUT-1 and 
RDE-12, co-localise to peri-nuclear localised punctate foci in the C. elegans germline known as 
mutator foci.  Mutator foci are proposed to be the key sites of siRNA amplification.  The mutator foci 
are not membrane associated but are instead proposed to exist as phase separated compartments, 
nucleated by the intrinsically disordered protein MUT-16 (Phillips et al., 2012, 2014; Yang et al., 2014; 
Zhang et al., 2011).  
 
1.3. xi  The efficiency of RNAi - core machinery and competition between pathways 
 As may have become apparent, the core RNAi machinery of all small RNA pathways in C. 
elegans and other organism consists of the same, or homologues of the same, central protein 
components.  These are RNA endonucleases such as dicer-like-proteins, DEAD/DEAH box helicases, 
dsRNA binding proteins (typically type II with a helicase domain) and of course argonaute (piwi-argo) 
family proteins.  In C. elegans as in other groups RDRPs play key roles in primary and secondary siRNA 
generation, however insects and mammals have lost all RDRP genes and therefore rely on 
bidirectional transcription to generate dsRNA duplexes (Lewis et al., 2018).  Many such core 
components were identified in mutants defective in the exo-RNAi response, so called RNAi defective 
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(RDE) mutants.  Since a sole dicer enzyme is responsible for the production a range of different small 
RNA in C. elegans additional factors must direct dicer to generate this specificity. 
In C. elegans, despite the robust and systemic nature of the RNAi response, it is none the less 
the case that certain tissues and genes are resistant to RNAi induced knock down, whilst other 
display almost total knockdown and some a partial knock down.  Furthermore the response to RNAi 
in C. elegans displays a stochastic variation or noise; within a population of identical worms exposed 
to the same stimulus, some will show RNAi induced knockdown whilst other will not (Arbel-Goren et 
al., 2014).  Alterations in the efficiency of RNAi can therefore be seen in changes both in the severity 
of the RNAi phenotype, caused by the degree of knockdown within that worm and in the percentage 
of worms in the population displaying a given phenotype.  
A range of mutants have been identified which display either an enhanced or reduced 
efficiency of RNAi (reviewed in Joyce et al., 2006).  In an enhanced RNAi (Eri) mutant genes which 
display little or no knockdown in a WT background can be knocked down efficiently, whilst in 
mutants with reduced efficiency very little response is seen. Mutations of many core components of 
the exogenous RNAi pathway leads to complete loss of the RNAi induced phenotype as seen in RNAi 
defective (Rde) mutants.  Mutant phenotypes reveal complex interdependencies and antagonisms 
between the availability of different pathway components.   
As already discussed, loss of function of the Argonaute RDE-1 leads to complete loss of the 
RNAi response, with primary exo-siRNAs generated in the same quantity but leading to no 
phenotype. (Parrish and Fire, 2001; Tabara et al., 1999).  Whilst loss of multiple WAGO/MAGO class 
Argonautes downstream leads to a reduced RNAi response, suggesting many WAGO/MAGO class 
Argonautes each contribute incrementally to RNAi, including SAGO-1, SAGO-2 and PPW-1.  MAGO 
availability appears to be a limiting factor in the efficiency of RNAi which efficiency can be increased 
by overexpression (Yigit et al., 2006). 
 In the exo-RNAi pathway the dsRNA binding protein RDE-4  acts as a dimer to bind long 
dsRNA and recruit DCR-1 (Tabara et al., 1999, 2002).  In RDE-4 loss of function mutants primary 
siRNA are produced at much lower than WT levels in response to injection of dsRNA.  The RDE-4 but 
not the RDE-1 defect can be partially bypassed by addition of siRNAs, suggesting a role for RDE-4 in 
the recognition of dsRNA leading to siRNA production (Parrish and Fire, 2001).  
The DExH/D box RNA helicase DRH-1  (Dicer related helicase) interacts with both RDE-4  and 
dicer and also plays a role in the RNAi response (Tabara et al., 2002). Deletion of DRH-1 leads to loss 
of anti-viral immunity in C. elegans due to lack of viral dicer targeting of viral RNA (Ashe et al., 2013).  
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DRH-1 is one of 3 C. elegans homologues of the mammalian viral recognition protein RIG-1. DRH-3 is 
required for an efficient RNAi response and in the endogenous RNAi response in the germline (Gu et 
al., 2009). 
Many RDE proteins have been found to have a role in secondary siRNA production, with 
some of the same proteins apparently involved in secondary siRNA production in both the exogenous 
and endogenous siRNA pathways (Zhang et al., 2012).  The  RDRPs RRF-1 and EGO-1 are required for 
secondary siRNA production,  with EGO-1 playing an essential role in the germline (Aoki et al., 2007; 
Smardon et al., 2000).  Many more factors are also needed for efficient RNAi response such as the 
ribonuclease RDE-8, which is recruited by RDE-1 to target transcripts and recruits RDRPs (Tsai et al., 
2015).  The helicases  DRH-3  and RDE-12 are also required  (Gu et al., 2009; Shirayama et al., 2014; 
Yang et al., 2014).  It is common for genes involved in the production of WAGO class 22G secondary 
siRNA to show a dosage-sensitive RNAi defective phenotype, as seen in rde-10,  rde-11, rsd-2, rsd-6 
and haf-6 mutants, where injection of high concentration of dsRNA can compensate for the defect 
(Zhang et al., 2012) .   
The secondary siRNA binding argonaute CSR-1 functions mainly in endo-RNAi pathway but 
also promotes exo-RNAi efficiency in the germline (Gu et al., 2009; Seth et al., 2013; Wedeles et al., 
2013a, 2013b; Yigit et al., 2006). 
It is thought that RNA interference originally evolved as a viral defence mechanism and 
competition between viral derived exo-siRNAs and endogenous small RNAs alters endogenous- siRNA 
and miRNA dependent gene expression in virally infected worms (Sarkies et al., 2013).  Furthermore 
antiviral immunity is lost in strains with a defective RNAi response. (Ashe et al., 2013). This RNAi 
based antiviral immunity does not require a functional systemic nor transgenerational RNAi response 
but appears to acts cell autonomously (Ashe et al., 2015).  
A range of mutants have also been identified which display an enhanced exo-RNAi response.  
So-called Enhanced RNA interference (Eri) mutants were first noted for their ability to enhance the 
efficiency of RNAi screens against refractory or neuronally expressed genes.  Many such mutants 
have been found to be loss of function in endogenous RNAi pathways components, leading to theory 
of competition for shared resources between the pathways (Sarkies et al., 2013; Zhuang and Hunter, 
2012b).  In such models loss of function in one pathway frees up shared components for use in the 
exo-RNAi pathway.  The 9 classical eri class mutants are all associated with DCR-1 and are thought to 
be required for endo-siRNA production (Zhuang and Hunter, 2011, 2012a, 2012b).  
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For example, loss of function mutants of RDRP rrf-3/ eri-2 display enhanced RNAi induced 
gene silencing and have been used to enhance RNAi screens (Simmer et al., 2003).  RRF-3 is 
suggested to compete with RDRPs RRF-1 or EGO-1 (Kishore et al., 2006; Massirer et al., 2012; Simmer 
et al., 2002, 2003).  Secondary Argonautes, DICER, and SID-1 are all proposed to be limiting resources 
as overexpression can increase RNAi efficiency (Zhuang and Hunter, 2012b).  Competition is also 
proposed to differ between tissues, contributing to tissue specific difference in RNAi (Zhuang and 
Hunter, 2011).  All 9 original Eri mutants could be rescued maternally and also enhance RNAi in the 
germline (Zhuang and Hunter, 2012a).  Several including eri-1, rrf-3, eri-3 and eri-5 also display a 
temperature sensitive sterility at 25°C. 
Other Eri mutants act by antagonising the RNAi pathway.  The RNAse T enzyme ERI-1 
degrades siRNAs and is expressed most strongly in the gonad and neurones, likely contributing to 
neuronal resistance (Jadiya and Nazir, 2014; Kennedy et al., 2004).  RNAi mediated gene silencing in 
the soma is also antagonised by the RNA editing adenosine deaminase ADR-2.  Repetitive transgene 
arrays in the germline are readily silenced whilst the silencing of repetitive arrays in the soma is less 
common.  However, loss of function of ADR-2 or its regulator ADBP-1  generates an RNAi 
hypersensitive background in which somatic transgenes are silenced via an rde-1 dependent 
mechanism (Knight and Bass, 2002; Ohta et al., 2008).  
Another group of Eri mutants are transcriptional repressors which act as part of the Rb 
complex and form a subset of the class B synthetic multivulval gene class (synMuvB).  This class of 
mutants includes Retinoblastoma (Rb) homologue lin-35, and lin-15B.  Loss of function of LIN-35 
results in an enhanced exo-RNAi response, including an enhanced germline and neuronal RNAi 
response, enhanced somatic transgene silencing,  reduced function in the endogenous RNAi pathway 
and temperature sensitive sterility, as seen in other ERI mutants (Joyce et al., 2006; Lehner et al., 
2006; Wang et al., 2005).  lin-35 mutants and other SynMuvB mutants which form part of the Rb 
complex also show misexpression of germline specific P-granules and other germline specific genes. 
The requirement for RDRP RRF-1 for an efficient RNAi response in the soma is also relaxed in lin-35 
mutants, possibly due to the germline restricted RDRP EGO-1 becoming more widely expressed  
(Wang et al., 2005; Wu et al., 2012).  The enhanced RNAi effects caused by loss of function of the Rb 
complex are additive to those seen in the classical Eri mutants (Wang et al., 2005). For example the 
strain KP3948 with genotype eri-1(mg366) IV; lin-15B(n744) X is frequently made use of due to its 
RNAi efficiency being greater than that of eri-1 mutants alone. 
LIN-35 is a key tumour suppressor regulating cell cycle transition and has numerous 
developmental roles.  In the developing embryo its expression is regulated by the miR-35-41 set of 
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miRNAs which have a critical role in early development.  The miR-35-41 family of miRNA have also 
been shown to regulate sensitivity of the exo-RNAi response, further highlighting the 
interconnectivity between the different small RNA pathways. The loss of miR-35-41 results in loss of 
LIN-35 accumulation, enhanced expression of endo-siRNA target genes- suggesting reduced function 
in the endo-siRNA pathway, and enhanced response to RNAi by feeding; supporting the idea of 
competition between these pathways influencing exo-RNAi efficiency.  This phenotype can be 
rescued by overexpression of lin-35 from transgenes or by the maternal rescue to miR-35-41 or lin-35 
(Massirer et al., 2012; Mushegian, 2016). 
Efficient RNAi in certain tissues, such as the pharynx, and efficient transgenerational RNAi 
has been shown to require the nuclear RNAi pathway (Burton et al., 2011; Shiu and Hunter, 2017).  
Initiation of the nuclear RNAi pathway requires early exposure to dsRNA such that the RNAi induced 
silencing in the pharynx is only seen in the second generation of RNAi by feeding experiments. 
However lin-15 and to a lesser extent eri-1 mutants the sensitivity and/or breadth of the critical 
window in which the nuclear RNAi pathway may be triggered is increased, allowing some degree of 
silencing in the first generation (Shiu and Hunter, 2017).  
 Other mutants with an enhanced RNAi response are involved in the transport of or 
localisation of the dsRNA or the RNAi machinery. The snare protein SEC-22 was recently found to 
interact with SID-5.  Loss of function of sec-22 results in a cell autonomous enhanced RNAi response 
(Zhao et al., 2017).   As previously discussed the correct localisation and targeting of both RNAi 
effectors and targets within the endomembrane system is likely to have an important role in the 
efficiency of small RNA mediated gene silencing (reviewed in (Kim et al., 2014)).  Loss of function of 
MUT-16 strongly reduces the efficiency of the exogenous RNAi response due to the disruption of the 
mutator foci and mutator protein complex (Phillips et al., 2012; Zhang et al., 2011). 
Interestingly insulin signalling mutants daf-2  and age-1 have also been reported to regulate 
the RNAi response (Wang and Ruvkun, 2004). The insulin like receptor DAF-2 and the PI3 kinase AGE-
1 are known to transduce signals regulating metabolism, development, stress resistance and lifespan 
but decreased DAF-2/ AGE-1 signalling also enhances the exo-RNAi response. Small RNAs are known 
to play critical roles in development and the dauer decision.  
Environmental conditions are commonly reported to affect the RNAi response and the 
influence the activity of the small RNA pathways.  A number of small RNA regulated processes are 
temperature dependent.  For example at 20°C germline expressed transgenes are rapidly silenced 
within a few generations of insertion but are not silenced at 25°C (Strome et al., 2001),  similarly 
levels of the siR-1 endogenous siRNA  are 10 fold lower at 25°C  than at 20°C (Fischer et al., 2013). 
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Temperature has been shown to affect the RNAi response in mosquitos, leading to increased 
susceptibility to viral infection (Adelman et al., 2013).  Physiological stresses such as growth at 25°C 
or starvation induced developmental arrest also trigger siRNA dependent changes to gene expression 
which may be inherited for several generation after the stress is removed (Rechavi et al., 2014; 
Schott et al., 2014).  Starvation has also been reported to affect the exo-RNAi response (Zhuang and 
Hunter, 2012a) and also leads to heritable changes in the piRNA pathway (Angelo, 2009).  Finally Lin-
35/Rb expression is also increased in response to starvation (Láscarez-Lagunas et al., 2014).  
 
1.4 The IP3 signalling pathway regulates RNAi 
Work in the Baylis lab found that the mutants of a number of components of the IP3 
signalling pathway displayed an altered RNAi response (Nagy et al., 2015).  Loss of function of 
PLCβ/EGL-8 or the IP3 receptor ITR-1 results in an enhanced RNAi response to feeding and transgene 
expression.  Whilst loss of IPP-5 leads to an RNAi resistant phenotype.  This shows that reduced IP3 
signaling leads to an enhanced exo-RNAi response whilst increased levels of IP3 as seen in ipp-5 
mutants leads to a reduced response.  Furthermore, the enhanced RNAi response  of itr-1 and egl-8 
mutants is additive to that seen in classical Eri mutants, such that eri-1; itr-1 double mutants are 
more sensitive to RNAi than eri-1 or itr-1 alone,  and eri-1;egl-8;lin-15B triple mutants are further 
enhanced beyond eri-1;lin-15B double mutants.  
Interestingly tissue specific rescue of itr-1 in the intestine, but not in target cells, was able to 
rescue the enhanced RNAi phenotype, suggesting that this is the site of action of the IP3 signalling 
pathway systemically regulating the RNAi response. This was found to be the case not only in the 
case of environmental RNAi, where dsRNA triggers must be taken up through the intestine, but also 
in transgene induced RNAi, with dsRNA produced in the pharynx able to silence GFP in the body wall 
muscle. This demonstrates that signaling in the intestine acts non-cell autonomously to affect the 
regulation of RNAi systemically. The intestine plays many roles in C. elegans, being not only 
important in the regulation of defecation but also as a key site of signaling in stress response 
pathways, host-pathogen interactions and aging. It is also the primary site of the synthesis and 
export of yolk proteins to the developing oocyte.  
These intriguing findings raise a number of questions; foremost, how the IP3 signaling might 
be acting to regulate the RNAi response and whether other small RNA pathways are affected and 
whether the RNAi response is being regulated in response to physiological or environmental 
conditions via the IP3 signaling pathway?  Although IP3 is a common second messenger utilized 
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downstream of a diverse range of cellular receptors the involvement of EGL-8/PLCβ suggests that G-
protein signalling is involved.    
 My aims in this thesis were to better understand the context of the IP3 signalling events 
which are regulating the RNAi response and to further investigate which aspects of the endogenous 
RNAi pathways were altered in IP3 signalling mutants.  Firstly, I sought to identify the upstream 
activator of EGL-8 in the pathway regulating RNAi by screening Gα signalling mutants for an altered 
RNAi response, using a range of assays.  EGL-8 is canonically activated by Gαq homologue ELG-30. 
However, EGL-30 was ruled out as an activator of EGL-8 in this mechanism, since EGL-30 loss of 
function does not result in an enhanced RNAi response.  Instead the Gαo/I homologue, GOA-1, was 
identified as the most likely activator of EGL-8 due to the strongly enhanced RNAi response in goa-1 
loss of function mutants.  Other Gα subunits and known regulators of GOA-1 and EGL-30 signalling 
interactions were also analysed and a loss of function mutant of the RGS protein EAT-16 was also 
found to have an enhanced RNAi response.  
 Next, with the aim of better understanding how changes in IP3 signalling might be influencing 
the RNAi response, I looked to see if the Eri phenotype of itr-1 mutants could be explained by 
changes to the endogenous small RNA pathways.  Small RNA sequencing was used to look for 
evidence of such changes, followed up with qPCR.  However, no substantial changes to the 
endogenous small RNA pathways were found.   
 Finally, following the interesting work of Shui and Hunter suggesting that classical Eri and 
SynMuvB mutants have an increased sensitivity to nuclear RNAi, I utilised the myo2p::GFP transgenic 
system to test for effects of IP3 signalling on nuclear RNAi.  The results suggest no specific alterations 
to the nuclear RNAi pathway in these mutants, although itr-1 mutants do have a mildly increased 
sensitivity.  
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Materials and Methods 
 
2.1  C. elegans maintenance 
 
All Worms were cultured on NGM (Nematode Growth Media) agar plates spread with OP50 E. coli 
and grown at 20°C unless otherwise stated.  Worms were cultured using standard media and 
standard techniques and were transferred regularly to avoid contamination, starvation or 
overcrowding as established and outlined in (Brenner, 1974; Lewis and Fleming, 1995).  See table 2.1 
for all C. elegans strains used in this work, with further details of strains given in the strains tables in 
the relevant chapters. 
 
2.1.i  NGM plates  
An NGM solution consisting of 1.5g NaCl, 8.5g agar and 1.25g peptone was dissolved in 487.5 ml 
distilled water, autoclaved and allowed to solidify for storage until needed (produced by the 
department media facility).  This NGM was then microwaved until melted, cooled to 65°C in an 
incubator, then allowed to stand at room temperature until cool enough to handle.  The following 
were added under aseptic conditions: 500μl 1M CaCl2, 500μl 1M MgSO4, 500μl cholesterol (5mg/ml in 
ethanol), 12.5ml 1M KPO4 (pH 6.0).  The final NGM solution was poured into petri dishes. 
 
2.1.ii  OP50 cultures and seeding 
All steps were carried out using aseptic technique.  Liquid culture of single OP50 colonies were grown 
overnight in standard LB broth (Lennox) at 37°C with shaking then stored at 4°C until needed.  Liquid 
OP50 culture was added to each NGM plate, spread and allowed to grow at 30°C overnight until a 
thin but confluent bacterial lawn was formed (30μl per 50mm plate, 200μl per 100mm plate).  
Spread plates were stored at 4°C until used.  
 
2.1.iii  Embryo preparation 
An embryo preparation using hypochlorite solution was used to produce axenised embryos in order 
to clean contaminated stocks and produce synchronised worm populations.  Plates of gravid adults 
cleared of bacteria were washed into a 15ml falcon tube into a total volume of 3.5ml M9 solution to 
which was added 0.5ml 5N NaOH and 1ml NaClO (5-10% bleach).  Tubes were vortexed 
intermittently until worms disintegrated to release eggs (~10min) at which point tubes were 
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centrifuged at 1300g for 30sec, to loosely pellet eggs, then the supernatant removed and replaced 
with sterile H2O and mixed.  To create synchronised L1 populations centrifugation, supernatant 
removal and rinsing was repeated the final time adding M9 buffer [3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 
1 ml 1 M MgSO4, H2O to 1 litre. Sterilize by autoclaving] to a final volume of 5ml.  Axenised eggs in 
M9 were incubated at 21°C overnight with gentle shaking to hatch into L1s in the absence of food.  
 
2.2  RNAi by feeding  
 
All RNAi experiments were carried out using RNAi by feeding using the system of IPTG inducible 
dsRNA expressing bacteria of the E. coli strain HT115(DE3) carrying modifications of the L4440 vector, 
as established by Timmons, Court and Fire, 2001.  The system works as follows:  HT115(DE3) carries a 
stably inserted and IPTG inducible T7 polymerase gene, the L4440 vector produces dsRNA products 
transcribed by the T7 polymerase (Figure 2.1) (Timmons et al., 2001).  dpy-13, lin-1, lin-31 and unc-15 
RNAi clones used were from the Ahringer RNAi library (Kamath and Ahringer, 2003), a clone carrying 
the plasmid pPD128.110 was used for gfp RNAi (Timmons et al., 2001),   a related clone with an RNAi 
plasmid  carrying the E. coli  chloramphenicol acetyl transferase (cat) gene was used as a control (a 
gift from A. Fire).  All experiments were carried out using NGM worm culture plates with added 
carbenicillin (50μg/ml) and IPTG (1mM) spread with dsRNA inducing bacteria (RNAi NGM plates). 
 
Figure 2.1. The L4440 vector used to express dsRNA. Image reproduced from dnai.org. Copyright 2003, Cold 
Spring Harbor Laboratory. All rights reserved, noncommercial, educational use only. Material in DNA Interactive 
may not be used in any form by organizations or commercial concerns, except with express permission. 
 
2.2.i  Procedure 
RNAi assay plates were established as follows: 6-10 egg laying adults (depending on strain fertility) 
were placed on an RNAi NGM plate and allowed to lay eggs for approximately 6 hours before being 
removed.  The F1 progeny hatched and matured on the plate and were scored for the relevant 
phenotype 3 days after setup, at the adult stage.  
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2.2.ii  RNAi bacterial cultures 
Cultures were grown on standard LB Agar plates with added carbenicillin (50μg/ml) and tetracycline 
(12.5μg/ml).  Single colonies of bacteria were picked in liquid LB broth (Lennox) with added 
carbenicillin (50μg/ml) and grown overnight at 37°C with shaking then stored at 4°C until needed.  
Overnight cultures were seeded (30μl /50mm plate) and spread onto NGM plates with added 
carbenicillin (50μg/ml) and IPTG (1μM) and grown overnight at 30°C.    
 
2.2.iii  RNAi assay scoring - lin-31, lin-1, dpy-13 and unc-15 
For lin-31, lin-1, dpy-13 and unc-15 assays 3 plates of RNAi treated worms were scored per strain and 
per repeat.  Worms were scored by placing the plate over a transparent grid of 5mmx 5mm squares 
and tallying according to phenotype of worms visible in each square at that time. Double counting 
was minimised by working systematically across the grid but could not be ruled out entirely due to 
the motile nature of the worms. Worms were viewed at 25x magnification using a dissecting 
microscope.  For lin-1 and lin-31 RNAi assays worms were counted as WT if no vulval phenotype was 
visible, MUV if multiple vulvas were visible, or protruding vulva if a prominent vulval bump was 
visible.  For unc-15 assays worms were scored as WT if no locomotive defect was observed, impaired 
if locomotion was abnormal, severe if locomotion was not possible but some movement of the head 
was seen or paralysed if completely immobile.  Stationary worms were poked in the tail to encourage 
locomotion before scoring.  For dpy-13 assays absolute measuring was not possible when scoring by 
eye alone.  Reduction in size was estimated by comparison to an untreated plate of worms of the 
same strain and worms were scored as severe if estimated to be less than half normal length, 
moderate if a definite reduction was discernible estimated less than ¾ length, WT if no effect was 
discernible. The natural variation in length of the strain tested made accurate scoring by eye difficult.   
 
2.2.iv  dpy-13 RNAi - measurement of worm length 
dpy-13 RNAi assays were repeated with an improved scoring technique. One plate of dpy-13 treated 
worms and one plate of control (cat) treated worms were set up per strain per repeat as previously 
described.  Sections of plate containing worms were photographed using a Leica MZ FLIII microscope 
set to 2.5x magnification paired with a Q imaging micropublisher 5.0 cooled RTV camera and 
accompanying Q imaging software and saved as a Tiff.  Following image capture worm length was 
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measured using the software ImageJ (ImageJ2,Fiji distribution) (Rueden et al., 2017; Schindelin et al., 
2012) by drawing a segmented line along the midline of the worm and measuring line length.  
2.2.v  GFP RNAi of GABAergic neurones 
One plate per strain of worms carrying the unc-47p::GFP  transgene were treated with gfp RNAi or 
control (cat) RNAi.  Young adult worms were mounted onto a 10 well multi-test microscope slide (MP 
biomedicals), in a solution of tricaine/levamisole (0.02% tricaine, 0.001% levamisole, in M9) and 
viewed with a Zeiss Axioskop 2plus microscope, equipped a Q imaging wLS broad-band LED 
illumination system, a Zeiss plan NEOFLUAR 20x objective lens, and a Q imaging micropublisher 5.0 
cooled RTV camera.  In each worm the number of GABAergic neurones with visible GFP fluorescence 
was counted.  Brightly fluorescent cell bodies were scored as 1, weakly fluorescent cell bodies as 0.5.  
Since the 4 neurones of the head were sometime difficult to distinguish these were excluded form 
final analysis to give a maximum score of 21.  
 
2.2.vi  Measurement of pharyngeal GFP following RNAi  
The fluorescence of strains carrying the myo2p::GFP transgene (see table 2.1 for strain details) was 
quantified in the F1 and F2 generation following either gfp RNAi or cat RNAi treatment for two 
generations or one generation of  gfp RNAi treatment followed by second generation cat treatment. 
For the starvation treatment group, prior starvation treatment was carried out by placing mixed 
populations on plates without food for 10 days.  Starved worms were reintroduced to food for one 
generation before assay set up to allow egg laying to resume prior to RNAi assay set up.  
 Young adult worms were mounted onto a 10 well multi-test microscope slide (MP 
biomedicals), in a solution of tricaine/levamisole (0.02% tricaine, 0.001% levamisole, in M9) and 
viewed with a Zeiss Axioskop 2plus microscope, equipped a Q imaging WLS LED illumination system, 
a Zeiss plan NEOFLUAR 20x objective lens, and a Q imaging micropublisher 5.0 cooled RTV camera.  
Worms were imaged with a focus on achieving a clear image of the pharynx whilst also capturing 
sufficient body to score for the presence of BWM fluorescence.  Worms were imaged without 
brightfield illumination.  This helped to maximise the dynamic range of fluorescence which could be 
captured but meant that in instances where GFP knock down was near total worms could not be 
seen in images.  In such cases a matched image taken under brightfield conditions was also captured.  
Images were analysed using image J (ImageJ2,Fiji distribution) (Rueden et al., 2017; Schindelin et al., 
2012) as follows: the file opened with bioFormats importer, channels were split to create 3 separate 
images and the channel 1 image was analysed.  The rectangular selector and selector rotator tools 
were used to fit a tight-fitting quadrilateral around the head of the worm from the nose to the base 
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of the pharyngeal bulb (as seen in Figure 2.2).  The measure tool was used to measure fluorescence 
intensity in this area and 3 background areas of approximately equal size, selected from different 
points in the image. Where the pharynx was not visible in the dark image the matched light image 
was used to select the pharyngeal region for measurement in the dark image.  The presence of 
fluorescence in the BWM nuclei was noted as present, absent or partial.  For convenience of scale 1 
AU was defined as the mean value of HB955 worms on cat RNAi across the F1 and F2 generations.  
Percentage change and normalised values were calculated by dividing the value for each worm by 
the mean value of cat treated worms of that strain in that generation.  
 
 
 
 
2.3  Small RNA library preparation 
 
Populations of Bristol N2 and itr-1(sa73) worms were synchronised by hypochlorite treatment of 
fecund adult worms to extract the embryos (as described in section 2.1.iv).  Embryos were removed 
from bleach and allowed to hatch in the absence of food in liquid suspension of M9 buffer at 20°C.  
L1 stage larvae were then plated onto NGM to grow as a synchronised population of worms.  As 
young adults worms were washed in M9 buffer and centrifuged into a pellet of packed worms. 10ml 
of TRIzol reagent (Invitrogen) was added per ml of packed worms and the suspension was flash 
frozen using a dry ice and ethanol bath before being stored at -80°C overnight.  Worms were lysed by 
repeated cycles of freezing in liquid Nitrogen, thawing at 37°C and vortexing for 1 minute. This was 
repeated 8 times.  Chloroform extraction using 0.2ml of chloroform per 1ml of TRIzol reagent was 
used to extract RNA from the lysed worms into the upper aqueous phase.  A second chloroform 
extraction was carried out with equal volumes chloroform and sample extract and the upper phase 
again selected. RNA was precipitated using isopropanol and washed in ice cold 75% ethanol. RNA was 
re-suspended in RNAase free water. Purity of RNA was assessed by measuring the 260/280 nm 
Figure 2.2. The pharyngeal area was 
selected as shown (yellow outline 
indicated by red arrow) and the pixel 
intensity within this area measured. 
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absorption reading using NanoDrop spectrophotometer (ND1000, ThermoFisher Scientific).  The 
presence of undegraded RNA in each sample was confirmed by agarose gel electrophoresis and 
ethidium bromide staining.  Samples were stored at -80°C.  
For the 5’ independent libraries 5µg total RNA was treated with 1µl RNA 5’ Polyphosphatase 
(Epicentre). RNA was then re-extracted by phenol extraction followed by chloroform/isoamyl-alcohol 
extraction. RNA was then precipitated overnight in ethanol and sodium acetate and re-suspended in 
RNAase free water. 5’ dependent and independent sequence libraries were then prepared as 
described in the TruSeq Small RNA sample preparation guide: RNA samples were then converted to 
cDNA sequence libraries and the fraction of the cDNA library corresponding to the small RNA 
population was selected by band extraction after agarose gel electrophoresis. Quality control was 
also carried out on the libraries prior to Illumina sequencing.  5’ dependent and 5’ independent 
libraries of WT and itr-1(sa73) C. elegans strains were prepared.  These 4 libraries were then 
sequenced using high throughput Illumina sequencing, 2 technical replicates per group. 
 
2.4  Quantitative real-time PCR 
 
Total RNA was extracted from synchronised population of N2, itr-1(sa73), egl-8(e2917), ipp-5(sy605) 
L1 worms: worms were synchronised by hypochlorite treatment of fecund adult worms to extract the 
embryos (as described in section 2.1.iv).  Embryos were removed from bleach and allowed to hatch 
overnight in the absence of food in liquid suspension of M9 buffer at 20°C followed by being 
centrifuged into a pellet of packed worms.  Worms were lysed in 10ml TRIzol per 1ml packed worms 
by repeated cycles of freezing in liquid Nitrogen, thawing at 37°C and vortexing for 1 minute.  This 
was repeated 8 times.  Chloroform extraction using 0.2ml of chloroform per 1ml of TRIzol was used 
to extract RNA from the lysed worms into the upper aqueous phase.  A second chloroform extraction 
was carried out with equal volumes chloroform and sample extract and the upper phase again 
selected. RNA was precipitated using isopropanol and washed in ice cold 75% ethanol.  cDNA was 
produced by reverse transcription using the Promega Reverse Transcription System according to 
manufacturer’s protocol and using random primers (Promega, 0.5μg/μl).  qPCR reactions were 
carried out using KAPA SYBR FAST qPCR kit and BioRad iCycler. 30ng total cDNA was used per 
reaction. 
qPCR protocol was as follows:  95.0°C for 05:00 min, 50X (95.0°C for 00:15, 60.0°C for 01:00), 95.0°C 
for 01:00, 50.0°C for 01:00, 80X( 55.0°C for 00:10).   
All test and control reactions were carried out in triplicate. Relative abundance of test gene mRNA to 
the control gene GAPDH mRNA in mutant strains compared to the N2 strain was calculated using the 
60 | C h a p t e r  2 -  M a t e r i a l s  a n d  M e t h o d s  
 
 
60 
 
ΔΔCt method implemented via the R package ‘ddCt’ (Zhang JD, Biczok R, Ruschhaupt M (2019). ddCt: 
The ddCt Algorithm for the Analysis of Quantitative Real-Time PCR (qRT-PCR). R package version 
1.40.0.).   See table 2.2 for qPCR primers used in this work.  
 
2.5 Statistical analysis and data presentation 
 
All Statistical analysis in chapters 3 and 5 was performed in R studio (version 1.2.1335), using R 
((version 3.6.1) (R Core Team (2019). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.))  
Most statistical analysis, including the fitting of analysis of variance models, fitting linear models, 
fitting generalised linear models, Tukey HSD tests and Wilcoxon rank sum tests, was carried out using 
functions of the R stats package. Additionally, the car package was used for Levene’s test (John Fox 
and Sanford Weisberg (2019). An R Companion to Applied Regression, Third Edition. Thousand Oaks 
CA: Sage. URL: https://socialsciences.mcmaster.ca/jfox/Books/Companion/), the package lme4 was 
used to fit generalised mixed linear models (Douglas Bates, Martin Maechler, Ben Bolker, Steve 
Walker (2015). Fitting Linear Mixed-Effects Models Using lme4. Journal of Statistical Software, 67(1), 
1-48. doi:10.18637/jss.v067.i01.) and the DHARMa package was used to assess the fit of models 
(Florian Hartig (2019). DHARMa: Residual Diagnostics for Hierarchical (Multi-Level / Mixed) 
Regression Models. R package version 0.2.4. https://CRAN.R-project.org/package=DHARMa) 
 Results figures were produced in R using the ggplot2 package (H. Wickham. ggplot2: Elegant 
Graphics for Data Analysis. Springer-Verlag New York, 2016), the scales package (Hadley Wickham 
(2018). scales: Scale Functions for Visualization. R package version 1.0.0.  https://CRAN.R-
project.org/package=scales) and the Viridis colour palette (Simon Garnier (2018). viridis: Default 
Color Maps from 'matplotlib'. R package version 0.5.1. https://CRAN.R-project.org/package=viridis). 
The cowplot package was used to assemble multipanel figures (Claus O. Wilke (2019). cowplot: 
Streamlined Plot Theme and Plot Annotations for 'ggplot2'. R package version 1.0.0.  https://CRAN.R-
project.org/package=cowplot). 
The statistical analysis of the small RNAseq libraries presented in chapter 4 was performed in 
SeqMonk (Andrews, 2011).  An unbiased probe set of continuous 40bp windowed probes covering 
the entire genome assembly was used to compare libraries.  Libraries were corrected for total read 
count.  The ‘intensity difference’ and ‘DeSeq2’ (Love, M.I., Huber, W., Anders, S. Moderated 
estimation of fold change and dispersion for RNA-seq data with DESeq2 Genome Biology 15(12):550 
2014) statistical testing tools were used to looks for probes which were differentially expressed 
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between the JT73 and N2 libraries.  Figures not generated using SeqMonk were generated using R 
after using the package ‘ShortRead’ to import sequence libraries (M. Morgan, S. Anders, M. 
Lawrence, P. Aboyoun, H. Pages, and R. Gentleman (2009): "ShortRead: a Bioconductor package for  
input, quality assessment and exploration of high-throughput sequence data". Bioinformatics 
25:2607-2608). GO term enrichment analysis was performed using WormBase (WormBase web site, 
http://www.wormbase.org, release WS272, date 2019). 
 
 
Strain Genotype Reference Labelled as 
N2 WT (Bristol) (Brenner, 1974) WT 
YY216 eri-9(gg106) (Pavelec et al., 
2009) 
eri-9 
JT73 itr-1(sa73) (Iwasaki et al., 
1995; Nagy et al., 
2015a) 
itr-1 
CB6614 egl-8(e2917) (Nagy et al., 
2015a; Yook and 
Hodgkin, 2007) 
egl-8 
PS3653 ipp-5(sy605) (Bui and 
Sternberg, 2002; 
Nagy et al., 
2015a) 
ipp-5 
Egl-30 mutants screened     
DA823 egl-30(ad805) I. (Brundage et al., 
1996; McMullan 
et al., 2012) 
egl-30 lof1 
MT1434 egl-30(n686) I. (Brundage et al., 
1996), (Trent et 
al., 1983) 
egl-30 lof2 
DA1084 egl-30(ad806) I. (Brundage et al., 
1996) 
egl-30 lof3 
CG21  egl-30(tg26) I; him-5(e1490) V. Bastiani et al., 
2003) 
egl-30 gof1 
CE1047 egl-30(ep271) I. (Fitzgerald et al., 
2006) 
egl-30 gof2 
PS4264 egl-30(sy676md186) I; him-5(e1490) V. (Bastiani et al., 
2003) 
egl-30 lof 
gof rescue 
PS4263 egl-30(md186) I; dpy-20(e1282) IV; 
syIs105[egl30::gfp + dpy-20(+)]. 
Bastiani et al., 
2003) 
egl-30 lof 
OE rescue 
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PS2444 dpy-20(e1282) IV; syIs36 [ egl-30::egl-30(+)]. (Bastiani et al., 
2003; Brundage 
et al., 1996; 
Hajdu-Cronin et 
al., 1999; 
Robatzek and 
Thomas, 2000) 
egl-30 OE 
Gα mutants screened     
MT363 goa-1(n363) (Dong et al., 
2000; Robatzek 
and Thomas, 
2000; Segalat et 
al., 1995) 
goa-1 lof1 
DG1856 goa-1(sa734) (Robatzek and 
Thomas, 2000) 
goa-1 lof2 
MT2426 goa-1(n1134) (Segalat et al., 
1995) 
goa-1 lof3 
PS1493 dpy-20(e1362) IV; syIs9.    (Hajdu-Cronin et 
al., 1999; Mendel 
et al., 1995) 
goa-1  OE 
KG421 gsa-1(ce81) (Schade et al., 
2005) 
gsa-1 gof 
NL795 gpa-7(pk610) (Plasterk et al., 
1999) 
gpa-7 lof 
NL1147 gpa-10(pk362) (Plasterk et al., 
1999) 
gpa-10 lof 
NL594 gpa-12(pk322) (Alam et al., 
2016; Plasterk et 
al., 1999; Yemini 
et al., 2013; 
Ziegler et al., 
2009a) 
gpa-12 lof 
BW1809 gpa-16(it143) ; him-5(e1490) (Johnston et al., 
2008) 
gpa-16 lof 
RB1800 gpa-17(ok2334) (Yemini et al., 
2013).  
gpa-17 lof 
Regulators of G-protein signalling mutants screened 
LX147 rgs-1(nr2017) III. (Dong et al., 
2000) 
rgs-1 lof  
MT8504 egl-10(md176) V. (Esposito et al., 
2010; Koelle and 
Robert Horvitz, 
1996; Porter and 
Koelle, 2010) 
egl-10 lof1 
JT609 eat-16(sa609) I.   eat-16 lof1 
LX1313 eat-16(tm761) I; egl-10(md176) V. (Wani et al., 
2012)  
eat-16: egl-
10 lof 
RM1702 ric-8(md303) IV. (Miller et al., 
2000) 
ric-8 lof1 
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RM2209 ric-8(md1909) IV. (Miller et al., 
2000) 
ric-8 lof2 
RB1145 ags-3(ok1169) (Hofler and 
Koelle, 2011) 
ags-3 lof 
JT603 gpb-2(sa603) I (Robatzek et al., 
2001) 
gpb-2 lof1 
        
DA541 gpb-2(ad541) I. (Robatzek et al., 
2001) 
gpb-1 lof2 
LX1270 rsbp-1(vs163) I. (Porter and 
Koelle, 2010) 
rspb-1 lof 
Unc-47::GFP transgenic strains  
EG1285 lin-15B&lin-15A(n765); oxIs12 (unc-47p::GFP + 
lin-15(+)) 
(McIntire et al., 
1997) 
EG1285 
HB900 itr-1(sa73)IV; him-5(e1462)V; oxls12X (Nagy et al., 
2015b) 
Itr-1 
HB450 goa-1(n363);  oxls12X This work goa-1 lof1 
HB451 syIS9; oxls12X (goa-1 xs) This work goa-1 OE 
HB452 egl-30(ad805); oxls12X This work egl-30 lof 
Pharyngeal GFP strains 
HB955 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]  
(Nagy et al., 
2015a) 
WT 2 
HB953 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP] 
(Nagy et al., 
2015b) 
WT 1 
HB948 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]; egl-8(e2917)V 
(Nagy et al., 
2015b) 
egl-8 1 
HB949 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]; egl-8(e2917)V 
(Nagy et al., 
2015b) 
egl-8 2 
HB951 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]; ipp-5(sy605)X 
(Nagy et al., 
2015b) 
ipp-5 1 
HB952 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]; ipp-5(sy605)X 
(Nagy et al., 
2015b) 
ipp-5 2 
HB954 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]; itr-1(sa73)IV 
(Nagy et al., 
2015b) 
itr-1 1 
HB956 ccIs4251 I [myo-3p::mitoGFP]; mIs12 II [myo-
2p::GFP]; itr-1(sa73)IV 
(Nagy et al., 
2015b) 
itr-1 2 
Table 2.1.  C. elegans strains used in this work.  Strains not created in the Baylis lab were supplied by the 
Caenorhabditis Genetics Centre (University of Minnesota). 
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Gene Primer Sequence 
GAPDH ED2822 TGGAGCCGACTATGTCGTTGAG 
ED2823 GCAGATGGAGCAGAGATGATGAC 
T02G6.4  AR2856 TGAATGCCGTAGGAGCAACC 
AR2857 GCATCTCCAAATAGGTGCAG 
F55C9.5  AR2858 GGAAACAATACCATTGGAGC 
AR2859 TTGGAAATGGAATCTCCTTC 
Y116F11A.1  AR2860 AGCAGCAAAAGCGATCGGAG 
AR2861 GTGCCAGCTCGCTAGGAGTG 
C11G6.2  AR2862 AGAGTAGTTTTGATGACTGG 
AR2863 CGATGATAATAAGTCGTGTC 
F52G3.4  
 
AR2864 ACAGTCCCGTGCCCATTCTG 
AR2865 TGTCGATTGCACTCCGTGTG 
C40A11.10  AR2866 TCGGACAATATCACTGGATC 
AR2867 GGTGTGATGCTATCGCTTAG 
Lin-35 AR2868 ACTAATACACCGCCACCATC 
AR2869  TCAAGAGAAACCCGTTGAAC 
Table 2.2. qPCR primers used in this work.  
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Identification of cell signalling mutants with an altered RNAi response 
3.1  Introduction 
 IP3 signalling, both in C. elegans and more widely is initiated by the activation of inositol 
specific phospholipases of the PLC family.  As previously discussed (see section 1.2.iv) the C. elegans  
genome encodes 5 putatively active PLC genes, 4 of which are clear homologues of mammalian 
counterparts, each known to play a role in the regulation of IP3 signalling in different contexts (Gower 
et al., 2005; Lackner et al., 1999; Miller et al., 1999; Yin et al., 2004) reviewed in (Baylis and Vázquez-
Manrique, 2012)).  In each case the PLC is activated by an upstream signal transducer of a particular 
type, principally heterotrimeric G-proteins, small G-proteins or receptor tyrosine kinases (reviewed in 
(Suh et al., 2008).  Like it’s mammalian counterpart PLCβ, EGL-8 is canonically activated by G-protein 
signalling and has been predicated to be capable of interaction with both the Gαq and Gβγ signalling 
components (Illenberger et al., 2003; Singer et al., 2002).  
 Since only plcβ homologue egl-8 loss-of-function mutants were found to display an enhanced 
RNAi phenotype comparable to that of an itr-1 loss-of-function mutant it seems clear that EGL-8 is 
responsible for the production of IP3 in the ITR-1 dependent signalling pathway regulating the 
exogenous RNAi response in C. elegans (Nagy et al., 2015).  The most obvious candidate for the 
upstream signalling component responsible for the activation of EGL-8 in this pathway was therefore 
the well-established canonical activator, the C. elegans homologue of mammalian Gαq subunit, EGL-
30 (Brundage et al., 1996).  However preliminary screens of egl-30 mutants for an altered RNAi 
phenotype performed in the lab showed no consistent RNAi phenotype and therefore no clear role 
for EGL-30 in this pathway, raising the possibility that heterotrimeric G-protein signalling involving a 
different Gα subunit could be regulating EGL-8 activation in this pathway.   
 A central goal of my project was therefore to identify the upstream signalling components 
regulating EGL-8 activation, and therefore IP3 production, in the signalling pathway modulating the 
exogenous RNAi response.  The approach I took was to screen existing mutant strains of candidate 
genes for an altered (enhanced or decreased efficacy) RNAi response, using RNAi by feeding to target 
knock down of genes known to have an incomplete penetrance of the RNAi induced loss of function 
phenotype in a WT background, but an easily scorable phenotype in an enhanced RNAi background.   
A range of such genes have been previously characterised and used in the identification of Eri 
mutants (Kennedy et al., 2004; Simmer et al., 2002; Wang et al., 2005).  It is commonly seen that in 
such an enhanced RNAi background, where the efficacy of RNA interference is improved, both the 
frequency of the occurrence of the knockdown phenotype in the population, and the severity of the 
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phenotype are increased.  When screening mutants for a global increase in the efficacy of the 
exogenous RNAi pathway it is important to characterise the efficacy of RNAi induced knockdown 
against a range of genes, operating in a variety of different pathways, in order to establish whether it 
is the RNAi response itself which is altered, or whether a more apparent phenotype is seen due to 
genetic interaction between the RNAi target gene and the mutant being screened.  In the latter case 
if a mutant is already partially compromised in a pathway regulating a given phenotype then further 
compromise to that pathway due to even partial RNAi induced knock-down of a second gene is more 
likely to produce the target phenotype, due to the genetic background being sensitised to that 
phenotype rather than due to any change in the efficacy of the RNAi.  This possibility warrants 
particular consideration when dealing with mutants of genes known to play diverse and pleiotropic 
roles in C. elegans, such as the Gα proteins and their second messengers.  
Using this approach, I screened a range of egl-30 mutants in order to test the preliminary 
finding that EGL-30 (Gαq) was not the upstream activator of EGL-8 (PLCβ) in the IP3 signalling 
pathway regulating the exogenous RNAi response.  I also screened a range of other Gα protein 
mutants based on the working hypothesis that heterotrimeric G-protein signalling involving a 
different Gα subunit was the upstream activator of EGL-8, which seemed the most likely scenario 
given that PLCβ is well established as an effector of GPCR/heterotrimeric G-protein signalling.  
Finally, I screened a number of mutants of proteins known to be involved in the regulation of 
heterotrimeric G-protein signalling in order to build a clear picture of the signalling network 
regulating the RNAi response.  
The RNAi target genes utilised were lin-31, lin-1, dpy-13 and unc-15.  All of which are well 
established as targets for measuring RNAi response; they have been previously used in the 
characterisation of eri mutants (Kennedy et al., 2004; Simmer et al., 2002)  and were used to 
characterise the altered RNAi response of itr-1, egl-8 and ipp-5 mutants (Nagy et al., 2015).  lin-31 
and lin-1 encode the heterodimeric components of the transcription factor complex downstream of  
the MAP kinase signalling pathway involved in vulval induction (Tan et al., 1998).  Loss of either lin-1 
or lin-31 leads to a multivulval phenotype, or in the case of a partial knock down the milder 
phenotype of a protruding vulva.  Dpy-13 encodes a component of the cuticle collagen, loss of which 
leads to altered body shape known as dumpy (Dpy) (von Mende et al., 1988).  unc-15 is a paramyosin 
ortholog loss of which leads to loss of locomotion (Kagawa et al., 1989).  Animals display a sluggish 
locomotion in the mildest case and complete flaccid paralysis in the most severe case, along with a 
variety of other phenotypes associated with loss of functional myosin such as an Egl phenotype.  All 
strains tested were compared to the wildtype strain Bristol N2, an eri-9 mutant strain, displaying an 
enhanced exo-RNAi response, as a positive control and an ipp-5 lof mutant strain, displaying a greatly 
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decreased efficiency of exo-RNAi as a comparison for a decreased response.  All strains were scored 
as adults after 1 generation of exposure to dsRNA by feeding.  
Neuronal GFP knockdown using GFP RNAi was used to confirm results in cases where an 
altered RNAi response seemed likely but complex strain phenotypes made phenotype scoring and 
ruling out compounding genetic interactions difficult.  Neuronally expressed genes are generally 
refractory to RNAi but knockdown is seen in enhanced RNAi backgrounds(Calixto et al., 2010; 
Kennedy et al., 2004; Lehner et al., 2006).  GFP knockdown is a good readout of exogenous RNAi 
efficacy, with gfp expression more likely to be truly independent of signalling pathway activity than 
endogenous genetic pathways such as those regulating vulval development, cuticle formation, or 
locomotion.   
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3.2  Results 
3.2.i  Investigating the role of EGL-30 (Gαq) in the regulation of the RNAi response 
If Gαq egl-30 were to be acting in its canonical role as the activator of PLCβ egl-8 in the IP3 
signalling pathway regulating the exo-RNAi response, then it would be expected that loss of function 
of egl-30 would phenocopy loss of function of egl-8 and itr-1, resulting in an enhanced RNAi 
response.  To test this hypothesis a range of previously characterised EGL-30 mutant strains were 
identified and selected for screening.  These included loss of function (lof), gain of function (gof), 
overexpression (OE), and loss of function mutants rescued by either a second masking gain of 
function mutation or by transgene (lof gof rescue/ OE rescue).  Each strain displays varying severities 
of egl-30 associated loss of function and gain of function phenotypes, representing a range of 
pleiotropic effects. Loss of function of egl-30 is associated with a severe Egl phenotype leading to 
bloating due to egg retention, lethargy/flaccid paralysis, which becomes more pronounced with age 
and causes a notably abnormal pattern of locomotion and foraging, reduced rate of pharyngeal 
pumping, and ovulation defects contributing to reduced fertility and egg laying, and reduced viability.  
Loss of function of egl-30 was found to suppress the lethal effects of arecoline seen in gpb-2 (eat-11) 
lof mutants (Brundage et al., 1996).  Gain of function or over expression of egl-30 causes a set of 
opposite phenotypes.  GOF mutants are hyperactive, spending less time at rest, change direction 
more frequently and have an exaggerated body bend. They also display a constitutive egg laying 
phenotype whereby eggs are more frequently and at earlier stages of development than WT strains 
(<4 cell stage).  The strains used are described in Table 3.1.   
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Strain name 
 
genotype 
 
labelled as 
 
variant/ description 
 
key phenotypes 
 
 
key references 
DA823 egl-30(ad805) I egl-30 lof 1 Likely near null. 
Intronic point 
mutation predicted to 
cause defective 
splicing of intron 2. 
 
Severe flaccid near 
paralysis, very sluggish 
with shallow tracks, 
severely bloated with 
eggs, reduced 
pharyngeal pumping, 
unresponsive to harsh 
body touch. Reduced 
behavioural and 
immune response to 
bacterial infection. 
Semi dominant 
suppressor of eat-11 
(gpb-2). 
(Brundage et 
al., 1996; 
McMullan et 
al., 2012) 
MT1434 egl-30(n686) I egl-30 lof 2 lof. 
Intronic point 
mutation predicted to 
cause defective 
splicing of intron 4. 
 
Sluggish with variable 
tracks, bloated with 
eggs, reduced 
pharyngeal pumping. 
 Semi dominant 
suppressor of eat-11 
(gpb-2). 
(Brundage et 
al., 1996), 
(Trent et al., 
1983) 
DA1084 egl-30(ad806) I egl-30 lof 3 lof.  
Point mutation 
leading to Ser(6) to 
Phe.  
 
Sluggish, bloated with 
eggs. 
 Semi dominant 
suppressor of eat-11 
(gpb-2). 
(Brundage et 
al., 1996) 
CG21  egl-30(tg26) I; 
him-5(e1490) V 
egl-30 gof 1 g/a substitution.  
Hypermorph GOF 
Hyperactive movement, 
increased coiling, 
melatonin resistant, 
small.  
Bastiani et al., 
2003) 
Table 3.1. egl-30 mutants used in work described in this chapter.  
Descriptions taken from referenced papers or from WormBase.     
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Strain name 
 
 
genotype 
 
 
labelled as 
 
 
variant/ description 
 
 
key phenotypes 
 
 
key references 
CE1047 egl-30(ep271) I egl-30 gof 2 Dominant, gain-of-
function 
g/a substitution 
leading to M to L 
substitution.  
Hyperactive movement, 
constitutive egg laying. 
(Fitzgerald et 
al., 2006) 
PS4264 egl-
30(sy676md186) 
I; him-5(e1490) 
V. 
egl-30 lof gof 
resuce  
Rescuing and gof. 
sy676 intragenic 
revertant in lof 
mutation md186. 
 Semi-dominant 
hyperactive movement 
with exaggerated body 
bends and constitutive 
egg laying. 
(Bastiani et al., 
2003) 
PS4263 egl-30(md186) I; 
dpy-20(e1282) 
IV; syIs105[egl-
30::gfp + dpy-
20(+)]. 
Integrated 
transgene 
egl-30 lof OE 
rescue 
[egl-30::GFP + dpy-
20(+)] including  all of 
the presumptive 5'-
transcriptional 
regulatory sequences, 
introns, and 
presumptive 3 
regulatory sequences 
for egl-30. 
partially rescue egl-
30(md186) with respect 
to pharyngeal pumping, 
egg laying and 
movement. 
Hypersensitive 
response to 
neurotransmitters in 
egg-laying assays. 
Bastiani et al., 
2003) 
PS2444 dpy-20(e1282) 
IV; syIs36 [ egl-
30::egl-30(+)]. 
egl-30 OE WT egl-30 
overexpressed. 
syIs36 [(pLB2) egl-
30(+) + pBS + (pMH86) 
dpy-20(+)].    
Hyperactive movement, 
exaggerated body 
bends, eggs laid 
constitutively and early 
stage, starved 
appearance.  
(Bastiani et al., 
2003; Brundage 
et al., 1996; 
Hajdu-Cronin et 
al., 1999; 
Robatzek and 
Thomas, 2000) 
Table 3.1 (continued). egl-30 mutants used in work described in this chapter.   
Descriptions taken from referenced papers or from WormBase.     
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The effects of lin-31 and lin-1 RNAi were measured by scoring the phenotype of adult worms 
as a WT (unaffected), multivulval phenotype (MUV) or a single protruding vulval phenotype 
(protruding).  Each worm was scored for the presence or absence of these phenotypes allowing the 
proportion of worms of each strain population with each phenotype to be calculated.  The results of 
the lin-31 RNAi assays against the egl-30 mutants are shown in figure 3.1.  All 3 egl-30 lof strains 
consistently show a lower level of response to lin-31 RNAi treatment than the WT strain, whilst some 
but not all egl-30 gof strains appear to show an enhanced response to lin-31 RNAi.  A higher 
incidence of MUV and protruding vulval phenotype is seen in the egl-30 gof 1 and egl-30 lof OE 
rescue strains, with response levels comparable to that of the eri-9 strains. A statistically significant 
but less dramatic increase is seen in the strain egl-30 lof+ gof, whilst no significant difference in 
response from the WT is seen in the strains egl-30 gof 2 and egl-30 OE.  
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Figure 3.1. Results of lin-31 RNAi by feeding on egl-30 mutants. Successful lin-31 knockdown during 
development results in a multivulval (MUV) phenotype, or a milder protruding vulva phenotype.  a- Box plots 
representing the range of values of the sum MUV or protruding vulval phenotypes seen for each strain. Box 
edges represent upper and lower quartiles with the central line representing the median. Each coloured dot 
represents one experimental plate with a median population of 104 worms, range 15-380. Statistical significance 
was assessed using logistic regression analysis, modelling the proportion of population affected, weighted for 
plate population, and including observation-level random effect. Statistically significant differences from WT are 
indicated. b- Represents the data shown in a but % MUV or protruding vulval is broken down by class. The mean 
percentage of worms of each strain with a MUV or protruding vulval phenotype is shown, error bars represent 
standard deviation (SD). Each row represents an independent repeat consisting of 3 replicate plates per strain. 
“nm” represents strain not tested in this repeat. Data for egl-8 and itr-1 strains is shown for comparison.  
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  The response to lin-1 RNAi, seen in figure 3.2, follows a very similar pattern to the response 
to lin-31 RNAi.  The egl-30 lof strains each exhibit a response comparable to (egl-30 lof1, egl-30 lof3) 
or lower than (egl-30 lof2) that seen in the WT strain, whilst the gain of function mutant egl-30 lof1 
(egl-30(tg26)) and the egl-30 lof +OE rescue strain carrying the, display a significantly enhanced 
response.  These are the same two strains which show the strongest response to lin-31 RNAi, once 
again with levels of response comparable to, or higher than, that of the eri-9 mutant.  In the case of 
both lin-31 and lin-1 RNAi treatment an clear increase in proportion of the population with the more 
severe MUV phenotype as well as an increase in protruding vulval phenotype is seen, as shown in 
figure 3.1b and 3.2b respectively.  The other gain of function and overexpression strains show no 
significant difference in response to lin-1 RNAi treatment compared to the WT, as was seen with   
lin-31. 
The implication from these results, that reduced egl-30 signalling may have an inhibitory 
effect on the RNAi response whilst reduced function may increase efficacy is a surprising result since 
this is the exact opposite of the response which would be expected if egl-30 is acting in its canonical 
role as an activator of IP3 signalling.  These results should be interpreted with the caveat that both 
lin-31 and lin-1 act downstream in the MAPK signalling cascade regulating vulval development. It 
was to be expected therefore, that a similar pattern of apparent sensitivities to lin-1 and lin-31 RNAi 
would be seen across the egl-30 mutants, since any potential genetic interactions between the 
target gene and egl-30 due to pathway specific interactions or background sensitivity to aberrant 
vulval development would be expected to be seen in both assays.  It was therefore important to 
assay the RNAi sensitivity of the egl-30 mutants using a range of independent assays.  
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Figure 3.2.  Results of lin-1 RNAi treatment on egl-30 mutants. a- Box plots representing the range of values of 
the sum MUV or protruding vulval phenotypes seen for each strain. Box edges represent upper and lower 
quartiles with the central line representing the median. Each coloured dot represents one experimental plate 
with a median population of 109 worms, range 12-221. Statistical significance was assessed using logistic 
regression analysis, modelling the proportion of population affected, weighted for plate population, and including 
observation-level random effect. Statistically significant differences from the WT strain are shown. b- Represents 
the same data shown in a, but % MUV or protruding vulval is broken down by class. The mean percentage of 
worms of each strain with a MUV or protruding vulval phenotype is shown, error bars represent standard 
deviation (SD).  Each row represents an independent repeat consisting of 3 replicate plates per strain.  Data for 
egl-8 strains is shown for comparison.  
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The effects of unc-15 RNAi treatment on the egl-30 mutants were assayed, (see figure 3.3) 
and showed a markedly different pattern of sensitivities to the lin-31 and lin-1 assays.  The egl-30 lof 
mutants all showed a high degree of paralysis and impaired locomotion, equivalent to the response 
seen in the WT strain.  This is very different from the reduced response seen to lin-31 and lin-1 RNAi.  
However, this result is less surprising given that loss of unc-15 and loss of egl-30 both result in 
lethargy and flaccid paralysis.  The apparent increased sensitivity seen in egl-30 lof1 mutants 
therefore is likely not a result of an increased sensitivity to RNAi but to an increased predisposition 
to the measured phenotype. Conversely the egl-30 gof2, egl-30 OE, and egl-30 lof gof rescue 
mutants all show significantly reduced percentage of paralysed and impaired worms compared to 
the WT.  The egl-30 gof1 overall shows no significant difference to the WT response, however the 
percentage of paralysed worms is decreased whilst the egl-30 lof OE rescue shows a greater than WT 
response.  The reduced paralysis seen in several of the gof strains could conceivably be in part be 
due to the hyperactive phenotype of these strains compensating for loss of unc-15 function, making 
the results of this assay difficult to interpret reliably.   
The dpy-13 RNAi assay provides a more independent assessment of the effect of RNAi 
sensitivity since the Dpy phenotype does not overlap with any known egl-30 phenotypes.  The 
results shown in figure 3.4a show that whilst some strains did appear to show a change in the 
frequency of occurrence of the Dpy phenotype some gof strains, such as egl-30 gof 1 show an 
increased frequency of Dpy worms, whilst egl-30 gof 2 show a decreased response. There is also a 
significant inconsistency between the behaviour of same strains between repeat experiments (fig 
3.4b).  I found that the dpy-13  RNAi phenotype manifested as a full spectrum of alteration in length 
with a high penetrance of a mild-moderate Dpy phenotype characterised by slightly shorter length 
but otherwise normal appearance seen in WT populations with a continual spectrum of reduction in 
length seen through to the severe Dpy phenotype, characterised by worm appearing at least less 
than half their normal length seen in eri-9 mutants.  The continuous nature of spectrum of this 
phenotype combined with the natural variations in worm length between strains made reliably 
scoring the phenotypes by eye into discrete categorisations challenging. 
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Figure 3.3. Results of unc-15 RNAi treatment on egl-30 mutants. Successful unc-15 knock- down results in a 
paralysis phenotype, with partial knock-down producing a milder impaired locomotion phenotype. The mean 
percentage of worms displaying the paralysed (green bars) or impaired locomotion phenotypes (blue) is shown 
for each strain, error bars represent standard deviation (SD). Number of worms per plate range 44-287, median 
84, with 3 plates per strain. Statistical significance was assessed using logistic regression analysis, modelling the 
proportion of the population with paralysed or impaired phenotype, weighted for plate population, fitted to a 
quasibinomial distribution.  Statistically significant differences from the WT strain are denoted by “***” 
(p<0.001), “**” (p<0.01), “*” (p<0.05), “.” (not significant 0.05<p<0.1), “ns” (not significant, p>0.1). 
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Figure 3.4. Effects of dpy-13 RNAi by feeding on egl-30 mutants. a- Box plots representing the range of values 
of the Dpy phenotypes seen for each strain. Each coloured dot represents one experimental plate with a median 
population size of 93 worms, range 11-236. Statistical significance was assessed using logistic regression 
analysis, modelling the proportion of the population with paralysed or impaired phenotype, weighted for plate 
population, fitted to a binomial distribution with strain as a fixed effect and with observational level random 
effect.  Statistically significant differences from the WT strain are as indicated.  b- Represents the same data 
shown in a, but % Dpy or protruding vulval is broken down by class. The mean percentage of worms of each 
strain with MUV and protruding vulval phenotypes is shown, error bars represent standard deviation (SD).   Each 
row represents an independent repeat consisting of 3 replicate plates per strain. “nm” represents strain not 
tested in this repeat. 
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 In order to try to improve the accuracy and the reliability of the dpy-13 RNAi assay I 
measured the effect of dpy-13 RNAi treatment by measuring the length of each worm from an image 
rather than scoring the phenotype by eye.  As can be seen from the variation in the size of the 
control treatment (CAT) worms in figure 3.5a (blue boxes) there is considerable variation in the 
natural length of the different strains when grown on the control bacteria, with most strains being 
significantly shorter than the WT.  The mean length of the worms of each strain raised on control 
bacteria was therefore used to normalise the length measurements for each strain allowing the 
change in length from expected length for each worm to be calculated (figure 3.5b).  As expected, 
eri-9 shows a clear reduction in mean length whilst ipp-5 shows no change.  Although several of the 
strains tested show a significant difference in change in length compared to the WT, in most cases 
this change in relatively small when compared to the levels change seen eri-9 mutants (figure 3.5b, 
3.6). Figure 3.5a shows the unnormalized data.  To better compare the measured and observational 
counts of the effects of dpy-13 the change in length was binned into categories and plotted to show 
the percentage of each strain displaying a reduction in length greater than 20, 40, or 60% (figure 
3.6).   
The results of these two methods of assaying the effect dpy-13 RNAi treatments are largely 
consistent.  In figure 3.4 the three egl-30 loss of function strains show no consistent significant 
difference from the WT.  This is also the case for egl-30 lo f1 and egl-30 lof 3 in figure 3.5, where egl-
30 lof 2 shows a very small but significant decrease compared to the WT.  The results seen for the 
egl-30 gain of function strains are less consistent.  egl-30 gof 1 show a significantly greater reduction 
in average length upon dpy-13 than the WT, but egl-30 gof 2 shows a decreased  shows a decreased 
prevalence of the Dpy phenotype (as seen in figure 3.5 and 3.6) as well as an increased incidence of 
the more severe Dpy phenotype (fig 3.4a, 3.4b and 3.6).  A non-significant and smaller increase in 
both of these measures is also consistently seen in the egl-30 lof OE rescue strain.  However, the 
other egl-30 gof or OE strains show either a slight decrease in the dpy-13 RNAi phenotype or no 
consistent change.  
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Figure 3.5. Reduction of length caused by dpy-13 RNAi by feeding treatment on egl-30 mutants. 
 a- The length of worms of each strain treated fed either control (cat) or dpy-13 RNAi cultures is shown for 
comparison. There is considerable variation in the control treated length of worms between strains. b- The 
reduction in length of worms compared to the mean control treated length for that strain in that set. Median 
n/strain =82, range 48-118. Statistical significance assessed by regression analysis. Linear model accounting for 
length, RNAi treatment and strain. Overall dpy-13 treatment results in a significant reduction in length. 
Statistically significant difference in response to dpy-13 RNAi treatment for the test strains compared to the WT 
strain are denoted by “***” (p<0.001), “**” (p<0.01), “*” (p<0.05), “.” (not significant 0.05<p<0.1), “ns” (not 
significant, p>0.1). 
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Figure 3. 6. Reduction of length caused by dpy-13 RNAi by feeding treatment on egl-30 mutants. The data from 
figure 3.5b is here represented as the frequency of dpy-13 RNAi treated worms of each strain which show a 
reduction in length of <20%, >20%, >40%, >60%.  
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Conclusion – EGL-30 is not the upstream activator of EGL-8 in this pathway 
Taken together the results of the lin-31, lin-1, unc-15 and dpy-13 RNAi assays against egl-30 
mutants paint an unclear picture (summarised in table 3.2), with inconsistent results seen between 
different strains of a similar nature in response to the same RNAi target, and with different patterns 
seen in the response of the same strain to RNAi treatment against different target genes.   
Comparably inconsistent results were seen in preliminary work (Baylis pers comm.).  However, a few 
strains do show a more consistent pattern.  egl-30 gof 1 shows an increased response to RNAi to all 
target genes apart from unc-15 as does the egl-30 lof OE rescue strain, which also shows a significant 
increase in response to unc-15 RNAi.  egl-30 gof 1 has the strongest gof phenotype of all the strains 
tested.  By comparison the 3 egl-30 lof mutant tested, show a tendency towards a reduced response 
with the exception of unc-15 RNAi (which may be an unrepresentative assay for reasons already 
discussed).  Whilst a few gain-of-function and overexpression mutant strains show an enhanced 
response in to both lin-31 and lin-1, and dpy-13 RNAi this is not seen for all strains.  This could be 
due to a number of reasons including the range of severities of the mutants, the differing nature of 
mutations or the tissue of action in the case of OE mutants.  
The only firm conclusion that can be drawn is that egl-30 loss of function mutants certainly 
do not display a consistent enhanced exo-RNAi response to RNAi by feeding as seen in itr-1 (IP3R) 
and PLCβ egl-8 loss of function mutants.  This makes it unlikely that Gαq EGL-30 is the upstream 
activator of EGL-8 in the IP3 signalling pathway regulating the exo-RNAi response.  Interestingly 
however the results do not rule out the possibility that increased EGL-30 function increases the RNAi 
response.  These results leave open the question of the identity of the upstream activator of EGL-8 
the most likely candidates being a different Gα protein or a Gβγ dimer.  
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Strain RNAi Response 
lin-31 lin-1 unc-15 dpy-13 
eri-9 ++ + ++ ++ 
ipp-5 lof - - - - - - - - 
egl-30 lof 1 - - n.s. (-) + n.s. (+) 
egl-30 lof 2 - -- n.s. - 
egl-30 lof 3 - - n.s. (-) n.s. ns 
egl-30 gof 1 ++ ++ n.s. (-) + 
egl-30 gof 2 n.s. n.s. - - - 
egl-30 lof gof 
rescue 
+ n.s. - - ns 
egl-30 lof OE 
rescue 
++ + + + 
egl-30 OE n.s. + (n.s.) - - n.s. (-) 
Table 3.2.  Summary of the RNAi response of the tested egl-30 mutants.  
Semi-quantitative summary of the changes seen in the RNAi response of the strains tested, 
relative to the WT strain.  + significant increase, ++ significant large increase, - significant 
decrease, -- large significant decrease (minimal response), ns no significant change. 
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3. 2.ii - Identifying Gα protein mutants with an altered RNAi response 
Having ruled out EGL-30 as a direct activator of EGL-8 a range of other mutants of Gα 
subunits were screened.  Candidate genes were selected based on the known expression pattern of 
the Gα subunit.  Of the 21 genes for Gα homologues encoded in C. elegans several are known to 
have a highly restricted expression pattern, being detected in a narrow range of mostly sensory 
neurones (Plasterk et al., 1999).   A neuronal role for the signalling pathway regulating RNA 
interference is possible however the intestine was previously identified as the most likely site of 
action of the IP3 signalling regulating this the RNAi response (Nagy et al., 2015), and no neurones 
directly innervate the C. elegans intestine.  Gα subunits with a broad expression pattern or which are 
known to be expressed in the intestine were therefore prioritised (see table 3.3).  As with egl-30 
mutants several of the other Gα mutants also show a broad range of phenotypes.  In particular the 
goa-1 lof mutants show an almost identical set of phenotypes as the egl-30 gof mutants, including 
hyperactive movement, constitutive egg laying and exaggerated body bend, whilst the goa-1 OE 
mutant phenocopies egl-30 lof.  The strains tested and their key phenotypes are further summarised 
in Table 3.3. 
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Strain name genotype labelled as variant/ description key phenotypes  key references 
MT363 goa-1(n363) goa-1 lof 1 Null. 
Large deletion of 
entire coding region.  
Hyperactive 
movement, 
constitutive egg laying, 
early stage eggs, 
increased amplitude of 
tracks.  
(Dong et al., 
2000; Robatzek 
and Thomas, 
2000; Segalat et 
al., 1995) 
DG1856 goa-1(sa734) goa-1 lof 2 Likely null. 
Substitution in aa52 
causing early stop.  
 Hyperactive 
movement, 
constitutive egg laying 
of early stage eggs, 
increased amplitude of 
tracks.  
(Robatzek and 
Thomas, 2000) 
MT2426 goa-1(n1134) goa-1 lof 3 Likely partial LOF 
G to A substitution in 
the initiation codon 
of goa-1.  
Hyperactive, 
constitutive egg laying, 
early stage eggs.  Less 
severe phenotype than 
n363 or sa734. 
(Segalat et al., 
1995) 
PS1493 dpy-20(e1362) 
IV; syIs9.    
goa-1 OE Integrated transgene 
carrying several 
copies of 
constitutively active 
goa-1. under control 
of goa-1 promoter. 
Lethargic/flacid 
paralysis, retain eggs.  
  
(Hajdu-Cronin 
et al., 1999; 
Mendel et al., 
1995) 
KG421 gsa-1(ce81) gsa-1 gof gof hypermorph 
Point mutation c/t 
substitution. 
 
Hyperactive 
locomotion, aldicarb 
hypersensitive, 
levamisole 
hypersensitive, oocyte 
meiotic maturation 
variant.  
(Schade et al., 
2005) 
NL795 gpa-7(pk610) gpa-7 lof lof. 
961 bp deletion. 
Body posture and 
locomotion variations, 
melatonin resistant, 
egg laying defective.  
(Plasterk et al., 
1999) 
Table 3.3. Gα mutant strains used in work described in this chapter. 
(not including the egl-30 mutants, see table 3.1).  Descriptions taken from referenced papers or from WormBase. 
Strain name genotype labelled as variant/ description key phenotypes  key references 
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NL1147 gpa-10(pk362) gpa-10 lof lof. 
2895 bp deletion and 
unknown 445bp 
insertion 
minor Body posture 
and locomotion 
variant- increased 
forward locomotion.  
(Plasterk et al., 
1999) 
NL594 gpa-12(pk322) gpa-12 lof Presumed lof. 
1935 bp deletion  
(Tc1 transposon 
excision) 
Minor body posture 
and locomotion 
variations. Axon 
regeneration defective, 
defective antifungal 
innate immunity. 
(Alam et al., 
2016; Plasterk 
et al., 1999; 
Yemini et al., 
2013; Ziegler et 
al., 2009) 
BW1809 gpa-16(it143); 
him-5(e1490) 
gpa-16 lof Presumed lof. 
g/a substitution 
exonic 
Spindle orientation 
defective in early 
embryo.  
(Johnston et al., 
2008) 
RB1800 gpa-17 
(ok2334) 
gpa-17 lof Presumed lof. 
1693bp deletion. 
Minor body posture 
and locomotion 
variants. carbon 
dioxide avoidance 
variant. 
(Yemini et al., 
2013).  
Table 3.3 (continued). Gα mutant strains used in work described in this chapter 
(not including the egl-30 mutants, see table 3.1).  Descriptions taken from referenced papers or from WormBase.     
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When challenged with lin-31 RNAi treatment multiple Gα mutant strains show a significantly 
higher incidence of MUV or protruding vulva phenotype than the WT reference strain N2 (figure 
3.7a).  The two goa-1 lof mutants, the gsa-1 gof mutant and gpa-16 lof mutants all show a significant 
increase in incidence of MUV/ protruding vulva phenotype, comparable to the eri-9 positive control.  
Comparison of the incidence of MUV phenotype compared to protruding vulval phenotype as shown 
in figure 3.7b reveals that in the case of gpa-16 the increased effects seen are largely due to an 
increase in the incidence of the milder protruding vulval phenotype.  Whilst in the case of goa-1 lof1, 
goa-1 lof 2 and gsa-1 gof an increase is seen in the incidence of both the MUV and protruding vulval 
phenotypes, with a significant increase in MUV phenotype compare to the WT.  However both goa-1 
lof and gsa-1 gof mutants also display a higher than WT incidence of vulval bump or protruding vulva 
when not treated with lin-31 RNAi (known phenotype, data not shown) which could suggest an 
increased susceptibility to the MUV phenotype and makes the lin-31 assay a less reliable indicator of 
any change in the underlying RNAi phenotype in these strains.  gpa-12 shows a significantly lower 
incidence of the phenotype whilst gpa-7, gpa-10 and gpa-17 show no significant difference in 
response.  
By comparison, in response to unc-15 RNAi treatment (figure 3.8) two out of three goa-1 
strains (goa-1 lof2 and goa-1 lof3) show an increased response with an increased incidence of both 
complete paralysis and significantly impaired locomotion caused by partial paralysis.  gpa-12 
mutants again show a dramatically decreased response.  Whilst goa-1 lof1, gpa-7 and gpa-17 shows 
no significant difference compared to the WT, gpa-10 shows a non-significant but noticeable 
increase compared to the WT. 
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Figure 3.7. Results of lin-31 RNAi by feeding on Gα mutants. Successful lin-31 knockdown during development 
results in a multivulval (MUV) phenotype, or a milder protruding vulva phenotype.  a- Box plots representing 
the range of values of the sum MUV or protruding vulval phenotypes seen for each strain. Box edges represent 
upper and lower quartiles with the central line representing the median. Each coloured dot represents one 
experimental plate with a median population of 99 worms, range 14-293. Statistical significance was assessed 
using logistic regression analysis, modelling the proportion of population affected, weighted for plate 
population, and including observation-level random effect.  Statistically significant differences from the WT 
strain are shown, denoted by “***” (p<0.001), “**” (p<0.01), “*” (p<0.05), “.” (not significant 0.05<p<0.1), “ns” 
(not significant, p>0.1). b- Represents the same data shown in a but % MUV or protruding vulval is broken down 
by class. Additionally, results of itr-1 and egl-8 strains are shown for comparison. The mean percentage of worms 
of each strain with a MUV or protruding vulval phenotype is shown. Error bars represent standard deviation 
(SD) Each row represent an independent repeat consisting of 3 replicate plates per strain. “nm” represents strain 
not tested in this repeat. 
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Figure 3.8.  Results of unc-15 RNAi by feeding treatment on Gα mutants. Successful unc-15 knock- down results 
in a paralysis phenotype, with partial knock-down producing a milder impaired locomotion phenotype. a- box 
plots represent the range of values for the % of worms of each strain displaying either a paralysed or severely 
impaired phenotype. Each coloured dot represents one plate with a median population of 71 worms, with 3 
plates per strain. Statistical significance was assessed using regression analysis, modelling the proportion of the 
population with paralysed or impaired phenotype, weighted for plate population, fitted to a gaussian 
distribution.  Statistically significant differences from the WT strain are denoted by “***” (p<0.001), “**” 
(p<0.01), “*” (p<0.05), “.” (not significant 0.05<p<0.1), “ns” (not significant, p>0.1). b - The mean percentage of 
worms displaying the paralysed (green bars) or impaired locomotion phenotypes (blue) is shown for each strain, 
error bars represent standard deviation (SD). Results of itr-1 and egl-8 strains are shown for comparison. “nm” 
represents strain not tested in this repeat. 
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Figure 3.9. Effect of dpy-13 RNAi treatment on G-alpha mutant strains. a- The length of worms of each strain treated 
fed either control (cat) or dpy-13 RNAi cultures is shown for comparison. There is considerable variation in the 
control treated length of worms between strains. b- The reduction in length of worms compared to the mean 
control treated length for that strain in that set. Median n/strain =54, range 33-186. Statistical significance 
assessed by regression analysis, linear model accounting for length, RNAi treatment and strain. Overall dpy-13 
treatment results in a significant reduction in length. Statistically significant difference in response to dpy-13 
RNAi treatment for the test strains compared to the WT strain are denoted by “***” (p<0.001), “**” (p<0.01), 
“*” (p<0.05), “.” (not significant 0.05<p<0.1), “ns” (not significant, p>0.1). 
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Figure 3.10.  Reduction of length caused by dpy-13 RNAi by feeding treatment against egl-30 mutants.  The 
data from figure 3.9 is shown again, here represented as the frequency of dpy-13 RNAi treated worms of each 
strain which show a reduction in length of <20%, >20%, >40% or >60%. Only eri-9, goa-1 lof1 and the goa-1 lof3 
populations contain worms with the most severe reductions in length, > 60 %.   
 
The results of the dpy-13 RNAi treatment assayed by measuring length show that, as was 
seen in the egl-30 mutants, there is significant variation in the length of the control treated worms 
(figure 3.9a, blue bars).  Even more variation is seen in the length of the dpy-13 RNAi treated worms.  
In order to easily compare the changes in length seen for each strain the measured length of each 
worm (length AU) was normalised according to mean length of the worms of each strain raised on 
control bacteria. This allowed the relative change in length from expected length for each worm to 
be calculated as seen in figure 3.9b.  The majority of strains also show significant differences in 
response to dpy-13 RNAi treatment compared to the wildtype (figure 3.9a, green bars and 3.9b).  
92 | C h a p t e r  3 -  Identification of cell signalling mutants with an altered RNAi response 
 
92 
 
However, in most cases these differences are small, with only 2 strains of the goa-1 lof 1 and goa-1 
lof 3 showing mutants showing an average reduction comparable to that of the eri-9 mutant.  These 
strains are also the only ones to show incidences of reduction in length greater than 60% as seen in 
figure 3.10.  The gpa-12 lof mutant which was significantly reduced RNAi response compared to WT 
upon unc-15 and lin-31 RNAi treatment does not show a significant decrease in length upon dpy-13 
RNAi treatment in comparison to the WT.  Very little change was also seen in the WT in this set of 
dpy-13 assays, making, a reduction in efficiency of RNAi difficult to detect, although a significant 
difference was still seen between ipp-5 and the WT. 
 
Conclusion – goa-1 lof strains frequently show a strongly enhanced RNAi response 
 The results of the RNAi assays for the different Gα strains tested are summarised in table 
3.4. The majority of Gα strains tested show no consistent pattern of an altered RNAi response 
compared to the WT strain across the three different RNAi treatments.  gpa-7 and gpa-10 show no 
significant difference to the WT in the frequency or severity of their response phenotypes to lin-31 
or unc-15 RNAi treatment, with a slight lightly enhanced response to dpy-13 RNAi treatment.  The 
gpa-12 lof strain shows a significant decrease in response to both lin-31 and unc-15 RNAi treatment 
but the response to dpy-13 RNAi treatment is very closely aligned to that seen in the WT strain.  gsa-
1 and gpa-16 both show an enhanced response to lin-31 RNAi treatment, with gpa-16 also showing 
an enhanced response to dpy-13 RNAi treatment. Unfortunately, the response of gpa-16 to unc-15 
RNAi was not tested due to the temporary loss of this line.  goa-1 lof2 shows a significantly and 
dramatic increased response to all the RNAi treatments tested, whilst goa-1 lof3 shows a similarly 
clear enhancement for the two RNAi treatments against which it was tested. goa-1 lof1 shows a 
clear enhancement in its RNAi response to lin-31 or dpy-13 RNAi treatment, but this enhancement 
was not detected in response to unc-15 RNAi treatment.  Nevertheless, the results of the 3 goa-1 lof 
strains taken together point to a strongly enhanced RNAi response.   
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Strain RNAi response 
lin-31 unc-15 dpy-13 
eri-9 ++ ++ ++ 
ipp-5 - - - - - 
goa-1 lof1 + Ns (-) ++ 
goa-1 lof2 ++ ++ + 
goa-1 lof3 nm ++ ++ 
gsa-1 gof ++ nm ns (+) 
gpa-7 lof ns ns (-) + 
gpa-10 lof ns ns (+) + 
gpa-12 lof - - -  ns 
gpa-16 lof + nm + 
gpa-17 lof ns ns - 
Table 3.4.  Summary of the RNAi response of the tested G-alpha mutants. Semi-quantitative 
summary of the changes seen in the RNAi response of the strains tested, relative to the WT 
strain.  + significant increase, ++ significant large increase, - significant decrease, -- large 
significant decrease (minimal response), ns no significant change. 
 
 
 
3.2.iii  Confirmation of results using the unc-47p::GFP transgenic system 
The complex phenotypes and potential pleiotropic interactions of the egl-30 and goa-1 
mutants with the RNAi targets make reliably interpreting the results of the RNAi assays based on 
developmental and behavioural phenotypes difficult.   I therefore wished to confirm that goa-1 lof 
mutants were indeed enhanced in their RNAi response using a method not based around the knock 
down of an endogenous gene.  The unc-47p::GFP transgenic system developed by the Ruvkun lab, 
where GFP is expressed in only the GABAergic neurones has been previously used in the 
characterisation of Eri mutants such as eri-1 (Kennedy et al., 2004).  It is therefore a well 
characterised system for assessing the efficacy of enhanced RNAi response by quantifying the loss of 
GFP fluorescence from the neurones upon GFP RNAi treatment.   unc-47 is expressed in all the 
GABAergic neurons of adult and larval stages.  The 26 GABAergic neurons of the adult 
hermaphrodite comprise of the RIS interneuron and ALV, DVB, 4 RME, 6DD and 3VD motor neurons 
which can each be easily visualised (White et al., 1986).  The neurons of C. elegans have been found 
to be refractory to RNAi in a WT background but knockdown is possible when the exo-RNAi response 
is enhanced (Kennedy et al., 2004). Both itr-1 and egl-8 mutants show enhanced knockdown of unc-
47p::GFP(Nagy et al., 2015).  The unc-47p::GFP transgene was first crossed into a goa-1 lof, goa-1 OE 
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and egl-30 lof background. The itr-1; unc-47p::GFP strain had been previously constructed.  The 
strain EG1285 (lin-15B&lin-15A(n765); oxIs12 (unc-47p::GFP + lin-15(+))), which does not show an 
enhanced RNAi response was used  as the reference to which levels of unc-47p::GFP knockdown  
were compared. RNAi by feeding using a GFP dsRNA construct was used to induce GFP RNAi.  The 
effects were quantified by scoring the 22 D-type, DVB, ALV and RIS neuron cell bodies for the 
presence of absence of visible fluorescence.  As a control the number of fluorescent neurones were 
also counted in control RNAi treated worms. All strains showed similar and consistently high 
numbers of fluorescent neurones (data not shown).   
Figure 3.11a shows the response of GFP RNAi on the GFP fluorescence in the GABAergic 
neurones in EG1285, itr-1(sa73) lof, goa-1 lof, egl-30 lof and goa-1 OE backgrounds.  In EG1285 loss 
of fluorescence from any neurons is rare, with the number of GFP positive neurones counted ranging 
from 22 to 16, with an average of 20 fluorescent neurones.  The median number of GFP positive 
neurones following GFP RNAi treatment in the itr-1 and goa-1 lof backgrounds is dramatically 
reduced, to 14 and 12 respectively. Notably the individual variation is extremely high, reflecting the 
stochastic nature of the RNAi process in each neuron.  The median number of GFP positive neurones 
in the egl-30 lof and goa-1 OE backgrounds is 20, showing no difference from that seen in EG1285 
although the distribution of the observed values is narrower, being comparable to that seen in 
untreated worms.    
This assay clearly supports the findings that goa-1 loss of function results in an enhanced 
RNAi phenotype, and that neither egl-30 loss of function nor goa-1 OE cause an enhanced RNAi 
phenotype.  However, it is not possible to conclude whether egl-30 loss of function nor goa-1 OE 
results in a reduced sensitivity to RNAi due to the unidirectional nature of this assay.   
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Figure 3.11. Knockdown of GFP flourescence in GABAergic neurones due to GFP RNAi by feeding.        
A significant loss of flouresecnce is seen in itr-1 lof (p<0.001)  and goa-1 lof (p<0.001) backgrounds but not in 
the egl-30 lof and goa-1 OE backgrounds, compared to EG1285.  The 22 D-type, DVB, ALV, RIS neurones were 
scored for their presence or absence of GFP.  Stastistical significance tested by ANOVA followed by Tukey HSD 
test.  
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3.2.iv  Investigating a role for regulators of the GOA-1 / EGL-30 antagonism – Regulators of 
G-protein signalling 
The finding that goa-1 loss of function leads to an increased efficiency in the exo-RNAi 
response suggests that goa-1, or the active Gβγ dimer from a Gαo containing heterotrimer (see 
chapter 1 -1.2.vii) is likely acting to activate egl-8 in the pathway regulating the RNAi response. 
Signalling by heterotrimeric G-proteins is carefully regulated by a range of proteins acting as 
activators or inhibitors of G-protein signalling- in particular of the Gα subunit.  To better understand 
how GOA-1 may be regulating EGL-8 activity I investigated whether any known regulators of GOA-1 
heterotrimeric signalling had an altered RNAi response.  Since GOA-1 and EGL-30 are known to signal 
antagonistically in a number of pathways in C. elegans known regulators of the Gαo/Gαq network 
were focussed on (as discussed in chapter 1 -1.2.viii).  
One of the key ways in which G-protein signalling is regulated is through influencing the 
GTP/GDP state of the Gα subunit.  Conformational change in the subcellular domains of the GPCR 
upon agonist binding triggers GTP/GDP exchange leading to dissociation of the active GαGTP and Gβγ 
subunits.  Gα subunits have inherent GTPase activity and so will in time return to GDP state, leading 
to reformation of the inactive heterotrimer.  In vivo interactions with accessory proteins serve to 
further regulate the timing and specificity of G-protein activation and interactions with effector 
proteins in a number of ways, including influencing the GDP/GTP state of the Gα subunit through 
GAP (GTPase activating protein) and GEF (Guanonucleotide exchange factor) activity (reviewed in 
(Lanier, 2004)).  GEFs promote formation of the active GαGTP state, complementing or substituting 
for the role of the GPCR and potentiating the time the G-proteins spend in the active conformation.  
Conversely RGS (regulator of G-protein signalling) proteins act as GAPs, stimulating the GTPase 
activity of Gα, accelerating the return to the inactive state and the termination of signalling (Watson 
et al., 1996).   
In C. elegans the antagonism between GOA-1 and EGL-30 signalling, which through the 
regulation of neurotransmitter secretion regulates, locomotive and egg laying behaviours is 
mediated by the GGL-domain containing R7 RGS proteins EAT-16, EGL-10 and RGS-1.  EAT-16 is an 
inhibitor of EGL-30 whilst EGL-10 is an inhibitor of GOA-1.  An interaction with GPB-2, the orthologue 
of mammalian Gβ5, is required for both EAT-16 and EGL-10 function (Chase et al., 2001; Robatzek et 
al., 2001). The R7 anchoring protein RSBP-1, a homologue of mammalian R7BP, is required to target 
EAT-16 to the plasma membrane (Porter and Koelle, 2010).  Other known regulators of this network 
include the GEFs RIC-8 and AGS-3 which together with GOA-1 also regulate spindle formation during 
embryogenesis (Hofler and Koelle, 2011; Miller and Rand, 2000; Miller et al., 2000), promote 
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GTP/GDP exchange and dissociation of the heterotrimer respectively.  Like EGL-10, RGS-1 is also a 
negative regulator of GOA-1.  The strains tested are described in table 3.5.  This group of strains was 
tested using the lin-31 and dpy-13 RNAi assays. 
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Strain genotype labelled as variant/ description key phenotypes key references 
LX147 rgs-1(nr2017) III. rgs-1 lof  Likely null. 
638bp deletion with 
35bp insertion.  
Weak egg laying 
defects.  
(Dong et al., 
2000) 
MT8504 egl-10(md176) V. egl-10 lof  Likely null. 
Deleted or severely 
rearranged. 
Retains eggs, slow, 
sluggish locomotion 
and foraging 
behaviour with 
shallow tracks, 
Long. Defective 
avoidance 
response. 
(Esposito et al., 
2010; Koelle 
and Robert 
Horvitz, 1996; 
Porter and 
Koelle, 2010) 
JT609 eat-16(sa609) I. eat-16 lof  lof 
c/t substitution. 
 
Hyperactive, lays 
early stage eggs, 
adicarb 
hypersensitive, 
levamisole 
hypersensitive. Eat 
 
LX1313 eat-16(tm761) I; 
egl-10(md176) V. 
eat-16: egl-10 
lof 
Likely double null. 
tm761 is a 1225bp 
deletion/ 16bp 
insertion. 
 
(Wani et al., 
2012)  
RM1702 ric-8(md303) IV. ric-8 lof 1 Strong lof. 
C/A substitution that 
converts alanine 275 
to glutamic acid.  
 
Retains eggs, 
sluggish 
locomotion, near 
paralysis in older 
worms, reduced 
body 
flexion/straight 
posture, reduced 
pharyngeal 
pumping and 
growth rate. Some 
embryonic lethality 
and early defects. 
(Miller et al., 
2000) 
Table 3.5. Regulators of G-protein signalling mutant strains used in work described in this chapter. 
Descriptions taken from referenced papers or from WormBase. 
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Strain genotype labelled as variant/ description key phenotypes key references 
RM2209 ric-8(md1909) IV. ric-8 lof2 lof. 
1.6 kb Tc1 
transposon insertion 
following amino acid. 
Poor growth and 
fertility at 25°C. 
Milder forms of the 
md303 phenotypes. 
(Miller et al., 
2000) 
RB1145 ags-3(ok1169) ags-3 lof Null. 
Estimated 1200bp 
deletion.  
 
Partial defects in 
food search 
behaviours after 
food deprivation. 
(Hofler and 
Koelle, 2011) 
JT603 gpb-2(sa603) I 
 
gpb-2 lof1  Likely null. 
g/a substitution 
causing premature 
stop codon after 
second WD40.  
Variable 
locomotion ranging 
from lethargic to 
hyperactive, 
intermittent 
exaggerated body 
bends. Egg laid 
slightly late stage, 
Eat. 
(Robatzek et al., 
2001) 
DA541 gpb-2(ad541) I. gpb-1 lof2 lof. 
Substitution causing 
W368X.  
 
Starvation 
hypersensitive, 
arecoline 
hypersensitive, 
intermittent 
exaggerated body 
bends, eggs laid 
slightly late stage 
pharyngeal 
pumping variant. 
(Robatzek et al., 
2001) 
LX1270 rsbp-1(vs163) I. rsbp-1 lof Null. 
169 bp deletion 
removing exon 2 and 
causing frameshift. 
Eggs laid early, 
hyperactive 
movement, slow 
development, Eat.  
Phenocopies eat-16 
null. 
(Porter and 
Koelle, 2010) 
Table 3.5 (continued). Regulators of G-protein signalling mutant strains used in work described in this chapter. 
Descriptions taken from referenced papers or from WormBase. 
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Figure 3.12 shows the results of the lin-31 RNAi assays.  The eri-9 and ipp-5 lof strains behave 
as expected consistently showing a dramatic increase and decrease respectively, compared to the 
WT, in the percentage of multivulval or protruding vulval phenotypes observed.  eat-16 lof also 
shows consistently high levels of MUV and protruding vulval phenotypes at levels comparable to 
those seen in the eri-9 mutant strain and is significantly enhanced compared to the WT in respect to 
incidence of these phenotypes.  A significant change in the opposite direction is seen in egl-10 lof, 
which shows lower than WT levels of the response to lin-31 RNAi, though not to the extreme of zero 
incidence seen in the ipp-5 mutant.  The striking difference in effect of lin-31 RNAi on eat-16 lof and 
egl-10 lof would seem to reflect the opposing roles of these two RGS proteins.  The eat-16;egl-10 lof 
double mutant shows a significantly enhanced response to lin-31, similar to that seen in eat-16 lof.  
As might be expected given the role known roles of both GPB-2 and RSBP-1 in assisting EAT-16 
function, gpb-1 lof1, gpb-1 lof2, rsbp-1 lof all show a significant enhancement of incidence of MUV 
and protruding  vulva phenotype, similar to that seen in eat-16 lof.  No significant difference from the 
WT is seen in rgs-1 lof.  Among the GEFs tested, neither of the ric-8 lof mutants show a significant 
difference from the WT whilst ags-3 shows a subtle but significant increase.  
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Figure 3.12. Results of lin-31 RNAi by feeding against mutants of G-protein regulators. a- Box plots representing 
the range of values of the sum MUV or protruding vulval phenotypes seen for each strain. Box edges represent 
upper and lower quartiles with the central line representing the median Each coloured dot represents one 
experimental plate with a median population of 67 worms, range 15-297. Statistical significance was assessed 
using logistic regression analysis, modelling the proportion of population affected, weighted for plate population, 
and including observation-level random effect and rep as random effects.  Statistically significant differences 
from the WT strain are shown. b- Represents the same data shown in a, but % MUV or protruding vulval is broken 
down by class. The mean percentage of worms of each strain with a MUV or protruding vulval phenotype is 
shown, error bars represent standard deviation (SD) Each row represent an independent repeat consisting of 3 
replicate plates per strain. “nm” represents strain not tested in this repeat. Results of egl-8 lof and itr-1 lof strains 
are shown for comparison.  
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 The results of dpy-13 RNAi treatment assayed by scoring phenotype presence by eye (figure 
3. 13 and by measuring (figure 3.14, 3.15) are largely concordant.  Once again figure 3.14a shows 
significant variation between strains in the average length of worms grown on control bacteria. This 
variation likely had a confounding effect on the scoring of the milder dpy-13 phenotypes by eye and 
requires the normalisation of the measured lengths by the within strain average in order to patterns 
in the change in length upon dpy-13 RNAi treatment.  A significant increase in % reduction in length 
compared to the WT is seen across eat-16 lof, egl-10 lof, rgs-1 lof, ags-3 lof and ric-8 lof 2 mutants, 
with both ric-8 lof1 and eat-16;egl-10 lof  showing a non-significant increase in average reduction in 
length (see figure 3.14b).  Both gpb-2 lof mutants show no significant change from the WT reduction 
in length, whilst rspb-1 lof is the only strain to show a significant decrease in reduction in length, 
compared to the WT strain.  A closer look at the distribution of the change in length of dpy-13 RNAi 
treated worms, seen in figure 3.15 shows that for most strains the vast majority of worms show no  
more variation length than that seen in control treated worms (<20% = no change). Even for strains 
which show a significant increase in reduction in length than that seen in the WT, differences are 
slight with an increase in the percentage of the population showing a moderate reduction in length 
of between 20-40%.  Only eat-16 lof1 and eri-9 populations consistently contain worms with the 
more dramatic Dpy phenotypes – reductions in length greater than 40 or even 60%.  
These results of the dpy-13 measured assays are largely compatible with those seen in figure 
3.13, where dpy-13 RNAi assays have been scored by eye.  The most notable exceptions to this are 
ags-3 lof and rsbp-1 lof, with ags-3 showing a non-significant slight decrease in incidence of Dpy 
phenotype whilst rsbp-1 shows a significant increase in incidence of Dpy phenotype.  These effects 
are the opposite to those seen when length is accurately measured. In the case of the rsbp-1 lof this 
conflict could in part me explained by the mis-scoring of worms of this strain as mildly Dpy due to the 
significantly shorter length of the control treated worms compared to the wildtype.  The variation in 
the measured length of dpy-13 treated worms of this strain is also highly variable.  
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Figure 3.13. Effects of dpy-13 RNAi by feeding on mutants of regulators of G-protein signalling mutants. 
Successful dpy-13 knockdown results in a distinctive Dpy phenotype. a- Box plots representing the range of 
values of the Dpy phenotypes seen for each strain. Each coloured dot represents one experimental plate with a 
median population size of 112 worms, range 40-288. Statistical significance was assessed using logistic 
regression analysis, modelling the proportion of the population with paralysed or impaired phenotype, weighted 
for plate population, fitted to a glm of a binomial distribution with strain as a fixed effect and with rep and 
observational level as random effects.  Statistically significant differences from the WT strain are shown. b- % 
dpy is broken down by class. The mean percentage of worms of each strain with MUV and protruding vulval 
phenotypes is shown, error bars represent standard deviation (SD). Each row represents an independent repeat 
consisting of 3 replicate plates per strain. “nm” represents strain not tested in this repeat. 
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Figure 3.14. Effect of dpy-13 RNAi treatment on Regulators of Gα signalling mutant strains. a- The length of 
worms of each strain treated fed either control (cat) or dpy-13 RNAi cultures is shown for comparison. There is 
considerable variation in the control treated length of worms between strains. b- The reduction in length of 
worms compared to the mean control treated length for that strain in that set. Median n/strain =46, range 26-
58. Statistical significance assessed by regression analysis, linear model accounting for length, RNAi treatment 
and strain. Overall dpy-13 treatment results in a significant reduction in length. Statistically significant 
difference in response to dpy-13 RNAi treatment for the test strains compared to the WT strain are shown. 
Results of egl-8 lof strain are shown for comparison.  
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Figure 3.15. Reduction of length caused by dpy-13 RNAi by feeding treatment against mutants of G-protein 
regulators. The data from figure 14 is shown again, this time showing this time the frequency of dpy-13 RNAi 
treated worms of each strain which show a reduction in length <20%, >20%, >40%, 60%. 
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Conclusion – eat-16 lof results in an enhanced RNAi response. 
The results of the RNAi assays testing the response of the known regulatory mutants of the GOA-1 
and EGL-30 antagonism to RNAi treatment are summarised in table 3.6.  The eat-16 lof strain alone 
shows a consistent and clear enhancement in the RNAi response to both lin-31 and dpy-13 RNAi 
treatments.  ags-3 lof also shows a less dramatic but significantly increased response to both lin-31 
RNAi and dpy-13 RNAi (detected when length measured), while ric-8 lof1 consistently shows no 
significant change from the wildtype in response to both treatments.   A consistent trend is also seen 
in the eat-16;egl10 lof double mutant.  However, all the strains tested show almost no consistency 
between response to lin-31 RNAi treatment and response to dpy-13 RNAi treatment, relative to the 
WT strain.  
Strain RNAi Response 
lin-31 dpy-13 dpy-13 (measured) 
eri-9 ++ ++ ++ 
ipp-5 - - - - - 
eat-16 lof ++ + ++ 
egl-10 lof - + + 
eat-16; egl-10 lof ++ ns (+) ns (+) 
gpb-2 lof1 ++ ns (+) ns 
gpb-2 lof2 ++ ns ns 
rspb-1 lof ++ ns (+) - 
rgs-1 lof ns ns (-) + 
ric-8 lof1 ns ns (+) ns (+) 
ric-8 lof2 ns + + 
ags-3 lof + ns (-) + 
Table 3.6.  Summary of the RNAi response of the tested regulators of G-protein signalling 
mutants. Semi-quantitative summary of the changes seen in the RNAi response of the 
strains tested, relative to the WT strain.  + significant increase, ++ significant large increase, 
- significant decrease, -- large significant decrease (minimal response), ns no significant 
change. 
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3.3  Conclusions – goa-1 lof and eat-16 lof but not egl-30 lof results in an enhanced RNAi 
response 
Drawing together the results of the Gα proteins screened for an altered RNAi response the 
goa-1 lof mutants standout for both the strength and penetrance of their response to lin-31, unc-15 
and dpy-13 RNAi treatment, with responses consistently comparable to the responses seen in the eri-
9 mutant strain, and in itr-1(sa73) and egl-8(e2917) lof mutants.  That this apparent increase in 
response to RNAi treatment is also seen in GFP RNAi knockdown in the unc-47p::GFP system, a 
phenotype independent assay, confirms that goa-1 loss of function does result in a general increase 
in the efficiency of the gene silencing  response to exogenous dsRNA, similar to that seen in the itr-1 
and egl-8 lof mutants.  
Although several other Gα mutants show an increased response to RNAi treatment against 
one or more targets, including the gsa-1 gof, gpa-10 lof, gpa-7 lof, gpa-16 lof and gpa-17 lof, none 
show a consistently increased response comparable to that seen in the goa-1 mutants.  gpa-12 
stands out for consistently showing a markedly low response to all RNAi treatments tested, although 
when length is measured there is no significant change in reduction in length caused by dpy-13 RNAi 
compared to the WT.  The lack of response to unc-15 RNAi treatment is particularly striking, although 
it should be noted that this was only tested on one occasion (figure 3.8).  Whether this reflects a 
decrease in the efficiency of the exo-RNAi response as is seen in the ipp-5 mutants is uncertain, since 
the changes seen in response to lin-31 and dpy-13 RNAi treatment are less dramatic.  GPA-12 is 
known to act, with RACK-1, upstream of EGL-8 and PLC-3 in a conserved signalling pathway 
regulating an innate immune response to injury and infection (Ziegler et al., 2009).  
Amongst the egl-30 mutant strains the general trend seen in response to lin-31 and lin-1 
RNAi treatment, of a decreased response amongst loss of function mutant and an increased response 
amongst some of the gain of function and OE mutants is poorly reproduced in other assays.  Amongst 
the lof mutants none show a significant reduction in response to dpy-13 RNAi treatment, and only 
egl-30 lof 2 shows a significant decrease in response to dpy-13 RNAi treatment.  Of the egl-30 gof and 
OE strains only egl-30 lof OE rescue shows a consistently enhanced response to all 4 treatment 
conditions compared to the WT strain. egl-30 gof 1 also shows a trend for enhanced response, being 
significantly increased in response to all treatments but unc-15 to which there is no significant 
difference to the WT.  However there seems to be no discernible consistent trend for any of the 
other egl-30 mutants.  The unc-47p::GFP assay confirmed that egl-30 lof does not enhanced the RNAi 
response but any reduction in response was unable to be confirmed due to limitations of the assay.  
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The potential confounding influence of the pleiotropic phenotypes of the egl-30 and goa-1 
mutants, as well as several of the other Gα mutants on the scoring and interpretation of the RNAi 
assays should be considered.  It is possible that one or more of the Gα mutants could have an 
unidentified role in the regulation of vulval development, whilst several of the mutants tested are 
known to display movement variants, and to have varying degrees of altered body length/shape.  The 
most obvious of these are the near paralysis seen in severe egl-30 mutants or goa-1 hypermorphic 
mutants which make it very difficult to reliably score or draw meaningful conclusions from the unc-
15 RNAi assay. It should also be noted that both the egl-30 OE and goa-1 OE transgenes contain dpy-
20 and are carried in a dpy-20 lof background, and as such could be potentially sensitised to the 
induction of the Dpy phenotype by dpy-13 RNAi.  For all of these reasons the testing of the suspected 
enhanced RNAi response using a system independent of confounding phenotypes, such as GFP 
knockdown in the unc-47p::GFP system is the crucial.   
On top of the differing patterns of response seen to the different RNAi targets for many 
strains it is worth noting the considerable variation seen across replicates of the same assay including 
in some cases contradictory results seen for some strains in different sets.  Sources of variation 
include different RNAi cultures, different IPTG batches and experimental error as well as natural 
variation resulting in part from the stochastic nature of the biological processes involved.   
What can be concluded is from these results and the result of the unc-47p::GFP GFP RNAi 
assays in an egl-30 lof background is that egl-30 lof mutants do not show an enhanced RNAi response 
as is seen in egl-8 and itr-1 lof mutants.  In fact, the balance of evidence points towards a potential 
RNAi resistant phenotype in egl-30 lof mutants and a possible enhanced RNAi phenotype in egl-30 
gof mutants.  Therefore, counter to the canonical, egl-30 cannot be the upstream activator of egl-8 in 
the IP3 signalling pathway regulating the RNAi response. Instead goa-1 has emerged as the most 
likely candidate for the upstream activator of egl-8, with goa-1 lof mutants showing an even greater 
enhanced RNAi response than that seen in itr-1(sa73) mutants at 20°C.  
GOA-1 and EGL-30 are known to signal antagonistically to regulate several independent 
processes in C. elegans including the modulation of locomotion and egg laying, L4 to adult lethargus, 
the ASH mediated avoidance response.  Cross talk in this antagonistic system occurs at a number of 
levels, downstream of EGL-30 activated EGL-8 signalling via the GOA-1 induced inhibition of DAG via 
DAG kinase,  but also upstream at the level of GOA-1 vs EGL-30 activation, mediated by the RGS 
proteins EAT-16,  EGL-10, RGS-1 and RGS-2 (not tested), and by the GEFs RIC-8 and AGS-3, with  GPB-
2 required by both EAT-16 and EGL-10,  and RSBP-1 required by only EAT-16.   Several of these 
regulators therefore phenocopy goa-1 and egl-30 mutants to varying degrees.  
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 Given the variation seen in many of the egl-30 strains in particular perhaps it is unsurprising 
that the responses of the regulators of G-protein signalling, selected for their known roles in the 
regulation of GOA-1 and/or EGL-30 signalling, to the lin-31 and dpy-13 RNAi assays are similarly 
mixed. egl-10 lof, which generally phenocopies egl-30 lof due to EGL-10s role in the inhibition of 
GOA-1, shows a decreased response to lin-31 RNAi but a slight increase in response to dpy-13 RNAi. 
eat-16 lof , which as negative regulator of egl-30, phenocopies goa-1 lof (Hajdu-Cronin et al., 1999), 
shows an opposite phenotype to egl-10 with respect to lin-31 RNAi treatment but the eat-16, egl-10 
and eat-16;egl-10 double mutant all show very similar responses to dpy-13 RNAi treatment.  Loss of 
function mutants of gpb-2 and rsbp-1, binding partners of egl-10 , and egl-10 and eat-16, 
respectively, show a clear increase in response to lin-31 RNAi treatment and no change, or a 
decrease in the case of  rsbp-1, in response to dpy-13 RNAi treatment. Whilst rgs-1 lof shows no 
change in response compared to the WT for lin-31 treatment, a small increase in response to dpy-13 
RNAi, a pattern also seen in both ric-8 mutants.  Although the opposing function of egl-10 and eat-16 
are not seen in the dpy-13 RNAi assays the strongly enhanced response of the eat-16 lof mutant in 
response to both lin-31 RNAi and dpy-13 RNAi treatments is strikingly similar to that seen in goa-1 lof 
mutants and suggests a possible general enhanced RNAi response.  
 
Figure 3.16. The antagonism between the goa-1 and egl-30 signalling pathways is hypothesised to be 
mediated by GPB-2, EAT-16 and EGL-10.  Reproduced from (Van der Linden et al., 2001). 
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The unc-47p::GFP system could be used in In order to confirm whether the results seen for 
eat-16 lof so far reflect an enhanced RNAi phenotype in accordance with that seen in goa-1 lof.  The 
involvement of eat-16 would strengthen the suggestion that egl-30 lof mutants show a decrease 
efficacy of RNAi.  The unc-47p::GFP transgenic system was unable to confirm this due to the 
unidirectional nature of this assay.  A better system to confirm the results of possible decreased RNAi 
mutants such as egl-30 lof, goa-1 OE/ gof,  and potentially gpa-12 lof, whilst still being free of 
confounding phenotypic variants would be a non-neuronal GFP transgenic system, in which GFP RNAi 
produces a strong but not total reduction in fluorescence in a WT background.   
There are a number of possible way in which goa-1 could be acting to regulate the egl-8/IP3 
signalling pathway in the regulation of the RNAi response. One possibility is that goa-1 is acting 
directly upstream of egl-8. Another is that goa-1 activity may influence egl-8 activity in a more distal 
manner, perhaps acting at a different of the signalling pathway in a different cell or even a different 
tissue. It is also possible that goa-1 is regulating the RNAi response via an independent pathway to 
egl-8, such that multiple signalling pathway converge on the regulation of the RNAi response. 
Ultimately epistasis analysis of goa-1; egl-8 or goa-1; ipp-5 double mutants would be needed to 
confirm whether goa-1 is acting upstream or in parallel to the IP3 signalling pathway to regulate the 
RNAi response.  Tissue specific transgenes could be used to attempt to rescue goa-1 in the intestine 
to see whether this is able to rescue the systemic RNAi phenotype, as it does in the case of itr-1 
mutants.  
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Do itr-1 mutants have an altered small RNA profile? 
 
4.1  Introduction 
 
Small RNA sequencing has been used extensively in C. elegans and other organisms to gain 
better understanding of the nature, origins, diversity and function of small endogenous RNAs (e.g. 
(Gent et al., 2010; Ruby et al., 2006; Sarkies et al., 2015; Shi et al., 2013)).  Small RNA sequence 
profiles are indicative of cell type, cell state and, at the organismal or population level, 
developmental state or population profile.  Small RNA sequence profiling can also reveal deficiencies 
in one or more branches of the endogenous small RNA pathways.  For example, loss of function 
mutants in components unique to the 26G siRNA pathway such as ergo-1, rrf-3, eri-1, eri-9 fail to 
accumulate 26G small RNAs, a change which is clearly evident by small RNA sequencing (Gent et al., 
2010).   
Whilst some RNAi pathway components are unique to a given pathway others are shared 
between pathways and act as a limiting resource to generate competition between pathways (as 
discussed in section 1.3.xi).  There is evidence for such competition for shared resources between the 
exo-RNAi and endo-siRNA pathways and between both the exo-RNAi, endo-siRNA and miRNA 
pathways (Zhuang and Hunter, 2012).  For example the classical Eri mutants such as eri-1, rrf-3 and 
eri-9 whilst enhanced for exogenous RNAi are defective in endogenous siRNA induced silencing (Lee 
et al., 2006).   One possible explanation for the altered exogenous RNAi efficiency of IP3 pathway 
mutants is that it is underpinned by changes in the endogenous small RNA pathways.  Changes such 
as a decrease in endogenous siRNAs would increase the availability of shared components for the 
exogenous pathway as is seen in the Eri mutants.  If there is a change in one or more branches of the 
endogenous RNAi pathways this change may be detectable via high throughput sequencing of small 
RNA libraries.  The endogenous classes of small silencing RNAs in C. elegans and their key 
characteristics are summarised in table 4.1. For a full discussion of the different endogenous small 
RNA types please see section 1.3.ii-1.3.vii.  
itr-1(sa73) is a temperature sensitive loss of function mutation in the IP3 receptor which acts 
as near WT at 16°C and near null at 25°C.  Even at the less restrictive temperature of 20°C itr-1(sa73) 
displays a strong Eri phenotype comparable to that of classical Eri mutants.  In order to look for 
differences in the endogenous small RNA population that might provide clues as to the mechanism 
through which the enhanced RNAi phenotype of itr-1 mutants is achieved, I prepared small RNA 
libraries of WT and itr-1(sa73) mutant worms.  Following small RNA sequence analysis, a qPCR based 
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experiment was designed to follow up on potential changes identified by small RNA sequencing using 
a broader range of IP3 pathway mutants, itr-1, egl-8 and ipp-5. 
 
Small RNA 
type 
Length   
and 5’ end 
chemistry 
Biogenesis Associated 
argonautes 
Known functions  
miRNA 21-24 nt, most 
22 nt 
5’mono P 
Primary transcripts 
from pri-miRNA 
encoding loci 
ALG-1, ALG-2, 
ALG-5 
Development 
26G siRNA 26 nt 
5’ mono p 
RDRP from pol II 
transcripts 
followed by Dicer 
cleavage. 
ERGO-1,  
 
ALG-3, ALG-4 
Oogenic gonad and throughout 
development 
Spermatogenesis 
22G siRNA 22 nt 
5’ tri P 
RDRP from 26G 
siRNA, piRNA and 
exo-siRNA target 
transcripts 
WAGO clade 
 
Various 
21U piRNA 21 
5’mono P 
piRNA clusters PRG-1 Silence transposons 
in the germline 
sdRNAs (sno 
RNA derived) 
Various 
5’ mono P 
Cleavage of Small 
nucleolar RNAs by 
Dicer 
 miRNA like 
tsRNA (tRNA 
derived) 
28–36 nt 
(tiRNAs) 
14–30 nt (tRF) 
5’ mono P 
Cleavage of tRNAs 
by Dicer 
 Various including ribosome 
biogenesis, intergenerational 
inheritance (Li et al., 2018) 
Table 4.1. The endogenous small RNAs of C. elegans.  
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4.2  Results of small RNA sequencing 
 
As small RNA expression is dependent on the stage of the worms it was important that the WT and itr-
1(sa73) populations were comparable.  Since the growth defects of itr-1(sa73) worms are such that 
comparable populations could not be achieved on mixed-stage plates libraries were prepared from 
synchronised populations of young adult worms grown at 20°C.  The adapter ligation reaction used to 
prepare the libraries for sequencing requires molecules to have 5’ mono-phosphate and 3’ hydroxyl 
groups, which are naturally present on the subset of small RNAs which are processed by Dicer.  Two 
different library types were prepared from the WT and itr-1 RNA extracts.  5’ independent libraries 
were phosphatase treated to convert 5’ tri-phosphate group to mono-phosphate prior to adaptor 
ligation and therefore include all small RNAs, whilst the untreated 5 prime dependent library captures 
only the subset of small RNAs with a 5’ mono-phosphate group (and does not include the 22G siRNAs).  
I made both 5’ dependent and 5’ independent libraries of WT itr-1(sa73) C. elegans strains.  These 4 
libraries were then sequenced using high throughput Illumina sequencing, with 2 technical replicates 
of each library.  
N2 5’ dependent, JT73 5’ dependent and JT73 5’ independent libraries all showed good 
overall read count.  In each case over 95% of reads mapped to the genome.  The N2 5’ independent 
library unfortunately had far lower total read count (circa 10 fold) and only 50% of reads successfully 
mapped to the genome.  The dramatically lower total read count and mapping efficiency of this 
library is indicative of the lower quality and it is therefore difficult to draw reliable direct 
comparisons between the N2 and JT73 5’ dependent libraries.  In spite of this, when distributions are 
corrected for total read count the quantile-quantile distribution of all 4 libraries is very similar, as is 
the profile of read length and other properties.   
 
4.2.i  N2 and itr-1 small RNA populations showed no obvious differences 
 Figure 4.1 shows the distribution of total reads in each library by length and 5’ nucleotide.  
Both the distribution of reads by length and the 5’ end composition of those reads is well matched 
between N2 and itr-1(sa73) populations in the 5’ end dependent libraries (Figure 4.1 a, b), showing 
no obvious differences.  Clear differences are evident between the 5’ end dependent and 5’ end 
independent libraries (a and b, c and d).  The most obvious difference being an increased 
representation of reads with a 5’ G. Many of these are likely to the secondary siRNAs, typically 22G 
reads which are not represented in the 5’ dependent library due to their 5’ end chemistry.  If the 
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dramatic difference in representation of the 36nt peak is ignored, then the distribution of reads in 
the N2 and JT73 5’ independent libraries is largely similar.   
 A relatively small number of reads with high copy number account for the majority of total 
reads in both the 5’ dependent and 5’ independent libraries.  These highly expressed reads belong 
mostly to the miRNA class.  Figure 5.2 shows the distribution of unique reads by length and 5’ 
nucleotide.  Here once again the distributions of reads in the N2 and JT73 libraries are extremely 
similar in both the 5’ dependent and 5’ independent libraries with the only obvious difference being 
the different representation of the 36nt reads between the 5’ independent libraries.  This difference 
seems likely to be an artefact created by the lower read count of the N2 5’ dependent library.  
Differing methods of biogenesis mean that whilst miRNAs are expressed in high copy number 
26G siRNAs are largely expressed as unique reads or in low copy number, with amplification 
following 22G production.  Comparing the histograms of total and unique reads the peak of 26G 
reads siRNAs is far more evident in the 5’ dependent library unique read distribution.  The presence 
of additional 22G reads in the 5’ independent libraries is even more evident in the distribution of 
unique reads than in figure 4.1.  
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Figure 4.1. Histograms showing total read counts by length and 5’ nucleotide. a) N2 5’ dependent, b) JT73 5’ 
dependent, c) N2 5’ independent, d) JT73 5’ independent. The increased proportion of 22G reads in the 5’ 
independent libraries is apparent in both the N2 and JT73 libraries.  There are no apparent differences in the 
distribution of reads between the 5’ dependent libraries.  Despite large differences in read count the composition 
of reads in 18-26nt range of N2 and JT73 5’ independent libraries is very similar.  
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Figure 4.2. Histograms showing unique read counts by length and 5’ nucleotide. a) N2 5’ dependent, b) JT73 5’ 
dependent, c) N2 5’ independent, d) JT73 5’ independent. In both a and a large contribution of 21U, and 26G 
RNAs can be seen. There is no apparent difference in the distribution of reads between the N2 and JT73 5’ 
dependent libraries. In both b and c the increased proportion of 22G reads in the 5’ independent libraries 
compared to the 5’ dependent libraries a and b is clear. A dramatic difference in 36nt reads is seen in the N2 vs 
JT73 library, but despite large differences in read count the composition of reads in 18-26nt range of N2 and JT73 
5’ independent libraries is very similar.  
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Although no obvious changes to the overall small RNA profile were apparent it was possible 
that there were specific changes to a subset of small RNAs.  The program SeqMonk (Andrews, 2011) - 
a tool to visualise and analyse high throughput mapped sequence data was used to carry out more 
in-depth analysis.  Specifically, in order to look in more detail at where in the genome reads were 
mapping to and whether there were any changes in the relative depth at each point between the N2 
and itr-1 libraries.  
Reads mapping to continuous 40bp windowed probes covering the entire genome assembly 
were compared.  Figure 5.3a shows a scatter plot of the number of reads (corrected for total read 
count) which map to each genomic location coloured by the genomic feature to which they map.  
This allows the composition of the libraries to be inferred and is consistent with the profiles seen in 
the read length distributions.  The majority of highly expressed reads map to genes encoding miRNA.  
A large number of reads also map to piRNAs of both high and low expression.  A mixture of sense, 
and majoritively, antisense oriented reads map to mRNA and pseudogenes representing siRNA 
targets. Smaller numbers of reads map to tRNAs, small nucleolar (sno) RNAs and rRNAs.  In the 5’ 
independent library (figure 5.3 b) a greater proportion of reads map to the mRNAs and pseudogenes, 
as would be expected due to the inclusion of 22G secondary siRNAs in the library. 
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a 
b 
Figure 4.3.  Scatter 
plots of read count 
coloured by the 
genomic feature to 
which they map.  
a- 5’ dependent 
libraries.  
b- 5’ independent 
libraries.  In both a 
and b JT73 library is 
mapped to the Y axis 
and the N2 library to 
the X axis.  Axes 
scales are 
logarithmic.  
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4.2.ii  itr-1 small RNA populations are enriched for subclasses of miRNA and siRNAs 
Although the scatter plot of normalised read counts for each probe position show no points 
of dramatic difference there are groups of points which are could be differentially expressed.  Using 
SeqMonk I tested for any statistically significant differences in read count between the N2 and JT73 
5’ dependent libraries, at each probe location, using the intensity difference and DeSeq2 tools.  
Intensity difference testing identified a small subset of points which appear to be differentially 
expressed between the two groups.  An alternative statistical analysis (DESeq2) identified a larger set 
of significant points as shown in figure 5.4.   
Notably Included in these statistically significant probe sets are a subset of microRNAs which 
form the mir-35-41 family.  All 7 of the miRNAs in this cluster have a slightly higher expression in the 
JT73 5’ dependent library than in the N2.  This set is of interest since the mir-35-41 family miRNAs 
have been shown to regulate RNAi sensitivity via the actions of LIN-35/Rb, a synMUV B gene and core 
component of a chromatin complex.  mir-35-41 family miRNAs positively regulate the accumulation 
of retinoblastoma homologue LIN-35/Rb and both mir-35-41  and lin-35 loss of function results in an 
enhanced RNAi response, upregulation of endo-siRNA target genes (Grishok et al., 2008; Lehner et 
al., 2006; Massirer et al., 2012; Wang et al., 2005; Wu et al., 2012).  However the mir-35 family are 
also important developmental regulators and are strongly expressed in oocytes and the early 
embryo.  It was therefore possible that differences in mir-35 family expression could be accounted 
for by changes in embryo number or stage between the two samples.  However, the far lower 
fertility of itr-1(sa73) mutants made this unlikely and levels of other miRNAs known to be expressed 
in the early embryo were no higher in the JT73 library than the N2 library (data not shown).  
The set of probes identified as significantly different by the DESeq2 analysis included reads 
which map to know ERGO-1 class siRNA targets.  One of the two major branches of primary siRNAs, 
ERGO-1 class siRNAs are produced in the oogenic gonad and early embryo but persist throughout 
development.  Highlighting other probes mapping to known ERGO-1 class siRNA targets (as identified 
in (Vasale et al., 2010))  shows that a large cluster of reads slightly more highly expressed in the JT73 
library 5’ dependent library as seen in figure 5.4b. 
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Figure 4.4.  Scatter 
plots of read 
intensity at each 
genomic location 
for the of N2 and 
JT73 5’ dependent 
libraries.  
a- Probes with 
significantly 
different reads 
intensity are 
highlighted. Blue -
probes identified by 
only DESeq2 
analysis, red -probes 
identified in the 
intensity difference 
analysis.   
b- probes mapping 
to ERGO-1 class 
siRNA targets are 
highlighted. All axes 
scales are 
logarithmic.  
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Since a mild enhancement of small RNAs mapping to ergo-1 targets and a more definite enhancement 
of miR-35-41 family miRNAs was seen in the JT73 library compared to the WT library I decided to use 
quantitative real-time PCR to investigate whether these changes translated to changes in mRNA levels 
of lin-35 and a small selection of previously identified ERGO-1 target genes.  lin-35 was an obvious 
target for further investigation due to its role as the regulator of RNAi downstream of mir-35-41 whilst 
ERGO-1 target genes were selected based on a combination of differential target siRNA expression in 
the small RNA sequencing data and target siRNAs which were found to be strongly enriched in an 
ERGO-1 Immuno-Precipitation experiment performed by (Vasale et al., 2010) and were therefore high-
confidence ERGO-1 class siRNA targets.  
 
4.2.iii  IP3 signalling mutants show no change in lin-35 or ERGO-1 target gene mRNA levels 
 qPCR primers were designed against lin-35 and four ERGO-1 target genes: F55C9.5, 
Y116F11A.1, C11G6.2 and C40A11.10.   To avoid any potential bias in enrichment created by different 
embryonic stages or numbers in adult worms and to maximise synchronicity qPCR was performed 
using RNA harvested from L1 worms. qPCR was performed on N2, itr-1(sa73), egl-8(e2917), and ipp-
5(sy605) mutants, using the housekeeping gene GAPDH as a control (see table 4.2 for strain details).  
The ΔΔCt method was used to calculate relative abundance of mRNA levels in the mutant compared 
to the WT samples.  The results of the qPCR analysis are shown in figure 5.5.  No significant change in 
relative abundance (expression fold change, tested by t-test) was detected in any of the target genes.  
  
Strain Genotype Variant/description Reference Labelled as 
N2 WT (Bristol)        (Brenner, 1974) WT 
JT73 itr-1(sa73) Near null at 25°C, partial lof at 20°C. 
Substitution leading to TS lof.   
(Iwasaki et al., 
1995; Nagy et al., 
2015) 
itr-1 
CB6614 egl-8(e2917) Likely Null. 
MOS1 transposon insertion. 
(Nagy et al., 
2015; Yook and 
Hodgkin, 2007) 
egl-8 
PS3653 ipp-5(sy605) Likely Null. 
951 bp deletion.  
 
(Bui and 
Sternberg, 2002; 
Nagy et al., 2015) 
ipp-5 
Table 4.2. Strains used in this chapter.  
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Figure 4.5. The Expression fold change of target gene transcripts as measured by qPCR and calculated by the 
ΔΔCt method. Ct values were normalised relative to the housekeeping control gene GAPDH and the WT strain 
N2 before expression fold change was calculated. No change significant difference in fold change was detected 
for any of the 5 target genes.  
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Since the results of the qPCR did not support the changes detected in the small RNA-seq 
analysis I looked for alternative explanations for the differences seen.  As previously mentioned 
differences in oocyte or embryo numbers or stage would offer one explanation for the changes 
however other miRNAs expressed in the early embryo showed no differential expression and the 
fertility defects of itr-1 analysis seemed to make this explanation unlikely since you would not expect 
higher number of developing embryos in itr-1 animals.  To look for alternative explanations for the 
differences detected in the small RNA libraries, I used WormBase  to perform gene set enrichment 
analysis for the genes to which probes with significantly higher expression in the itr-1 5 prime 
dependent library mapped.  Phenotypes for which this set of genes were enriched included 
endomitotic oocytes (Emo) and decreased oocyte number. These phenotypes are consistent with 
those of itr-1 mutants and so are not unexpected however they could be sufficient to explain the 
enrichment of mir35-41 since upon further investigation, as well as in developing embryos and 
oocytes, high expression of mir-35-41 genes are also associated with an Emo phenotype, as seen in 
itr-1 mutants.   
Other GO terms for which the genes to which probes with significantly higher expression in 
the itr-1 5 prime dependent library mapped were enhanced for were biological adhesion, peptide 
biosynthesis, actin based processes, and regulation of cellular amide metabolic processes. With the 
set of genes including cadherin cdh-1, ints-8 and hsp-1, all of which have links to membrane 
transport/ localisation.   
Since the results of the qPCR make it unlikely that the enhanced RNAi phenotype of itr-1 
mutants can be explained by changes to either the ERGO-1 siRNA pathway or changes to lin-35 levels 
I looked for genes showing large differences in small RNA read mappings which were not part of the 
mir-35-41 or ERGO-1 pathways.  Levels of reads mapping to the long intergenic region linc-12 were 
significantly higher in the JT73 5 prime dep library as were reads mapping to Y116A8B.1 and 
T05E12.8.  All three genes are associated with the daf-2 the insulin like receptor pathway.  Mutation 
of this pathway also show to enhanced RNAi response (Wang and Ruvkun, 2004).  However, such 
changes to the reads mapping to these genes could simply be consistent with the altered germline 
composition of itr-1 mutants stemming from the severe fertility defects.  
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4.3  Conclusions - changes to the endogenous small RNA pathways of IP3 signalling mutants 
remain elusive  
 
Although analysis of Small RNA-seq data of WT and itr-1 adult worm populations suggested 
an enhancement of a subset of small RNAs in JT73 worms, including the miRNAs mir-35-41 and 
ERGO-1 class siRNAs a follow up study using Q-PCR to look at transcript levels of lin-35 and ergo-1 
target genes showed no changes between WT, itr-1, egl-8, and ipp-5 populations of L1 worms.  Since 
the Q-PCR was performed at a different developmental stage to the RNA-seq it is possible that robust 
changes would be seen in adult worms or at a different stage. The L1 stage was chosen to maximise 
synchronicity between strains with variable developmental timing and therefore maximise 
comparability between the samples without any confounding factors such as differences in germline 
composition or developmental stage.  However, this approach comes with the limitation that 
although all the target genes are expressed in the L1 stage several are more strongly expressed in 
other stages.  Another consideration is that although mir-35-41 family mutants are decreased in LIN-
35/Rb protein levels no change in lin-35 transcript levels was detected by Massirer et al.  who 
propose that lin-35  regulation by mir-35-41 occurs at a post-transcriptional level, possibly via 
intermediates.  Given this it is possible that even if mir-35-41 levels are altered in IP3 signalling 
mutants you would not see a change in lin-35 transcript levels.  
However, a major caveat to the small RNA sequencing data is that although technical 
replicates were sequenced both WT and itr-1 libraries come from a single biological replicate of each 
and as such the differences seen may not be a reliable representation of the differences between the 
two strains.  Although statistically significant, the changes seen are relatively slight and repeat 
sequencing with more biological replicates would be needed to ensure that the changes detected are 
robust and representative.  Ideally synchronised mixed populations would be used to create the 
libraries in order to capture the small RNA state at all developmental stages.  However, the fairly 
severe growth defects of the itr-1(sa73) worms, which are slower to develop and more variable, 
meant that comparable populations could not be achieved on mixed-stage plates. Instead I used 
synchronised populations of young adult worms for sequencing, however even achieving equivalent 
populations at the young adult stage was challenging due to the variability in growth and 
development of itr-1(sa73) mutant, such that the time period during which all worms complete their 
final molt is far broader than for WT worms.  This makes achieving perfectly synchronised 
populations beyond the L1 challenging and was the reason why L1 worms were chosen for the qPCR 
experiment, in order to maximise perfect synchronicity and reduce stage dependent variability.    
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 In summary no gross changes to the small RNA profile of itr-1 mutants were detected by 
small RNA sequencing suggesting no drastic changes in levels of any of the endogenous small RNA 
pathways and as such no impairments to the miRNA, 26G siRNA or piRNA pathways were detected. 
The lower quality of the N2 5’ independent library makes it more difficult to reliably compare 
changes to the 22G siRNA population of the itr-1 and WT worms however no change was suggested.  
Although a subset of reads were identified as enhanced in the itr-1 5’ dependent library subsequent 
qPCR failed to confirm the changes suggested to mir-35-41 and ERGO-1 subsets and it is possible the 
enhanced genes can be explained by the Emo and other germline phenotypes of the itr-1 mutants.  
Overall, no satisfactory explanation for the enhanced RNAi phenotype of itr-1 mutants could be 
found by small RNA sequencing analysis. 
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Do IP3 signalling mutants display an altered nuclear RNAi response? 
 
5.1 Introduction - The nuclear RNAi pathway 
 
In addition to the mechanisms of small RNA directed post-transcriptional gene silencing which take 
place in the cytoplasm, both the exogenous and endogenous RNAi pathways can also direct 
transcriptional gene silencing (TGS) and other effects within the nucleus.  miRNAs, siRNAs and 
piRNAs have all been found capable of triggering TGS, either directly or indirectly in a variety of 
systems.  Having multiple levels at which the expression of target genes can be regulated allows for 
fine-tuned control in endogenous gene regulation and for a more robust silencing response in the 
exogenous RNAi pathway.  In C. elegans the major effectors of piRNA, endo-siRNA and exogenous-
siRNA types are the 22G secondary siRNAs which bind to WAGO clade argonautes to form the central 
components of a number of downstream pathways – the WAGO, CSR-1 and nuclear RNAi pathways.  
The WAGO and nuclear RNAi pathways act in parallel to mediate silencing in the cytoplasm and 
nucleus respectively whilst the CSR-1 pathway protects targets from aberrant silencing.   
Evidence of a link between RNA induced silencing and changes to transcriptional activity was 
first seen in plants and yeast with very similar effects now established in C. elegans as well as 
Drosophila and mammalian cells.  In Arabidopsis dsRNA was shown to lead to changes in target gene 
transcription and promoter methylation (Mette et al., 1999, 2000; Mette, Matzke and Matzke, 2001).  
In the yeast S. pombe loss of key RNAi pathway components was found to lead to de-repression of 
silenced genes, with alterations in histone methylation and surrounding chromatin state, and non-
coding RNAs produced from the cen region in S. pombe have been found to be important for the 
maintenance of centromeric heterochromatin and the silencing of transgenes, and maintenance of 
the histone methylation in these regions in an RNAi dependent manner (Reinhart and Bartel, 2002; 
Volpe et al., 2002).   
In C. elegans the first evidence for RNAi silencing of nuclear transcripts came from 
observations of the co-silencing of genes expressed in an operon, and co-transcribed into a single 
pre-mRNA, such as lin-1/lin-26.  RNAi directed against either mature mRNA induces the same lethal 
phenotype as a lin-26 null mutation, which cannot be explained by loss of lin-1 alone (Bosher et al., 
1999).  A similar result is seen with the silencing of the lin-15 bicistron by RNAi against lin-15a or lin-
15b.  Observations that co-suppression acted via an RNAi related mechanism further supported a 
nuclear role for RNAi (Ketting and Plasterk, 2000).  Evidence of RNAi induced TGS in the soma came 
from observations of the unexpected silencing of the elt-2::GFP reporter by RNAi by feeding 
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constructs not targeting GFP and from observations of that co-suppression.  The elt-2::GFP reporter 
transgene is expressed in the intestinal cells of C. elegans.  Silencing was found to be inducible by 
feeding on bacteria expressing dsRNA complementary to only the repetitive transgene backbone.  
Silencing was found to be occurring at the transcriptional level with decreased levels of pre-mRNA  
and changes to the chromatin state including decreased histone H4 acetylation, and to be dependent 
on dcr-1 and a number of other genes implicated in RNAi and chromatin remodelling (Grishok, 
Sinskey and Sharp, 2005).   
RNAi induced TGS is dependent upon the production of secondary 22G siRNAs (as discussed 
in section 1.3.vii) The production of new siRNAs from the target mRNA enables a phenomenon 
known as transitive RNAi whereby silencing can spread beyond the initial target site, along the 
mRNA.   Further work using the elt-2::GFP transgenic system found that RNAi by feeding targeting 
GFP (GFP dsRNA treatment) silenced not only the elt-2::GFP transgene but also the endogenous elt-2 
gene due to the transitive spread of the silencing signal to sequences expressed in cis to the original 
target sequence; this  led to the silencing of complementary sequences expressed in trans.  Such 
treatment results in the deposition of histone marks and second generation silencing is dependent 
on the efficiency of nuclear silencing (Burton, Burkhart and Kennedy, 2011; Zhuang, Banse and 
Hunter, 2013; Mao et al., 2015).   
Forward genetic screens for mutants deficient in nuclear RNA silencing lead to the isolation 
of NRDE (Nuclear RNAi Deficient) mutants, each a critical component in the nuclear arm of the 
exogenous RNAi response (Guang et al., 2008, 2010).  Characterisation of such mutants has shed 
light on the mechanisms of the nuclear RNAi pathway in C. elegans and has revealed that two parallel 
pathways act in the soma and germline, with many shared NRDE components but with a different 
central argonaute.  In the soma the Argonaute NRDE-3 is the central component of the nuclear 
siRISC. Whilst in the germline HRDE-1 acts in a similar and extended role to also permit 
transgenerational inheritance of silencing (as discussed in section 1.3.viii) 
 Primary exo-siRNA, endo-siRNAs, piRNAs all trigger secondary siRNA production upon 
binding to target mRNAs in the cytoplasm.   These 22G siRNAs are produced through un-primed 
synthesis by RdRPs rrf-1 and ego-1 from the target mRNA template.  22G siRNAs in the cytoplasm are 
bound by a range of WAGO clade argonautes to amplify the initial silencing response, including the 
nuclear argonautes NRDE-3 in the soma and HRDE-1 in the germline.  NRDE-3 contains a bipartite 
nuclear localisation signal (NLS) but is cytoplasmically localised in the absence of a 22G small RNAs.  
The presence and binding of siRNAs allows both siRNA /NRDE-3 to be transported into the nucleus 
(Guang et al., 2008).  In the nucleus siRNA/NRDE-3 binds to complementary sequences of nascent 
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pre-mRNA transcripts and recruit further effector proteins including NRDE-2, NRDE-4 and NRDE-1 to 
form the RNA induced transcriptional silencing complex or RITS.  NRDE-2 associates with 
siRNA/NRDE-3 complex and is required for co-transcriptional silencing of the nascent pre-mRNA via 
mechanisms which include inhibition of RNA pol II during transcript elongation (Guang et al., 2010).   
 In addition to polymerase inhibition nuclear RNAi activity includes changes to chromatin at 
the target locus.  The pre-mRNA associated complex of siRNA/NRDE-3 and NRDE-2 further recruits 
NRDE-1 and NRDE-4, all of which are required for chromatin association of NRDE-1 and the 
associated H3K9 trimethylation and H3K27 trimethylation, markers of gene silencing (Burkhart et al., 
2011; Mao et al., 2015).  Chromatin methylation requires recruitment of additional factors including 
the methyltransferases SET-25, SET-32 and MET-2 which all contribute to H3K9me3.  Whilst histone 
methylation was shown not to be essential for efficient nuclear silencing  (Kalinava et al., 2017), 
factors mediating histone methylation and other chromatin modifications do play an important role 
in the transgenerational maintenance/re-establishment of silencing (Ashe et al., 2012; Luteijn et al., 
2012; Shirayama et al., 2012; Mao et al., 2015; Woodhouse et al., 2018).   
The methylation marks directed by nuclear RNAi are especially evident in the F1 progeny of 
worms exposed to the primary trigger (Mao et al., 2015). Interestingly, marks seem to be 
redeposited in a secondary siRNA dependent process each generation.  Primary siRNAs may also be 
passed down.  In the soma silencing is only effectively maintained for a single generation however 
additional mechanisms are in play in the germline (Sapetschnig et al., 2015; Xu et al., 2018).  
In the germline HRDE-1 acts in place of NRDE-3 as the argonaute at the heart of the nuclear 
RNAi pathway.  There are a number of differences in the behaviour of this HRDE-1/germline pathway 
compared to its somatic counterpart; most notably the ability for stable transgenerational silencing 
of germline genes.  Whilst somatic nuclear silencing induces and strengthens silencing in the 
generation following dsRNA exposure, silencing is quickly lost in subsequent generations.  The nature 
of the inheritance of RNA induced silencing in both the germline and soma remains only partially 
understood.  A combination of cytoplasmic and nuclear WAGO clade argonautes are required for 
efficient transgenerational inheritance (Buckley et al., 2012; Xu et al., 2018).  It may be the primary 
siRNAs which are passed onto the F1 to establish the silencing of somatic genes and re-establish the 
secondary siRNA population.  In the soma secondary siRNA do not appear to be transmitted/ capable 
of further amplification in future generations.  By contrast the production of tertiary siRNA in the 
germline allows the re-establishment of the siRNA pool in subsequent generations and hence the 
maintenance of silencing  (Sapetschnig, Sarkies, Nicolas J. Lehrbach, et al., 2015).  
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The endogenous functions of the nuclear RNAi/argonaute pathways are varied (as discussed 
in section 1.3.viii).  Loss of function of any of the core NRDE components leads to a mortal germline 
(mrt) phenotype with the gradual loss of fertility over several generations.  Many of these 
phenotypes closely align with those seen in piRNA mutants and are likely caused by loss of 
transposon silencing in the germline.  Loss of NRDE-3 which functions only in the soma results in a 
milder phenotype than other NRDE mutants.  There are likely many somatic endogenous roles of 
nuclear RNAi.  In C. elegans NRDE-3 bound siRNAs target pre-rRNAs to regulate rRNA homeostasis 
(Zhou et al., 2017) and in human cells nuclear localised argonautes have been shown to direct 
alternative splicing (Alló et al., 2009; Ameyar-Zazoua et al., 2012).  miRNAs have also been found to 
play important roles in the regulation of gene expression through TGS in the nucleus (reviewed 
(Huang and Li, 2012)).  
 
5.1.i  The nuclear RNAi pathway in response to exogenous RNAi 
The majority of tissues in C. elegans, with the notable exception of the neurones, are 
competent for silencing by exo-RNAi, however a few including the pharynx and vulval muscle have 
been reported to be resistant.  Shiu and Hunter recently showed that whilst GFP expression in the 
pharynx is resistant to silencing in the first generation of exposure to the dsRNA trigger, GFP is 
efficiently silenced in the second generation of exposure and that this silencing requires the nuclear 
RNAi pathway (Shiu and Hunter, 2017).  Their finding show that a critical window exists early in the 
lifecycle of C. elegans during which the worm is competent for nuclear RNAi, and pharyngeal GFP can 
be silenced, with the pathway becoming increasing incompetent from hatching onwards.  They also 
found that in Eri mutants of the SynMuvB class, such as lin-35 to extend the competent window. 
My aim was to use the myo2p::GFP transgenic system to probe whether background 
mutations in my genes of interest affected the efficiency of RNAi induced gene silencing in the 
pharynx, as a proxy for the nuclear RNAi response.  I confirmed findings that pharyngeal GFP is only 
substantially reduced in the second generation of RNAi by feeding and also investigated whether 
prior starvation of worms, a strong environmental signal, had any effect on the efficiency of RNAi in 
the pharynx.  
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5.2  Results 
 
 I used strains carrying the myo-2p::GFP transgene mIS12, and myo-3p::GFP transgene 
ccIs4251, which express GFP in the pharyngeal muscle, and in all muscle with nuclear and 
mitochondrial localisation, respectively.  A strain carrying both of these transgenes had been 
previously crossed to ipp-5(sy605), itr-1(sa73), egl-8(e2917) strains to generate new strains carrying 
the transgenes in ipp-5(sy605), itr-1(sa73), egl-8(e2917) and WT genetic backgrounds.  Details of the 
strains used, their genotype and the cross from which they derived are given in table 5.1.  
RNAi was induced by feeding on bacteria expressing dsRNA complementary to gfp or to the 
bacterial gene cat as a control.  Adult worms were placed on plates, allowed to lay eggs for 
approximately 6 hours then removed.  The progeny of these worms are labelled as F1, and their 
progeny as F2.  Worms were fed either control RNAi bacteria for two generations, gfp RNAi bacteria 
for two generations, or gfp RNAi in the F1 followed by control RNAi in the F2.  Live worms were 
imaged, and the level of pharyngeal fluorescence quantified using ImageJ.  Whilst fluorescence 
intensity of the pharynx was precisely quantified, expression of the pan-muscular myo-3p::GFP was 
simply scored as present, absent or partial (if knockdown was evident but incomplete).  A 
representative image showing GFP expression in a control treated worm is shown in figure 5.1.  
 
 
 
 
 
 
 
Figure 5.1. A representative image of a 
WT control treated worm. GFP expression 
is seen clearly in the pharyngeal muscles 
and localised to the nuclei of the body wall 
and other muscles The area in which 
pharyngeal fluorescence was measured in 
shown by the yellow outline.  
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Strain 
name 
genotype Labelled 
as 
Variant description From same cross 
as 
HB955 ccIs4251 I; mIs12 II WT 2 ccIs4251 I [myo-
3p::mitoGFP]; mIs12 II 
[myo-2p::GFP] 
ccIs4251 
HB954, HB956 
HB953 ccIs4251 I; mIs12 II  WT 1 HB951, HB952 
HB948 ccIs4251 I; mIs12 II; 
egl-8(e2917)V 
egl-8 1 Likely null. 
MOS1 transposon 
insertion. 
HB949 
HB949 ccIs4251 I; mIs12 II; 
egl-8(e2917)V 
egl-8 2 HB948 
HB951 ccIs4251 I; mIs12 II; 
ipp-5(sy605)X 
ipp-5 1 Likely null. 
951 bp deletion.  
 
HB953, HB952 
HB952 ccIs4251 I; mIs12 II; 
ipp-5(sy605)X 
ipp-5 2 HB953, HB951 
HB954 ccIs4251 I; mIs12 II; itr-
1(sa73)IV 
 
itr-1 1 Near null at 25°C, partial 
lof at 20°C. 
Substitution leading to TS 
lof.   
HB956, HB955 
HB956 ccIs4251 I; mIs12 II; itr-
1(sa73)IV 
itr-1 2 HB954, HB956 
Table 5.1. The C. elegans strains used in this chapter. See (Nagy et al., 2015) for details of these strains.  
 
5.2.i  Levels of transgene expression vary between strains. 
 In order to establish a baseline level of GFP expression from the transgene in the pharynx the 
level of fluorescence of the pharynx was quantified in worms following control RNAi treatment.  
There is a high degree of variability in the expression of the GFP transgene in the pharynx, both 
within and between strains, as shown in figure 5.1.  The level of pharyngeal fluorescence is 
significantly lower in the WT 2 strain, than in the mutant strains and WT 1 strain.  There are also 
significant but less dramatic differences in fluorescence between the WT 1 strain and the two itr-1 
strains as seen in figure 5.2).  The reasons for these differences are unclear.  Shui and Hunter found 
that the transgene was expressed more strongly amongst mutants defective in transgene silencing, 
however, the differences in behaviour between the two WT strains suggests that a significant  
amount of variation in fluorescence, and presumably transgene expression, may be due to random 
variation in silencing behaviour,  or other differences in the genetic background rather than being 
attributable to the gene of interest.  The very high degree of variability in fluorescence intensity 
measured between worms of the same strain supports the theory of an inherently stochastic 
mechanism of somatic transgene silencing.  The fluorescence intensity of the myo-3::GFP transgene, 
which is expressed outside of the pharynx,  was not quantified precisely however expression was 
scored as present, absent or partial.  myo-3::GFP transgene was visibly expressed in all control 
treated  worms. 
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Figure 5.2. Difference in fluorescence intensity of control treated worms.  There is a high degree of variability 
both within and between strains.  Between strain differences were tested statistically using anova followed by 
Tukey HSD test.  All strains show a significantly higher level of fluoresence than the strain WT 2, and several also 
show significant differences from strain WT 1,  as indicated in the plot.  The box plots represent the range of the 
recorded data points. The central line represents the median with the box edges representing the upper and 
lower quartiles.  Coloured dots represent individual worms with colour  indicating the data set and generation in 
which they were recorded.  Strains WT 1 and ipp-5 2 were included in only the rep 2 data set.  
 
5.2.ii  Effects of RNAi treatment in the first generation 
As would be expected given the reports of the pharynx being resistant to RNAi, gfp RNAi 
treatment had only a limited effect on the fluorescence intensity of the pharynx in the F1, despite 
clear loss of fluorescence in the body wall muscles.  As shown in figure 5.3.a, following a single 
generation of either gfp RNAi or control treatment most strains showed a small reduction in 
fluorescence intensity of in the pharynx, however not all strains behaved the same.  Significance 
testing using an analysis of variance model followed by post-hoc testing shows a significant global 
effect of gfp compared to control treatment.  Looking at the effect on each strain no significant 
change is seen in either of WT or egl-8 strains, while both of the itr-1 strains show significantly lower 
levels of pharyngeal fluorescence following gfp treatment than control treatment.  Neither ipp-5 
strains shows any decrease in fluorescence following gfp treatment. In the strain ipp-5 1 significantly 
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higher levels of fluorescence were recorded after gfp treatment than after control treatments whilst 
in ipp-5 2 there is no significant change.  With the exception of the ipp-5 strains, all other strains 
show a trend for a small reduction in pharyngeal fluorescence intensity following treatment with gfp 
RNAi.   The effects of gfp RNAi on GFP fluorescence outside of the pharynx were in line with the 
expected behaviour of itr-1, egl-8 and ipp-5 mutants (see figure 5.3.b).  Individuals from both WT 
strains show a range of gfp knockdown, from complete loss of visible fluorescence in the bwm, to the 
loss of fluorescence in only some bwm nuclei.  All individuals from the itr-1 and egl-8 strains showed 
a complete loss of GFP fluorescence in the bwm, whilst the majority of worms belonging to the ipp-5 
strains showed no loss of fluorescence.  
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Figure 5.3. a - Effect of gfp RNAi treatment on the fluorescence intensity of the pharynx in the F1 generation. 
In the F1 generation gfp RNAi treatment has a small yet significant overall effect.  Significant difference between 
the control and gfp treated groups was found in some strains, as indicated.  Statistical significance of treatment, 
strain and interaction thereof was tested using an anova followed by Tukey test.  Box plots representing the 
range of the recorded data points are shown. The cetral line represents the median with the box edges 
representing the upper and lower quartiles. Outliers to the expected data range are shown as points. b- Effect 
of gfp RNAi treatment on the fluorescence of the bwm in the F1 generation.  GFP expression in the body wall 
muscle of each worm was scored as not visible, partial (visible in some nuclei) or full (no visible reduction). Lines 
are constructed of dots coloured according to bwm GFP state, each dot representing a single worm.  
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5.2.iii  Effects of RNAi treatment in the second generation 
Although gfp RNAi treatment had little effect on pharyngeal fluorescence in the first 
generation, due to the resistance of the pharynx to RNAi, exposure in the first generation would be 
expected to trigger knockdown of GFP expression in the second generation, due to the production of 
secondary siRNAs engaging the nuclear RNAi response (Shiu and Hunter, 2017).  Consistent with the 
findings of Shiu and Hunter that RNAi in the pharynx requires the nuclear RNAi pathway, which can 
only be triggered during a critical period early in development, the overall effect of gfp RNAi 
treatment in the F1 generation was a dramatic reduction in pharyngeal fluorescence in the F2 
generation (p<<0.001).  As can be seen in figure 4.3.a gfp RNAi treatment in both the F1 and F2 
generation, or in the F1 generation alone resulted in a clear and significant reduction in the level of 
pharyngeal fluorescence intensity across all strains tested, with the notable exception of ipp-5 2.  In 
all strains a large variability in fluorescence levels is seen following both control or gfp treatment.  
Across the WT 1, WT 2,  itr-1 1, itr-1 2, egl-8 1, egl-8 2 and ipp-5 1 strains the same general 
trend in response to gfp RNAi treatment is seen, whilst the strain ipp-5 2 shows no significant 
reduction in response to either one or two generations of exposure to gfp dsRNA.  Since the baseline 
level of fluorescence expression differs between strains, the level of pharyngeal fluorescence as a 
percentage of the mean fluorescence of control treated worms of that strain was calculated and is 
shown in figure 5.4.b.  This allows any differences in response between strains to be better 
compared.   Whilst the difference in behaviour of the ipp-5 2 strain is most obvious there is also a 
statistically significant differences in behaviour between the WT 1 and several other strains, though 
these are small compared to the overall effects of treatment. There is no significant difference 
between the response of the ipp-5 1 strain and either WT strain.  In response to the ‘F1 gfp, F2 gfp’ 
RNAi treatment both itr-1 1, itr-1 2 and egl-8 2 have a significantly greater mean percentage 
reduction fluorescence.  This difference is also seen in response to ‘F1 gfp, F2 control’ treatment in 
both itr-1 and both egl-8 strains.   
A high variability in response is seen across all strains, with some individuals from all strains 
showing no detectable reduction in pharyngeal GFP in response to either gfp treatment condition, 
whilst the majority show substantial GFP knockdown.  In the strain ipp-5 1 the median response to 
both ‘f1 gfp, f2 gfp’ and ‘f1 gfp, f2 control’ treatments is slightly less than that seen in the WT strains 
and is greatly less in ipp-5 2 where no response is seen.  Conversely the median response is slightly 
greater in all itr-1 and egl-8 strains.  
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Figure 5.4.  Effect of gfp RNAi treatment on the fluorescence intensity of the pharynx in the F2 generation.    
a-Across all strains except ipp-5 2, the expected response of a significant difference in fluorescence intensity of 
the pharynx of gfp vs control treated worms is seen in the second.  Exposure to gfp dsRNA in only the first 
generation leads to a clear decrease in GFP expression (p<<0.001), whilst exposure in the first and second 
generations leads to and even great decrease (p<<0.001).  Significance of response, both globally and for each 
strain (as shown) was tested statistically using anova followed by Tukey test. b- The fluorescence intensity of 
the pharynx following one or two generation of RNAi treatment is shown as a percentage of the mean value for 
control treated worms of that strain.  The red line indicates the median level of fluorescence of ‘F1 gfp, F2 gfp’ 
treated worms of both WT strains combined.  Significance values indicate difference from the equivalent 
treatment group of the WT 1 strain, tested using Wilcoxon rank sum test. 
139 | C h a p t e r  5 -  Do IP3 signalling mutants display an altered nuclear RNAi response? 
 
139 
 
In order to test whether the nuclear RNAi response is entirely dependent on inherited 
silencing signals or whether re-exposure strengthens the response worms exposed to GFP RNAi 
treatment in the F1 were treated with either gfp or control RNAi bacteria in the F2 generation.  
Exposure to gfp RNAi treatment in the only the first generation (‘F1 gfp, F2 control’) still results in a 
clear reduction in pharyngeal fluorescence in the F2 generation, clearly demonstrating the hereditary 
component of the nuclear RNAi pathway, even when targeting a somatically expressed gene.  
However interestingly the level of apparent GFP knock down resulting from only F1 exposure (‘F1 
gfp, F2 gfp’) is significantly less than that seen in worms exposed to GFP dsRNA for both generations 
(p<<0.001).  These differences can be seen clearly in the density chart in figure 5.5.a which shows 
that the three different treatment conditions result in distinguishable populations with separate 
peaks but overlapping density distributions.  
Shui and Hunter reported that early exposure to dsRNA expressed from a heat inducible 
promoter can trigger nuclear RNAi in that same generation.  Differences in the fluorescence intensity 
seen between worms exposed for GFP RNAi treatment for both generations and those exposed in 
only the f1 generation could suggest an additive effect of distinct inherited and early exposure 
components contributing to silencing, or could reflect differences in levels of initial trigger, simply 
resulting from length of exposure.    
 Unlike the fluorescence in the pharynx, fluorescence in the body wall muscles was 
substantially recovered in the F2 generation of ‘F1 gfp, F2 cat’ treated worms (see figure 5.5b, 
compared to 5.3b) with most worms showing partial of full fluorescence.  As in the F1 generation the 
proportion of worms showing no visible fluorescence, partial fluorescence and full bwm 
fluorescence, following either ‘F1 gfp, F2 cat’, or ‘F1 gfp, F2 gfp’ treatment, varies by strain.  As would 
be expected the itr-1 and egl-8 RNAi enhanced strains show the strongest response, whilst the strain 
ipp-5 2 shows almost no response.  The ipp-5 1 strain shows a strength of response intermediate 
between the WT strains and ipp-5 2.  These results show the same pattern of response as was seen in 
the pharynx.   
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Figure 5.5.  a- Re-exposure to primary dsRNA stimulus aids silencing in the second generation. The combined 
density distribution for normalised pharyngeal fluorescence intensity in the f2 generation of all strains tested, 
coloured by treatment, reveals distinct peaks for ‘F1 control F2 control’, ‘F1 gfp, F2 control’, ‘F1 gfp, F2 gfp’ 
treated populations.  Exposure to gfp primary dsRNA in the first and second generation is the treatment most 
likely to result in maximal silencing. The wide distribution of the intensity values recorded for control treated 
worms show the high degree of variability in the level of transgene expression.  b- GFP expression in the body 
wall muscle in the F2.  Worms were scored as not visible, partial (visible in some nuclei) or full (no visible 
reduction). Lines are constructed of dots coloured according to bwm gfp phenotype, each dot representing a 
single worm. bwm fluorescence was substantially recovered in the F2 generation of F1 gfp, F2 control treated 
worms (compared to 5.3.b). 
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5.2.iv   Does starvation affect the nuclear RNAi response? 
Starvation is an environmental cue and a physiological stress which has been shown to 
trigger the production and transgenerational inheritance of siRNAs in C.  elegans (Rechavi et al., 
2014).  In order to test whether the prior starvation of worm populations has any inherited effect on 
the efficiency of the nuclear RNAi response populations of worms belonging to the WT, ipp-5, itr-1 1, 
itr-1 2 and egl-8 2 strains were first starved for 10 days then transferred to OP50 plates for 2 days to 
allow an egg laying adult state to be reached before being transferred to cat or gfp RNAi plates and 
allowed to lay eggs.  
 Prior starvation did not have a significant effect on the mean levels of fluorescence intensity 
measured in the pharynx in either generation of most strain.   As can be seen in figure 4.6.a a few 
strains did show weakly significant difference (p<0.05) in the mean level of pharyngeal fluorescence 
in either the F1 or F2 generation, however, there seems to be no pattern to these changes.  Although 
there is no significant difference in the mean of the starved and unstarved treatment groups of the 
cat treated itr-1 2 worms there is significant heteroskedasity, tested using Levene’s test.  This 
heteroskedacity is also seen in the gfp treatment group of itr-1 2, which also shown a significant 
difference in mean and in the cat treatment group of the ipp-5 strain.  All other strains however 
show no significant difference in either mean or heteroskedacity.  No differences were seen in the 
gfp fluorescence outside of the pharynx.  
 In the f2 generation no significant differences in heteroskedacity or mean are seen between 
the starved and unstarved treatment groups for among the cat RNAi treated worms, however some 
small but significant difference in mean and detected in the gfp RNAi groups.  Prior starvation seems 
to increase the pharyngeal fluorescence intensity of gfp treated itr-1 1 strain worms, whilst it is 
decreased in egl-8 2 strain worms. No other strains show any significant difference.   
Overall there seems to be no effect of starvation on the nuclear RNAi response however the 
increased variation in pharyngeal GFP intensity following starvation which is seen in the f1 
generation but not the f2 may indicate a more general effect of starvation on transgene expression.  
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Figure 5.6.  The effect of starvation on pharyngeal fluorescence intensity.  Starvation increases the variation in 
the levels of pharyngeal intensity measured in the f1 but not the f2 generation as measured by the Levene’s test, 
in particular in the strain itr-1 2. Statistical significance of difference in mean was tested using the pairwise 
Wilcoxon signed-rank tests and is indicated as ns=not significant, *=p<0.05.  
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5.3  Conclusions 
 The IP3 signalling mutants tested do appear to show some changes in the strength of nuclear 
RNAi induced silencing as itr-1 1, itr-1  2, and egl-8 2 mutants all show a significantly greater mean 
percentage change in pharyngeal fluorescence intensity  in the F2 generation, following either gfp 
RNAi treatment than the WT strains.  One of the two ipp-5 mutant strain tested, ipp-5 2 was shown 
to be almost entirely resistant RNAi induced GFP knockdown in the pharynx whilst the ipp-5 1 strain 
showed a response more similar to the WT strains.  
 The compromised nuclear RNAi response seen in the ipp-5 2 strain is comparable to that 
seen in both nrde-3 and rde-1 mutants (Shiu and Hunter, 2017); but as in the case of rde-1 mutants 
this change is likely the result of up-stream changes in the exogenous RNAi response  altering the 
availability of material for engagement by the nuclear RNAi pathway.  Why a comparable response is 
not seen in the strain ipp-5 1 is unclear. It is worth noting that the ipp-5 1 strain was also less 
resistant than ipp-5 2 to RNAi in the body wall muscle in both the F1 and F2 generation, although 
both strains were still less sensitive than the WT strains.  The reasons for the differences in behaviour 
of the two ipp-5 strains will need to be resolved in order to confirm that ipp-5 loss of function 
decreases sensitivity to nuclear RNAi.  The first step in resolving these discrepancies would be to 
sequence both strains to confirm that both as homozygous for the same ipp-5 lof mutation, as 
expected.  
 RNAi enhanced mutants belonging to the Eri and SynMuvB classes show clear evidence of 
silencing in the pharynx in the F1 generation, proposed to be due to an extension of the critical 
window for initiating the nuclear RNAi response (Shiu and Hunter, 2017).  Such a change is not seen 
in the IP3 signalling mutants tested.  No change is seen in the egl-8 strains and although some itr-1 1 
and itr-1 2 worms show evidence of slight pharyngeal silencing, the mean level of pharyngeal 
fluorescence of gfp treated groups being significantly lower than control groups,  this is very different 
from the dramatic silencing seen across WT, itr-1 and egl-8 strains in the  F2 generation.   
 Additional controls with a known specific effect on the nuclear RNAi pathway would allow for 
better evaluation of the differences in pharyngeal silencing seen in IP3 signalling mutants in the first 
and second generation.  A nuclear RNAi defective mutant such as nrde-3 should be used as a 
negative control whilst lin-35 should be used as a positive control for enhanced nuclear RNAi. 
Without these controls it is difficult to judge whether the changes seen to pharyngeal GFP silencing 
are due to any specific effect on the nuclear RNAi pathway.  
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 The subtle enhancement of pharyngeal GFP silencing seen in the itr-1 and egl-8 mutants in 
the F2, and the lack of silencing in ipp-5 2, seem more likely to reflect changes in the RNAi response 
upstream of the engagement of the NRDE-3 pathway.  Changes which increase the response to the 
primary siRNA pathway are likely to result in an increase in secondary siRNA production and 
therefore increase the availability of 22G siRNAs for engagement by the NRDE-3 pathway.  Such 
changes would be expected to strengthen the nuclear RNAi response even without changes to the 
critical window for nuclear RNAi.  Overall, this data suggests that the IP3 signalling pathway has no 
specific effect on nuclear RNAi, but that the general changes in RNAi sensitivity seen in IP3 signalling 
mutants do extend to the nuclear RNAi response. 
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Chapter 6 
 
Discussion 
 
How does IP3 signalling regulate the 
RNAi response?  
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Discussion- How does IP3 signalling regulate the RNAi response? 
 
 Reduced IP3 signalling as seen in itr-1 (IP3 receptor) or egl-8 (PLCβ) loss-of-function mutants 
leads to an enhanced response to RNAi.  This enhancement is also proportional to the degree of ITR-
1 function.  In the temperature sensitive mutant itr-1(sa73) no change to the RNAi response is seen 
at 16°C, a strong enhancement is seen at 20°C, and the strongest response is seen at 25°C, equivalent 
to that seen in other itr-1 null mutants.  Conversely increasing IP3 signalling by overexpressing itr-1 or 
by loss of function of the Inositol phosphatase ipp-5, strongly reduces the efficacy of the RNAi 
response.  It was previously shown that rescuing IP3 signalling in the intestine by expression of WT itr-
1 from the intestinal specific promoter vha-6p is sufficient to restore the WT RNAi response in other 
tissues.   Rescuing IP3 signalling in the intestine resulted in WT RNAi response to both endogenous 
genes introduced by feeding and WT silencing of GFP transgenes in neurones, body wall muscle 
(BWM) and the pharynx, even when dsRNA is produced from transgene expression in the pharynx, 
rather than being introduced by feeding.  Rescuing IP3 signalling in neurones did not affect the RNAi 
response (Nagy et al., 2015).  In the work presented in this thesis I have screened a number of cell 
signalling mutants, potential regulators of the IP3 signalling pathway, for an altered response to RNAi 
by feeding, analysed the small RNA profile of itr-1 mutant worms and assayed the nuclear RNAi 
response of itr-1, egl-8 and ipp-5 mutants, with the aim of better understanding how alterations in 
IP3 signalling  causes changes the RNAi response.   
 
6.1  Conclusions and future work 
 
6.1.i  G-protein signalling mutants with an altered RNAi response 
 As the well-established upstream activator of EGL-8 (PLCβ), EGL-30 (Gαq) loss-of-function 
was expected to lead to an enhanced RNAi response, comparable to that seen in egl-8 or itr-1 lof 
mutants. However this is not the case.  Of the three egl-30 lof mutants screened, which range in 
severity from a likely null mutation to partial loss-of-function, none displayed a consistent enhanced 
response to RNAi by feeding targeting lin-1, lin-31 or dpy-13.  The responses of the five different egl-
30 gof and overexpression mutants tested were more variable and ranged from a largely WT 
response, to a consistently enhanced RNAi response seen in the strain egl30 gof1, and egl30 lof OE 
rescue.  The only RNAi target gene where this pattern of results was not seen was in response to unc-
15 silencing.  However, the flaccid paralysis and hypermobility seen in egl-30 lof and gof mutants 
respectively, makes this an unsuitable assay for testing the RNAi response in these mutants.  The lack 
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of an enhanced RNAi response in egl-30 lof mutants was confirmed assaying neuronal GFP 
knockdown in the unc-47::gfp transgenic system.  Overall, these results demonstrate that elg-30 loss-
of-function does not cause an enhanced RNAi response and may cause a mild reduction in RNAi 
response, whilst egl-30 gain-of-function or overexpression may lead to an enhanced RNAi response.  
 It is clear that EGL-30 is not the upstream activator of EGL-8 in the pathway regulating RNAi 
sensitivity.  Alternative Gα subunits, which could be acting as the activator of egl-8, either directly or 
through Gβγ, were therefore screened for an altered RNAi response.  I found that loss of function of 
the Gα0 homologue goa-1 results in an enhanced RNAi phenotype analogous to that seen in egl-8 
mutants. This enhanced RNAi phenotype was robust, seen in several different goa-1 lof in response 
to lin-31, unc-15 and dpy-13 RNAi and was confirmed using the unc-47p::GFP transgenic system.  
Other Gα mutants produced more mixed results. Several showed an altered response in one or more 
RNAi assay, which in some cases could be due to specific genetic interactions with the target.  Gpa-12 
showed a reduced response to lin-31 and unc-15 RNAi, but this was not replicated in dpy-13 assays.  
gpa-16 showed a moderate enhancement in response to both lin-31 and dpy-13 assays. 
 Working from the hypothesis that goa-1 and egl-30 may be signalling antagonistically in the 
pathway regulating RNAi sensitivity, as is known to be the case in the regulation of egg-laying and 
locomotion, I tested proteins known to regulate this antagonism for an altered RNAi response.  These 
included the RGS family GAPS EAT-16, EGL-10 and RGS-1, the GEFS RIC-8 and AGS-3, GPB-2, the Gβ 
orthologue and homologue of mammalian Gβ5 , which interacts with both EAT-16 and EGL-10 to 
mediate their repression of  EGL-30 and GOA-1 respectively, and RSPB-1, required for the localisation 
of EAT-16 to the cell plasma membrane.  Loss-of-function mutants of eat-16, gpb-2 and rspb-2 all 
showed a strongly enhanced response to lin-31 RNAi, whilst egl-10 showed a reduced response, 
results which strongly support the hypothesis of goa-1 and egl-30 signalling antagonistically.  
However, this pattern of results was not replicated in dpy-13 RNAi assays, where both eat-16 and 
egl-10 showed an enhanced response. This enhancement was strong in the case of eat-16 and milder 
in egl-10 and no significant change in response was seen in the eat-16;egl-10 double mutant nor in 
either gpb-2 mutant.  The mixed results of these mutants mean that need further investigation is 
needed to clarify a potential role for eat-16 in the regulation of RNAi sensitivity.   
 The pleiotropic effects of many Gα proteins and their regulators make accurately assaying 
alterations in the RNAi silencing of many endogenous genes difficult.  The locomotive phenotypes of 
goa-1, egl-30, egl-10 and eat-16 among others complicate the scoring of Unc assays and differences 
in sizes make accurately scoring Dpy phenotypes by eye difficult.  Even when assays can be scored 
accurately it is difficult to rule out a more specific regulatory role for the gene in question in the 
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developmental or neuronal signalling pathway being assayed, which is why it is important to test the 
RNAi response of mutants using a variety of target genes.   
 However, the scoring accuracy of the assays used could be improved in some ways.  
Measuring the length of worms in the dpy-13 RNAi assay from images of worms, is time consuming 
but improves the accuracy of this assay.  It may be possible to automate the measurement process 
using image analysis software.  MUV phenotypes could be assayed more accurately by testing alleles 
which seem to alter the RNAi response in a strain carrying a fluorescently expressed vulva marker. 
This would allow multivulval phenotypes to be scored definitively without relying on the protruding 
vulva phenotype.  Since Gα signalling is likely to have a role in vulval development it is also important 
to confirm that there is no increased incidence of MUV phenotypes in the untreated or control 
treated worms.  
 The use of the unc47p::GFP transgenic system is a powerful tool for confirming the enhanced 
RNAi phenotype of mutants however an improved assay is needed for measuring reduced RNAi 
phenotypes due to the very low knockdown neuronal GFP seen in WT backgrounds.  Assaying GFP 
knockdown in a non-neuronal tissue such as the BWM, with the myo3p::GFP transgene ccIs3251 
would be a good option.  When this transgene was used as a control for knockdown in the neuronal 
RNAi assay intermediate partial to complete knockdown was seen in a WT background, complete 
knockdown was seen in an enhanced RNAi background such as itr-1 and no knockdown or partial 
knockdown was seen in the reduced RNAi background of ipp-5 mutants.  Assaying silencing of this 
transgene in the BWM by GFP RNAi therefore allows for bi-directional modulation in the RNAi 
response to be accurately detected.  This system could be used to confirm the potentially reduced 
RNAi sensitivity of egl-30 lof mutants and goa-1 OE mutants, and the potentially enhanced RNAi 
sensitivity of egl-30 gof mutants.  The gpa-12 lof mutant should also be tested using this system 
using this system to confirm or rule out a reduced RNAi response.  gpa-16 lof and eat-16 lof should 
be tested for enhanced RNAi response using the unc-47p::GFP system.  It is important to control for 
any underlying differences in transgene expression by scoring GFP knock down in worms fed on 
control expressing dsRNA against a control target gene (such as the cat (Escherichia coli 
chloramphenicol actetyltransferase) gene). 
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6.1.ii - How Could GOA-1 be regulating EGL-8 activity? 
 Although goa-1, egl-8 and itr-1 all show an enhanced response to RNAi further work is 
needed to confirm that they are acting in the same pathway.  Epistasis analysis of goa-1;egl-8 and 
goa-1;ipp-5 will shed light on whether goa-1 is acting in the same pathway or in parallel to IP3 
signalling  to regulate RNAi.  If goa-1 is acting in the same pathway as egl-8 it is likely to be acting as 
the direct upstream activator, although a more distal role is also possible.  goa-1 could even be 
acting in the same pathway as egl-8 but in another tissue, downstream of an extracellular signal 
produced in response to IP3 signalling in the intestine.  The unc-47p::GFP system should  be used to 
confirm whether the RNAi response of goa-1:egl-8 double mutants is greater than that seen in either 
single mutant.  An additive effect would suggest they are acting in independent pathways to regulate 
RNAi.  goa-1;eri-1 and egl-8;eri-1 double mutants should be used as controls, as the egl-8;eri-1 
double mutants is already known to have an additive effect the RNAi response.  Analysis of the RNAi 
phenotype of goa-1;ipp-5 as compared to egl-8;ipp-5 double mutants will provide additional 
information.  If goa-1 is in fact acting downstream of IP3 signalling, then the enhanced RNAi 
phenotype of goa-1 lof would be expected to be epistatic to the reduced RNAi phenotype of ipp-5 
lof.  Due to the manner in which IPP-5 acts to influence abundance of IP3, as opposed to being part of 
the direct signalling pathway if goa-1 is acting upstream of ipp-5, ipp-5 lof is unlikely to completely 
rescue the goa-1 enhanced RNAi phenotype.  It will therefore be important to compare the RNAi 
phenotype of goa-1;ipp-5 and egl-8;ipp-5 double mutants.  If the results of the analysis of double 
mutant strains suggest that goa-1 is acting upstream of egl-8 in the IP3 signalling pathway regulating 
RNAi sensitivity, then tissue specific rescue experiments, expressing goa-1 from the vha-6p intestinal 
promoter, could be used to confirm the likelihood of goa-1 acting in the same cell as egl-8 and itr-1 in 
the regulation of this response. 
 If GOA-1 is acting directly upstream of EGL-8 how might it be positively regulating EGL-8? 
PLCβ is canonically activated by EGL-30 via an interaction mediated by the PLCβ specific CTD.  
However the regulation of PLCβ enzymes is a complex process, controlled by two autoinhibitory 
domains, interactions with the plasma membrane, interactions with scaffold proteins, negative 
regulators, and activation by Gβγ subunits and Rho family small G-proteins in addition to Gαq 
(reviewed (Lyon and Tesmer, 2013)).  In particular the Gβγ subunit of mammalian Gαi containing 
heterotrimers is has been shown to regulate Ca2+ signalling via PLCβ1 in synergy to Gαq (Rebres et al., 
2011) .   Since goa-1 is the C. elegans homologue of mammalian Gαi/o activation by the Gβγ subunit of 
a GOA-1 heterotrimeric G-protein is a possibility.  It is also possible that GOA-1 could directly activate 
EGL-8 or recruit a further factor(s) to do so.  It is becoming increasingly clear that in many cases cell 
signalling pathways are not linear but exist as part of complex and overlapping networks, mediated in 
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part by interactions with scaffolding proteins to form signalling complexes. How these signalling 
complexes affect regulation of PLCβ and other signalling enzymes is not yet understood.  
 Though results are mixed, the data suggests EGL-30 may be acting in opposition to GOA-1 
and PLCβ EGL-30 in this pathway.  One explanation for this behaviour could be that EGL-30 
completes for binding of PLCβ, with GOA-1 or Gβγ.  There are numerous instances of GOA-1 and EGL-
30 signalling antagonistically in C. elegans however the nature of the interactions mediating this 
antagonism are not well understood(Collins et al., 2016; Esposito et al., 2010; JH and M, 2000; Miller 
et al., 1999, 2000; Tanis et al., 2008).  Competition for binding of GPB-2 between the EGL-30 inhibitor 
EAT-16 and the GOA-1 inhibitor EGL-10, regulating the activation state of GOA-1 vs EGL-30 has 
shown to be a regulator of  this antagonism in some behaviours (Chase et al., 2001; Van der Linden et 
al., 2001; Robatzek et al., 2001; Zwaal et al., 1996).  Confirmation of if and how egl-30 and eat-16 and 
egl-10 may affect RNAi response may help to better understand how goa-1 may be interacting with 
egl-8.  
 Whether by GOA-1, the Gβγ subunit, or another means, EGL-8 is being activated in response 
to an unknown upstream stimulus, most likely acting via a GPCR.  The C. elegans genome encodes 
approximately 1300 putative GPCRs. Most of these are orphan receptors with no known ligand and in 
most cases unknown roles.  This is partly because studies of loss of function mutations in C. elegans 
GPCRs suggest that mutation in a single GPCR rarely produced a noticeable phenotype, however 
some phenotypes have been noted in multi-mutants.  Approximately 1200 of these are predicted to 
be chemosensory receptors, and several more are expressed in only a narrow subset of neurones.  
Based on the available data of known expression patterns and G-protein coupling, the list of 
candidate GPCRs for an initial screen can be narrowed down substantially.  Mutants for some of 
these candidate GPCRs are available and for some and multi mutants are available.  The available 
candidate mutants should be screened for an altered RNAi response.  Failing any promising results 
utilising existing mutants, knockout could be generated for candidate GPCRs for which mutants are 
unavailable. Should this fail to yield results a broader reverse or forward genetic screen for mutants 
with an enhanced RNAi response could be carried out in an attempt to identify the receptor 
upstream of the IP3 signalling pathway regulating sensitivity to RNAi.  A reverse genetic screen of 
strains engineered to carry multiple GPCR would likely be the best approach and is increasingly 
feasible given development of genetic engineering techniques such as CRISPR based approaches 
which have already been used successfully in C. elegans.  
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Figure 6.1.  Propposed model for the regulation of EGL-8 by GOA-1 in an IP3 signalling pathway regulating the 
RNAi response. If goa-1 is confirmed to be acting as the upstream activator of egl-8 this could be via a direct 
interaction or via Gβγ.  A possible antagonism between goa-1 and the canonical activator of egl-8, egl-30 could 
be mediated by the GEFs eat-16 and egl-10.  
 
6.1.iii  The small RNA profile of itr-1 worms 
 Comparison of the small RNA populations of itr-1 and WT worms, in the absence of stresses 
or exo-RNAi stimulation showed no gross changes.  Changes to the endogenous small RNA 
population would be expected if one of the endogenous RNAi pathways was compromised in itr-1 
mutants.  Although some more specific enhancements were found these were not dramatic and 
qPCR based follow up experiments no differences between WT and IP3 signalling mutants.  
 The major caveat of this work is that the growth and fertility defects of itr-1(sa73) are severe 
enough, even at the intermediate temperature of 20°C, that it was not possible to generate matched 
mixed populations of WT and itr-1 worms, which would have captured changes at every  
developmental stage.  Instead synchronised populations of young adult worms were used.  miRNA 
expression is a tightly controlled developmental regulator and as such profiles are tissue stage 
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specific. It is therefore possible that changes to specific miRNA populations may have been missed by 
sequencing only young adult worms.  
 Given the lack of changes to endo-siRNAs profiles of itr-1 mutants it is very unlikely that the 
enhanced RNAi response seen in itr-1 and egl-8  can be accounted for by  decreased IP3 signalling 
leading to a down regulation in the endo-siRNA pathway, increasing availability of resources to be 
redirected to the exo-siRNA pathway.  However, it does remain possible, if unlikely,  that sufficient 
resources are available for WT endo-siRNA function in the absence of an RNAi stimulus, and that 
reduced IP3 signalling favours the redistribution of resources to the exogenous RNAi pathway only 
when it is active.  The failure of the WT 5’ independent library means that differences in the 22G 
secondary siRNA population (which is not captured in the 5’ dependent libraries) could not be 
accurately compared.  The up regulation of secondary siRNA production or the up regulation of core 
components of the exo-RNAi pathway in response to reduced IP3 signalling therefore both remain 
possibilities. These possibilities could be tested by the sequencing and comparison of 5’ dependent 
and 5’ independent small RNA libraries from WT and IP3 signalling mutant worms treated with RNAi 
against an endogenous target gene.  The choice of target gene must be made carefully so as to limit 
knock on affects which could affect small RNA profiles, developmental targets such as lin-31 for 
example would be unsuitable since this leads to a change in the developmental identity of a number 
of cells, whilst a widely expressed neuronal target such as unc-15 could be suitable choice.  The use 
of a non-endogenous target such as a GFP expressing transgene could be analytically difficult as 
these sequences would not map to the C. elegans genome.  The egl-8(e2917) may be a better choice 
than itr-1(sa73) for sequencing experiments since it displays milder growth and fertility defects, but a 
similarly altered RNAi response. It may therefore be possible to generate well matched mixed 
populations of WT and egl-8 worms which would allow changes across all developmental stages to 
be captured.   
6.1.iv  The nuclear RNAi response  
 Testing the nuclear RNAi response, utilising fact that RNAi silencing in the pharynx is 
dependent on nuclear RNAi, showed a modest alteration in nuclear RNAi mediated silencing in IP3 
signalling mutants.  Shi and Hunter found that in WT worms GFP silencing in the pharynx is only seen 
in the second generation of exposure to dsRNA due to the narrow developmental window, early in 
development, during which dsRNA exposure is needed in order to engage the nuclear RNAi response 
(Shiu and Hunter, 2017).  I found a small but significant decrease to pharyngeal fluorescence in the F1 
generation of itr-1 mutants; however, this decrease was not seen in the egl-8 strains.  In the F2 
generation, enhanced silencing was detected in itr-1 and egl-8 mutants, and a resistance to silencing 
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was clear in one of the two ipp-5 mutant strains (possible reasons for and work needed to resolve 
this discrepancy is discussed in chapter 5).  Specific changes to the developmental window during 
which dsRNA exposure is needed in order to initiate the nuclear RNAi pathway, as is seen in lin-35 
mutants were not tested for, but it is possible that a similar change is present in IP3 mutants.  
Alternatively it is possible that enhanced sensitivity at an earlier stage of the RNAi pathway, 
increasing the availability of siRNAs to be engaged by the nuclear RNAi machinery is sufficient to 
account for the changes seen, without any specific alterations to nuclear RNAi machinery.  If there 
were significant changes to the window of opportunity for initiating nuclear RNAi in itr-1 and egl-8 
mutants I would expect to see a more first-generation silencing, as was reported for lin-35 mutants 
(Shiu and Hunter, 2017). 
 To better understand how IP3 signalling is affecting the nuclear RNAi response these 
experiments should first be repeated with the inclusion of a lin-35 mutant strain so that F1 silencing 
can be directly compared between lin-35 and itr-1 mutants.  nrde-3 (nuclear argonaute) mutants, 
defective in nuclear RNAi should also be included as a control.   
 The finding that IP3 mutants display an altered nuclear RNAi response is further evidence of a 
clear role for IP3 signalling in the modulation of the exogenous RNAi response. However, the specifics 
of the interaction between IP3 signalling and the RNAi response remain elusive. The lack of major 
changes to the endogenous small RNA profiles of itr-1 mutants suggest that the endogenous RNAi 
pathways are not compromised in IP3 signalling mutants. This is consistent with the hypothesis that 
an IP3 signalling pathway is specifically regulating the exogenous RNAi response.  To better 
understand the possible ways in which IP3 signalling could regulate the RNAi response, known 
mechanisms of regulation should be considered.  
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6.2  How could IP3 signalling influence the RNAi response? 
 
6.2.i  Influences on the efficacy of the RNAi response in C. elegans  
 To better understand how IP3 signalling, most likely in the intestine, might be affecting the 
RNAi response throughout the organism we must consider all the potential points of regulation of 
the exogenous RNAi response, both systemically and intracellularly.  The different ways in which 
other characterised RNAi mutants exert their effects must also be considered.  Three factors 
principally determine the efficacy of the RNAi response in C. elegans: 1- Exposure and availability of 
dsRNA to initiate silencing. Transport mutants affect the availability of dsRNA to the silencing cells. 2- 
sensitivity of the silencing cell to the dsRNA. The recipient cell must be competent for RNAi response 
and must have sufficient resource of RNAi machinery. 3- the target gene.  Some genes are less 
receptive to silencing but why is unclear. In many cases increasing either availability of dsRNA or 
sensitivity can overcome this, as is demonstrated to by the use of genes which are not effectively 
silenced in the WT background to screen for enhanced RNAi mutants.  Most RNAi mutants fit into 
one of two categories – either they act on or in the core exo-RNAi pathway or endogenous RNAi 
pathways, or they act in the intercellular and/or intracellular transport of silencing RNAs.  Figure 6.2 
outlines the key stages of the exo-RNAi response in C. elegans. Any stage in the transport, 
amplification and silencing process is a potential point of regulation as efficiency at each stage 
contributes to a robust silencing response. 
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Figure 6.2.  The exogenous RNAi pathway in C. elegans.        
Each stage in the RNAi pathway is a potential point of regulation. On the left some of the proteins known 
to contribute to each stage of the RNAi process. Though not all are essential, all contribute to an efficient 
and effective silencing response.  
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6.2.ii  Availability of dsRNA trigger 
 It is clear from the strong systemic response to RNAi in C. elegans that silencing RNAs are 
spread between cells and tissues. Although much has been learnt from the identification of SID and 
RSD mutants many aspects of the mechanisms involved in intercellular spread remain poorly 
understood. What is known about the proteins required for an effective systemic response suggests 
there may be several mechanisms of import, export and transport involved.   
 dsRNA dosage at the receiving cells depends on both the initial exposure/uptake and the 
efficiency of delivery to the effector cell.  Although in many cases a relatively small amount of initial 
dsRNA trigger is need to trigger the RNAi response due to the efficient amplification mechanism, 
initial dosage is none the less an important factor in the strength of response, with a higher dose of 
dsRNA leading to a stronger response via all methods of induction.   
 Could the altered RNAi response of the IP3 signalling mutants be explained by alterations in 
exposure to dsRNA trigger?  In the case of RNAi by feeding increased environmental uptake of 
dsRNAs, either by increased consumption of bacteria, the amount of time bacteria spend in the gut, 
or increased expression of SID-2 could lead to a higher dosage of dsRNA being delivered to the 
intestinal cells and therefore a stronger RNAi response.  itr-1 mutants are constipated due to reduced 
IP3 signalling leading to a lengthened defection cycle (Dal Santo et al., 1999; Espelt et al., 2005; 
Teramoto and Iwasaki, 2006) and are also slower to develop such that the time period of exposure to 
dsRNA when measuring KD of a developmental gene is slightly lengthened.  However these 
possibilities were investigated by Nagy et al. and mutant animals with similar defecation and growth 
phenotypes to itr-1 were not found to  have an increased RNAi response (Nagy et al., 2015).  
Consistent with this the growth and defecation phenotypes seen in egl-8 mutants are milder than 
those seen in egl-8 mutants but the enhancement to the RNAi response is comparable.  The 
canonical egl-30, egl-8, itr-1 signalling pathway regulates pharyngeal pumping, with loss of function 
of any of these genes leading to reduced feeding.  Differences in feeding therefore cannot explain 
the enhanced response to RNAi by feeding seen in itr-1, and egl-8 lof mutants.  Therefore whilst it is 
important to consider the effect which defection and growth phenotypes may have, when combined 
with the reduced feeding seen in itr-1 mutants, and more mildly in egl-8 mutants the dosage of 
dsRNA to which egl-8 and itr-1 mutants are likely to be exposed to remains lower than would be 
expected for e WT animal.  Furthermore changes in feeding, defecation or environmental uptake of 
dsRNA from the gut are clearly insufficient to explain the enhanced RNAi phenotype of egl-8 and itr-1 
mutants since this is also seen in response to other methods of induction, such as transgene 
expression.  
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 SID-2 is a dsRNA receptor found in membranes facing the intestinal lumen. It is only required 
for the initiation of RNAi by feeding where is actively transports long dsRNAs from the lumen to the 
intestinal cells. (Hunter et al., 2006; McEwan et al., 2012; Winston et al., 2007).  SID-2 dependent 
uptake is dependent on the PH of the lumen and is likely by endocytosis. Increased expression of SID-
2 would increase uptake and therefore increase the response to RNAi by feeding.  However, a change 
in SID-2 expression would not explain the increased response of IP3 and egl-8 mutants, and 
decreased response of ipp-5 mutants to dsRNA introduced by injection or transgene expression.  This 
phenomenon cannot then be explained as a simple dosage effect. 
 Efficient systemic response by any method of induction requires export from the donor cell, 
stable transport through the pseudocoelom and import to the recipient cell.  Changes to any one of 
these stages could alter the dosage of RNA trigger received. The most likely conduit for the spread of 
RNA species around C. elegans is the pseudocoelom or PC, a fluid filled intercellular space.  The 
relatively low abundance of initial trigger needed and dependence on amplification and secondary 
siRNA production for a strong response might logically lead to the suggestion that siRNA species 
might be transported.  However, experimental evidence points instead to dsRNAs being the main 
mobile species in C. elegans, with amplification occurring as a downstream event within the recipient 
cell where silencing is occurring.  
 By studying the silencing response in different RNAi mutants with mosaic rescue, Jose, Garcia 
and Hunter (Jose et al., 2011) found that long dsRNA and at least one other species of dsRNA is 
transported intercellularly.  This second species is an intermediate in the production of the mature 
siRNA, having already been processed by DCR-1 (dicer), the long dsRNA binding protein RDE-4 and 
the nucleotidyl transferase MUT-2/RDE-3 before export, bypassing the requirement for these 
proteins in the receiving cell (Jose et al., 2011).   RDE-4 is required for recruitment of dicer whilst, 
MUT-2 modifies the RNA. The RDE-4 and MUT-2/RDE-3 mutants display an interesting third tissue 
rescue phenotype, whereby rescuing expression in tissues containing neither the donor not receiving 
cell can rescue the defects in the RNAi pathway.  Presumably this is mediated by the export of dsRNA 
from the donor cell, import and processing into short dsRNA in the tertiary cell, re-export and import 
into the recipient cell to initiate silencing.  The ways in which RNAs are recruited to become mobile 
RNAs and if they are specifically modified for this purpose are unknown.   
 Efficient delivery of sufficient dsRNA trigger to each cell is therefore an important step in 
initiating robust silencing.  Mutants which cause changes to export from the donor cells or uptake 
into the recipient cell alter the efficacy of the systemic RNAi response.  One key protein for an 
efficient systemic RNAi response in C. elegans, regardless of the initiation method, is SID-1. SID-1 is 
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an integral membrane channel, strongly selective for dsRNA.  The selectivity of SID-1 for dsRNA 
supports the finding that transport of single stranded small RNA species, such as the active siRISC 
bound siRNA or secondary siRNAs, is unlikely to be contribute to the systemic RNAi response in C. 
elegans. SID-1 is not required for export of dsRNA from donor cells into the pseudocoelom but is 
required for entry into the recipient cells, an in particular entry into the cytosol (either from vesicles 
or external). Evidence of a length bias in SID-1 transport is mixed, with some studies finding some 
selectivity for longer dsRNAs whilst other studies suggest no selectivity, and even a faster rate of 
shorter dsRNA transport in vitro (Jose et al., 2009; Li et al., 2015; Shih et al., 2009; Winston et al., 
2002).  Loss of function of SID-1 leads to a complete loss of systemic RNAi.  SID-1 is expressed in the 
PM of most cells in C. elegans with the notable exception of neurones. This lack of SID-1 expression is 
a limiting factor in the RNAi response to neuronal genes, since overexpression of  SID-1 in neuronal 
cells can overcome the natural tendency of neurones to be refractory to RNAi (Calixto et al., 2010). 
IP3 signalling mutants also display enhanced response to neuronal RNAi, however this phenotype is 
also seen in the classical Eri mutants.  Regardless of the low or absent SID-1 expression in neurones 
some dsRNA must be able to enter cells and initiate a response in mutants where cells are more 
sensitive.  Whist SID-1 expression is important for an effective systemic RNAi response SID-1 
transport from the PC directly into the cytosol is not the only dsRNA import pathway.  Changes to 
SID-1 expression are therefore one way in which sensitivity to RNAi can be altered.  Interestingly 
enhancing SID-1 expression in neurones was found to cause a reduced RNAi phenotype more 
generally. This is thought to be due to the increase uptake RNA into cells overexpressing SID acting as 
a sink for dsRNA, reducing the availability of dsRNA to be taken up by other cells (Calixto et al., 2010).  
 Studies of the requirements of SID-1 in parental RNAi demonstrate multiple functional roles.  
In the embryo, the yolk protein receptor RME-2 functions in dsRNA import, with RAB-7, SID-5 and 
SID-1 needed for trafficking and release into the cytosol from the endosome (Wang and Hunter, 
2017).  
  Trafficking and localisation within the endomembrane system is clearly an important part of 
the RNAi response.  RSD-3 is an epsinR homologue which localises to the trans-golgi network and is 
thought to be required for endocytosis of dsRNAs via clathrin coated vesicles (Imae et al., 2016).  SID-
5 seems to be expressed in all tissues where it localises to the late endosome. SID-5 is required for 
export of dsRNAs from donor cells and it is also hypothesised to mediate the release of RNA from 
endosomes into the cytosol  (Hinas et al., 2012).  Loss of SID-5 leads to loss of the systemic RNAi 
response whilst loss of the endomembrane protein SEC-22 leads to an enhanced RNAi response 
(Zhao et al., 2017).  SID-3 is an effector protein Kinase, homologue of mammalian ACK1.  Like ACK1 in 
mammals, SID-3 regulates actin dynamics downstream of CDC42 (Lažetić et al., 2018).  
159 | C h a p t e r  6  –  Discussion- How Does IP3 signalling regulate the RNAi response? 
 
159 
 
 How dsRNAs are recruited or modified to become mobile is poorly understood, as is the way 
in which they are transported between cells.  Changes to the efficiency of transport of the mobile 
dsRNA responsible for the spread of silencing is therefore a possible way in which the systemic RNAi 
response could be modulated.  dsRNAs appear to be stable in the extracellular environment of the 
pseudocoelom but how this is achieved is unknown.  Regulation of the stability of mobile dsRNAs is 
another possible point of control which could be influenced by IP3 signalling.   
 
6.2.iii  Changes to the RNAi sensitivity at the level of the effector cell 
 Many of the proteins identified from mutant screens for enhanced RNAi- the classical Eri 
mutants - are now thought to form part of the ERI complex, the core set of biogenesis factors 
required for 26G siRNA production.  Whilst some ERI complex components are required for both 
endogenous and exogenous small RNA production such as DCR-1, DRH-3 and RDE-4, other  
components including the RdRP  RRF-3, exonuclease ERI-1 and Tudor domain proteins ERI-5 and ERI-
3 are only required in endo- siRNA production (Pavelec et al., 2009). Loss of function of these 
components compromises the endogenous siRNA pathway but leads to an enhanced sensitivity to 
exogenous dsRNA.  The competition model postulates that the lack of, for example RRF-3, makes 
components such as DRH-3, DCR-1, and RDE-4 more available to process exo-dsRNA.  This suggests a 
finely balanced antagonism between the endogenous and exogenous RNAi pathways where 
influencing the availability of siRNA biogenesis factors could regulate efficiency of both pathway 
(Zhuang and Hunter, 2012).  22G siRNAs produced downstream of both the endogenous and 
exogenous RNAi pathways are also likely to compete for binding to secondary argonautes.  
Competition also differs between tissues. Of the eri-1, rrf-3, eri-3, eri-5, eri-6/7, eri-8, eri-9 and eri-11 
mutants, not all show an enhanced RNAi phenotype in all tissues and the degree of enhancement 
differs by both strain and tissue.  Interestingly all 8 of these mutants show strong somatic maternal 
rescue of the Eri phenotype in response to dpy-13, unc-73 and hmr-1 RNAi,  but not of the 
spermatogenesis defects shared by eri-1, rrf-3 and eri-3 mutants (Zhuang and Hunter, 2011).  The 
ability for Eri defects to be maternally rescued demonstrates that either the maternal contribution to 
the embryo includes either the Eri components themselves or the 26G siRNAs in sufficient quantities 
to compete with the exo-siRNA pathway and restore the balance of competition to WT levels.   
 Beyond its role in the ERI complex the RNA exonuclease Eri-1 is thought to further antagonise 
the exogenous RNAi pathway by degrading exo-siRNAs and miRNAs.  Eri-1 is widely expressed but is 
particularly strongly expressed in the gonad and in neurones, where RNA degradation is thought to 
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contribute to the low sensitivity of these cells to RNAi (Kennedy et al., 2004).  Reduction in Eri-1 is 
another way in which RNAi sensitivity can be increased (Jadiya and Nazir, 2014).  
 Following primary siRNA biogenesis, the amplification of silencing through the production of 
secondary siRNAs is a further point of potential regulation.  Mutants including RDE-10, RDE-11, RSD-
6, RSD-4 and HAF-6 are compromised in this stage and exhibit a far weaker RNAi response. RSD-6 and 
RSD-4 were originally thought to be defective in the spread of silencing due to their ability to respond 
to RNAi by injection but not to feeding.  However, a better understanding of the stages in the RNAi 
pathway has allowed this to be refined. Mutants defective in the amplification of silencing are can be 
described as dosage sensitive since the much higher dosage of dsRNA provided by injection rather 
than feeding allows these silencing defects to be overcome (Han et al., 2008; Zhang et al., 2012). 
 A further set of enhanced RNAi mutants belong to the synMUVB class of mutants and form 
part of the Rb complex (Ceron et al., 2007; Lehner et al., 2006).  These include lin-35/Rb and lin-15b.  
The Rb complex is a transcriptional repressor but the precise mechanisms by which lin-35/Rb 
regulates RNAi is still poorly understood.  In part it may be due to the misregualtion of normally 
germline restricted genes for RNAi such as the RdRP ego-1 (Wu et al., 2012).  EGO-1 functions in 
place of RRF-1 in the RdRP module for secondary siRNA production in the germline, possibly allowing 
for increased production of secondary siRNAs in the soma of Lin-35 mutants.  Consistent with this the 
Nuclear RNAi response which is dependent of secondary siRNA production is enhanced in LIN-35 
mutants. The time sensitive window during which dsRNA exposure is needed to trigger nuclear RNAi 
is also relaxed in LIN-35 mutants (Shiu and Hunter, 2017).  Similarly to the classical Eri mutants, 
maternal rescue of lin-35/Rb  reduces RNAi hypersensitivity (Massirer et al., 2012).  
 In the analysis of the itr-1 small RNA seq library I identified the miR-35-41 miRNA family as 
mildly enhanced compared to N2 worms.  miR-35-41 regulates lin-35 expression and deletion of mir-
35-41 results in an enhanced RNAi phenotype (Massirer et al., 2012).  This therefore suggested a 
possible link between IP3 signalling and the regulation of the exo-RNAi response via the miR-35-
41/lin-35 pathway.  However, qPCR failed to detect and changes in lin-35 transcript levels and whilst 
there are a number of reasons why this could be the case (as discussed in chapter 4) the endomitotic 
phenotype of itr-1 mutants is a more likely source of the changes in miR-35-41 expression seen.  IP3 
signalling cannot be acting via the same route as either Rb complex mutants (lin-35, lin-15b) or eri-1 
to regulate the RNAi response, since the very strongly enhanced RNAi response of the eri-1(mg366); 
lin-15b(n744)  double mutant is further enhanced in the eri-1(mg366); lin-15b(n744); egl-8(e2917) 
triple mutant.  Therefore, IP3 signalling must be regulating RNAi sensitivity by another mechanism.   
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 As already discussed the lack of any significant changes to endo-siRNAs profile detected seen 
in the small RNA seq experiment make it unlikely that IP3 signalling down regulates the endo siRNA 
pathway, increasing availability of resources to be redirected to the exo-siRNA pathway.  The up 
regulation of secondary siRNA production or the up regulation of core components of the exo-RNAi 
pathway in response to reduced IP3 signalling both remain possibilities. As discussed, this could be 
tested by the sequencing and comparison of 5’ dependent and 5’ independent small RNA libraries 
from WT and IP3 signalling mutant worms treated with RNAi against an endogenous target gene.   
 Correct trafficking on dsRNAs within the endomembrane system is likely to be important for 
both the export of mobile dsRNA and the import of dsRNAs for siRNA production.  Correct sub-
cellular localisation of siRNAs and components of the siRICS is also is also likely to be important for an 
efficient silencing response, although much about the subcellular localisation of siRNA processing 
remains poorly understood.  In mammalian cells the Rough ER has been shown by Stalder et al. to be 
the major site of siRISC loading and silencing.  They also showed that whilst subcellular organisation 
is important for the efficiency of RNAi response it is not essential for silencing- disruption of loading 
of the siRISC at rER by depletion of components of the RISC-loading complex makes the slows 
silencing, as does nocodazole treatment.  Whilst perturbation of ante-retrograde transport with 
brefeldin A leads to accumulation of products in ER and increased RNAi efficiency (Stalder et al., 
2013).  The ER is also the largest store of intracellular calcium, and therefore the location of many 
calcium channels including the IP3 receptor.  What is more, the dynamic structure of the ER is a key 
aspect of cell function, changing with cell state and in response to intracellular signals, including in 
response to calcium signalling (reviewed (Schwarz and Blower, 2016)).    
 The insulin-like signalling pathway regulates response to stress and longevity in C. elegans via 
the regulation of transcription factor DAF-16.  Loss of function of the insulin-like receptor DAF-2 or 
the downstream PI3-kinase AGE-1 results in an enhanced RNAi response which is not seen in the 
absence of DAF-16 function (Wang and Ruvkun, 2004).  How the many DAF-16 regulated changes in 
gene expression lead to changes in RNAi response is unknown, however since DAF-16 regulated 
processes include the dauer response which is dependent on the endogenous siRNA pathway, this 
regulation may not be specific to the exo-RNAi response (Bharadwaj and Hall, 2017).   
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6.2.iv  Role of the intestine in regulating RNAi 
 Despite its small cell number, the C. elegans intestine is not merely a primitive digestive 
system but a complex factory of many overlapping roles.  These include acting as a protein factory for 
the production and export of yolk proteins for the oocytes, as a signalling hub for the regulation of 
various physiological processes, and as the interface between the worm and the surrounding world.  
All three of the Caenorhabditis virus so far discovered  target intestinal cells (Félix and Wang, 2019).  
 Rescuing IP3 signalling in the intestine by expression of WT itr-1 from the well characterised 
intestinal specific promoter vha-6p is sufficient to rescue the RNAi phenotype systemically, restoring 
the WT RNAi response in other tissues. This is seen not only in response to RNAi by feeding but also 
in response to dsRNAs produced intracellularly.  Complete rescue of the RNAi response was 
demonstrated for GFP silencing in neurones, in response to RNAi by feeding and in both the BWM 
and the pharynx, in a transgenic system whereby dsRNA is produced from a transgene in the 
pharynx, and partially rescue was seen in response to lin-1 RNAi by feeding.  
 Therefore, the best evidence for the site of action of the IP3 signalling pathway regulating 
RNAi sensitivity is that it is acting non-cell autonomously in the intestine.  Since the effects of itr-1, 
egl-8 and ipp-5 mutants are seen not only in response to RNAi by feeding, these effects cannot be 
explained by the regulation of the import of dsRNA from the intestine. However, several other 
possibilities remain open.  I propose four hypotheses for how IP3 signalling in the intestine could be 
exerting a systemic effect on RNAi.  
 
6.2.v  Hypotheses for the role of IP3 signalling in the regulation of RNAi 
1- Oocyte provisioning 
Given the role of the intestine in the production of yolk proteins for oocyte provisioning, the role 
demonstrated for the yolk protein receptor RME-2 in the entry of dsRNAs into the embryo, and the 
maternal rescue phenotype seen in several Eri mutants, the possibility that IP3 signalling could be 
regulating the RNAi response via oocyte provision should be considered.  Changes to maternal 
factors -the proteins or RNAs produced in the intestine and imported into the embryo- could lead to 
changes in the expression of components of the exo-RNAi pathway in the next generation, altering 
the sensitivity of the cells to respond to dsRNA.  In this case itr-1, egl-8 and ipp-5 mutants would be 
acting as maternal effect mutants.  This could be confirmed by maternal rescue experiments, 
involving crossing WT and IP3 signalling mutants. The temperature sensitive mutant itr-1(sa73) could 
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also be utilised be used If signalling occurs in the parent then embryos laid at 16 but raised at 20 will 
show a WT response.  
2- Intestinal sink 
 Enhancing sid-1 expression in neurones was found to cause a reduced RNAi phenotype more 
generally. This is thought to be due to the increase uptake RNA into cells overexpressing SID acting as 
a sink for dsRNA, reducing the availability of dsRNA to be taken up by other cells (Calixto et al., 2010).  
Could IP3 signalling in the intestine lead to changes in the expression of sid-1 which reduce or 
increase the availability of mobile dsRNAs for uptake by other cells?  If this were the case changes to 
RNAi sensitivity in the intestine would show the opposite pattern to other tissues.  This hypothesis is 
easily tested by assaying the response of itr-1, egl-8, ipp-5, and goa-1 mutants in response to RNAi of 
intestinal gene targets such as act-5, gtl-1, and ife-2.  
3- Changes to the stability or transport of mobile RNAs 
 Very little is known about factors which affect the stability of mobile dsRNA in the 
extracellular environment of the pseudocoelom, however the stability of these mobile RNAs is crucial 
for an effective systemic RNAi response.  It is conceivable that IP3 signalling in the intestine could 
regulate the secretion of RNA binding proteins, or RNases which influence the stability of mobile 
RNAs and therefore the systemic RNAi response.  If such stability factors are factors are required for 
the efficient transport of mobile RNAs through the extracellular space then I argue that the unique 
position of the intestine as the gateway of the environmental RNAi response would make this the 
most likely tissue to produce such factors.   
 In this hypothesis the enhanced RNAi phenotype of itr-1, egl-8 and goa-1 mutants is entirely 
mediated via changes to the systemic transport of mobile RNAs.  Counter to this idea is the 
observation that changes to GFP silencing in the pharynx of itr-1 and ipp-5 mutants is also seen when 
silencing is induced by dsRNAs expressed in that same tissue.  In this scenario a substantial 
proportion of the dsRNA produced would have to be exported to the pseudocoelom and reimported 
into cells of the same tissue, in order for changes to mobile RNA transport to influence silencing. 
However, there are reasons to think that this may be the case.  The ability of silencing to be rescued 
in rde-4 and mut-2 mutants by expression in a third tissue demonstrates that there must be sufficient 
long dsRNA exported from the donor cells, imported into the third tissue for processing by dicer, re-
exported as short dsRNAs and imported into the receiving cell in sufficient quantities to compensate 
for a lack of primary exo-siRNA production in the donor and recipient cells.  This implies a very active 
flow mobile RNAs between cells, and there is no a priori reason to assume that export of dsRNAs 
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should be any less prevalent when dsRNA is produced in the same cell as the target gene as in other 
scenarios.     
 The hypothesis that IP3 signalling is regulating changes to the stability or systemic transport 
of mobile RNAs could be tested in sid-1 mutant background.  If silencing of GFP in the pharynx in 
response to dsRNAs expressed in the same tissue is still enhanced in itr-1 mutants in a sid-1 null 
background, when no systemic spread of mobile RNAs can occur then IP3 signalling is not regulating 
the RNAi response via changes to the systemic spread of mobile RNAs. 
4- Humoral signal altering RNAi sensitivity in distal cells 
 Arguably the most likely scenario for how IP3 signalling in the intestine could alter the RNAi 
sensitivity of cells in other tissues is via the production of a humoral signal.  In response to this signal 
the RNAi sensitivity of receiving cells could be altered in a number of ways; changes to degradation 
or intracellular trafficking of exo-siRNAs, or dsRNA intermediates, changes to availability of core 
component of the exo-RNAi pathway involved in primary or secondary siRNA production.  For 
example the enhanced RNAi phenotype of Eri mutants such as RRF-3 suggests that components of 
the RdRP module responsible for secondary siRNA are a limited resource, increased expression of the 
RdRP module would therefore be expected to enhance production of secondary exo-siRNAs without 
compromising the endogenous siRNA pathway.  Such a model is consistent with the changes seen in 
the nuclear RNAi response of IP3 signalling mutants.  In this model it is possible that goa-1 is acting at 
the level of the receiving cell to regulate the response to the humoral signal.  
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Figure 6.3.  Possible models for the regulation of RNAi sensitivity by IP3 signalling in C. elegans.        
A- The anatomy of the alimentary canal and germline. Image Modified from Worm Atlas (wormatlas.org).               
B- Signalling in the intestine influences RNAi sensitivity in the other tissues.  This could be achieved by changes 
in efficiency of transport of mobile dsRNAs (2,3), or changes to the sensitivity of the receiving cell either in 
response to a humoral signal or changes in maternal factors (1,4).  
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6.3  Beyond C. elegans - Cell signalling regulating RNAi pathways  
 A growing body of evidence form studies in mammalian and other in neuronal systems 
suggests that the rapid regulation of miRNA levels is a key mechanism in neuronal plasticity.  In clear 
examples of cell signalling pathways altering gene expression via miRNA pathways,  several different 
studies have found that neuronal stimulation via diverse extracellular signals such as Serotonin, 
NmDA, mGluR and BDNF can lead to rapid degradation of specific miRNAs,  reversing transcriptional 
silencing and altering gene expression (reviewed (Fu et al., 2016)).  Fu, Shah and Baraban suggest 
that the miRNA system in itself could be thought of as a second messenger system, responding to 
extracellular stimuli to regulate gene expression.  This intriguing idea towards a more generalised 
and complex view of the cellular signalling pathways, reflecting the reactive and dynamic role small 
RNA pathway seem to play in regulating gene expression.  
 Brain derived neurotrophic-factor (BDNF) is a widely expressed secreted protein important 
for healthy brain function, including differentiation and neuronal plasticity.  BDNF stimulation of 
neurones in the hippocampus leads to BDNF dependent aborization via specific changes in gene 
expression to allow dendrite arborization which are regulated by rapid changes in miRNA activity.  
BDNF, signalling via a RTK/ MAPK signalling pathway regulates miRNA activity in two ways. Increased 
expression of miRNA maturation factors, dicer and TRBP, both part of the risc loading complex acts 
non-specifically to increase global miRNA production, thereby repressing the expression of a broad 
set of genes. This is accompanied by the simultaneous activation of the lin-28 pathway, leading to 
the specific degradation of let-7 family miRNAs and therefore increase translation of let-7 target 
transcripts.  Combination of global changes via altering dicer expression and specific changes. (Huang 
et al., 2012). 
 The process of long-term potentiation (LTP) in neurones, a form of synaptic plasticity, is 
known to be highly dependent on IP3 and Ca2+ signalling events.  The NMDA receptor is a ligand gated 
calcium channel and a major mediator of excitatory neurotransmission, whilst the mGluR receptor 
family are glutamate stimulated GPCRs, which can regulate calcium signalling via both Gαq activation 
of PLCβ and via interactions with NMDAR via a protein scaffold (reviewed (Willard and Koochekpour, 
2013)) .  Studies of LTP in the rat hippocampus found that activation of the NMDAR bidirectionally 
regulates changes to miRNAs associated with the Ago2-RISC.  NMDA signalling promotes decay of 
some mature miRNAs, whilst other miRNAs show increased expression and increased association 
with Ago2.  Group 1 mGluR signalling was also shown to alter miRNA expression during LTP.  
Expression of the primary miRNAs corresponding to the mature miRNAs which are downregulated in 
response to NMDAR signalling are upregulated by group 1 mGluR signalling (Pai et al., 2014; Wibrand 
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et al., 2010).  The direct mechanisms of this regulation are unknown, although NMDAR signalling has 
also been shown to alter P-body localisation and composition.  Interestingly blockade of NMDAR 
signalling is known to increase expression of the IP3 receptor in hippocampal neurones (Cai et al., 
2004), whilst group 1 mGluR receptors activate the Gαq/PLCβ/IP3 signalling cascade.  A role for IP3 
signalling in the regulation of miRNA expression in mammalian neurones is therefore likely.  
 One of the mechanisms through which signalling pathways have been shown to regulate 
small RNA levels in neuronal cells is via the translin/TRAX complex, or C3PO.  C3PO is an octameric 
RNase involved in small RNA processing.  Both the function and the constituent components, translin 
and closely related protein TRAX, of C3PO appear to be well conserved with homologues identified in 
yeast, flies and humans.  In human cell lines and  D. melanogaster translin/TRAX increases the rate of 
siRNA passenger strand degradation, promoting the formation of the active RISC in the exo-RNAi 
pathway (Liu et al., 2009).  In human cell lines translin/TRAX can also degrade pre-miRNAs by 
targeting mismatched stem bulges for cleavage (Asada et al., 2014), whilst in D. melanogaster C3PO 
also functions in passenger strand cleavage in the endo-siRNA pathway (Liu et al., 2019).  
 Very interestingly a direct interaction between PLCβ and C3PO has been shown by to be 
involved in the regulation of both the exo-siRNA and miRNA pathways in mammalian neuronal cell 
lines (Aisiku et al., 2010; Philip et al., 2012, 2013).  In mammalian systems there are 4 PLCβ genes, 
with further alternative isoforms. Whilst Gαq localisation appears to be limited to the PM, together 
with the majority of PLCβ, a significant proportion of PLCβ is also localised to the cytosol and the 
nucleus.  In an attempt to identify potential alternative activators or biding partners of cytosolic PLCβ 
Aisiku, Runnels and Scarlata carried out a yeast two hybrid screen using the C terminal helical domain 
of PLCβ1 as bait.  This screen identified C3PO component TRAX as a high affinity binding partner of 
PLCβ1, an association verified in vivo, where cytosolic PLCB colocalises with C3PO (Aisiku et al., 
2010).  Furthermore, TRAX and competes with Gαq for binding of PLCβ. Overexpression of TRAX 
leads to a reduction Gαq/ PLCβ signalling as demonstrated by a reduction in both PIP2 hydrolysis and 
Ca2+ signalling following stimulation.  Conversely overexpression of Gαq leads to a reduction in 
cytosolic PLCβ expression.  The result of PLCβ interaction with C3PO is to reduce the rate of 
hydrolysis of the passenger strand of exo-siRNAs, leading to a reduction in siRNA activity.  This 
reduction in catalytic activity appears to be specific to rapidly hydrolysed siRNA, with changes in 
Gαq/PLCβ signalling only affecting the RNAi of some genes (Philip et al., 2012, 2016; Sahu et al., 
2014).  PLCβ regulation of trax also has endogenous roles, regulating the expression of some miRNAs 
and in the regulation of cell cycle progression.  In PC12 cells PLCβ/TRAX was found to associated with 
different CDKs at different points of cell cycle to regulate progression (Scarlata et al., 2016, 2018).  A 
direct role for PLCβ1 and PKCα in the control of erythropoiesis via the regulation of miR210 levels has 
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also been demonstrated.  MTH induced erythroid differentiation is inhibited by enhanced PLCβ 
signalling or decreased PKCα, leading to a loss of miR-210 expression via an unknown mechanism 
(Bavelloni et al., 2014).  
 Whilst this connection between G-protein signalling, PLCβ and RNAi is intriguing, neither 
components of the C3PO heteromer, TRAX and translin appear to be present in C. elegans.  Despite a 
seemingly well conserved role for the translin/TRAX (C3PO) complexes from human to drosophila no 
role for translin/TRAX complexes in RNAi has been reported in C. elegans and neither translin nor 
TRAX homologues have been identified in the C. elegans genome. Consistent with this, I carried out 
blast searches which failed to find a likely homologue despite translin/TRAX homologues being 
present in many non-mammalian lineages, including other nematodes.  Further, in this system the 
binding of PLCβ to TRAX in the cytosol, rather than to G-proteins at cell membrane, would lead to a 
reduction in both IP3 production and the RNAi response, the opposite of the pattern seen in C. 
elegans.   
 Despite the apparent lack of direct translatability of this mechanism of regulation to C. 
elegans, this does highlight the potential role of non-canonical interactions in the regulation of cell 
signalling or RNAi.  In particular, the competition for binding of PLCβ between Gαq and TRAX seen 
here leads to PLCβ and its canonical activator Gαq acting in opposition in the regulation of RNAi.  In 
the case of PLCβ/TRAX signalling is not occurring via IP3 production, however this none the less 
demonstrates that the interactions between Gαq and PLCβ are not limited to the roles of activator 
and effector but can and are utilised in more complex systems of regulation.  Could a similar 
competitive binding model account for the difference in the roles of egl-8 and egl-30 in RNAi 
regulation in C. elegans?  In such a model goa-1 or the GBγ subunit from a goa-1 heterotrimeric G-
protein could directly compete with egl-30 for the binding and activation of egl-8.  
 In plants, a number of cellular regulators of RNAi have been identified including the 
conserved protein AtRLI2, and calmodulin-like protein rgs-CaM (regulator of gene silencing–
calmodulin-like protein).  AtRLI2 and its mammalian homologue ABCE1 (ATP-binding cassette sub-
family E member 1) have multiple conserved functions in RNA processing and also both act as 
suppressors of RNAi.  Furthermore, overexpression of human ABCE1 from the myo-3 promoter in C. 
elegans inhibits GFP RNAi in the BWM (Kärblane et al., 2015).  Several virally encoded suppressors of 
PTGS have been identified in plants.  A search for plant proteins which interact with one such 
suppressor identified the Calmodulin related proteins rgs-CaM, and rgs-CaM itself was found to act 
acts as a suppressor of RNAi (Anandalakshmi et al., 2000).  As a calmodulin-like proteins rgs-CaM 
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contains multiple EF-hand calcium binding domains, demonstrating a direct link between calcium 
signalling and control of RNAi in plants.  
 
6.2.4  Why regulate the RNAi response? 
 Whether by the production of a humoral signal to regulate the RNAi response throughout 
the organism, or by an alternative mechanism, such a change would be expected to be carefully 
regulated and could be acting in response to physiological or environmental factors.  However, 
speculation of what such an upstream stimulus is likely to be is hampered by the poor understanding 
of the endogenous roles of the exogenous RNAi response.  The RNAi response is an important 
antiviral defence, not only in C. elegans but in plants and other animals.  In C. elegans mammalian 
RIG-1 homologue DRH-1 is essential for initiation of the antiviral response but is dispensable for RNAi 
(Ashe et al., 2013). This implies that there may be endogenous roles of exo-RNAi beyond an antiviral 
response.  Environmental RNAi is clearly not an accidental side-effect of the systemic transport of 
endogenous dsRNAs, since it relies on the expression and localisation of the specialised dsRNA 
transported SID-2 in cell membranes facing the intestinal lumen.  Understanding the reasons for 
environmental RNAi may shed light on why and when regulation of the RNAi response is required.   
 There has been speculation about the potential for silencing RNA species themselves to act 
as messengers at the intracellular, intercellular, and even transgenerational level.  The systemic 
nature of the RNAi response allows dsRNAs to transmit information about the state of one cell to, 
other cells in the organism, where it influences the expression of genes in that cell in response – 
essentially acting as a humoral signal. miRNAs have been shown to act as intercellular signals in 
plants and the detection miRNAs in extracellular fluids in mammals, has led to the suggestion that 
they may also do so in animals.  As with other signals there must be careful regulation not only at the 
level of the producing cell but at the level of the receiving cell, which must be competent to interpret 
that signal and respond correctly.   
 In conclusion the negative regulation of an IP3 signalling pathway in C. elegans results in a 
systemic enhancement of RNAi response, whilst increased IP3 signalling results in resistance to RNAi.  
This response appears to be specific to the exogenous RNAi pathway since no changes were detected 
in the endogenous small RNA profiles of itr-1 mutants.  Counter to the canonical model of PLCβ egl-8 
activation by Gαq homologue egl-30, the Gαi/o homologue goa-1 is proposed to act as the upstream 
activator of PLCβ egl-8, with possible negative regulation by egl-30.  This signalling pathway most 
likely acts in the intestine to regulate RNAi sensitivity systemically, either through changes tot eh 
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efficiency of transport of mobile RNAs or through changes to sensitivity of distal cells to these mobile 
RNAs, either in response to a humoral signal in the adult worm or though changes in gene expression 
in the adult worm resulting from maternal factors.  
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